The DOI matches its Crossref record; 350 of the 351 references it cites were found in a registry or an index; none of the 473 sources its claims cite is checked for support yet.
Intracellular Iron Transport and Storage: From Molecular Mechanisms to Health Implications
Open accessAbstract
Maintenance of proper "labile iron" levels is a critical component in preserving homeostasis. Iron is a vital element that is a constituent of a number of important macromolecules, including those involved in energy production, respiration, DNA synthesis, and metabolism; however, excess "labile iron" is potentially detrimental to the cell or organism or both because of its propensity to participate in oxidation-reduction reactions that generate harmful free radicals. Because of this dual nature, elaborate systems tightly control the concentration of available iron. Perturbation of normal physiologic iron concentrations may be both a cause and a consequence of cellular damage and disease states. This review highlights the molecular mechanisms responsible for regulation of iron absorption, transport, and storage through the roles of key regulatory proteins, including ferroportin, hepcidin, ferritin, and frataxin. In addition, we present an overview of the relation between iron regulation and oxidative stress and we discuss the role of functional iron overload in the pathogenesis of hemochromatosis, neurodegeneration, and inflammation.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This review synthesizes molecular mechanisms controlling intracellular iron transport and storage, emphasizing ferroportin, hepcidin, ferritin, and frataxin, and links dysregulation to hemochromatosis, neurodegeneration, and inflammation. It argues that labile iron must be tightly controlled because iron is essential but can drive Fenton chemistry and oxidative damage.
Key findings
- Iron is essential for oxygen transport, oxidative phosphorylation, DNA biosynthesis, and xenobiotic metabolism, but excess labile iron generates reactive oxygen species via the Fenton reaction; ∼25 mg of iron is needed daily for erythropoiesis and other vital functions, while only 1 to 2 mg comes from intestinal sources, making storage and recycling critical.
- Ferritin is the major iron-storage protein: it consists of 24 heavy and light subunits and can sequester 4,500 iron atoms; the H subunit has ferroxidase activity that converts Fe2+ to Fe3+ for storage, and cytoplasmic, mitochondrial, nuclear, and serum ferritin forms have distinct features.
- Ferroportin is the only known iron exporter; hepcidin negatively regulates it by binding and triggering internalization and degradation. Hepcidin is a 25-amino-acid peptide whose expression is increased by iron and inflammation and decreased by hypoxia and anemia.
- Frataxin deficiency causes Friedreich ataxia, most commonly (96% to 98%) from homozygous GAA repeat expansion; prevalence is estimated at 1 in 50,000 among whites, with normal individuals having fewer than 35 repeats and patients ranging from 100 to >1,000 repeats. Frataxin is involved in iron–sulfur cluster biosynthesis, heme synthesis, and mitochondrial iron homeostasis.
Methods
- Narrative review; no primary experiments are reported. The paper synthesizes published literature on intracellular iron transport, storage, regulation, and disease.
- It covers molecular mechanisms including transferrin/transferrin receptor, DMT1, ferroportin, hepcidin, ferritin, and frataxin, and discusses hereditary hemochromatosis types 1–4, neurodegeneration, and inflammation.
- Main analysis is qualitative integration of cited studies, tables, and models; no systematic search strategy or meta-analysis is described.
Limitations
- Stated: many mechanisms remain unclear, including the exact function of HFE in TfR1 regulation, how C/EBPα participates in global iron sensing and hepcidin regulation, crosstalk between lysosome- and proteasome-mediated ferritin degradation, sources and physiologic function/regulation of serum ferritin, and whether oxidative damage is tightly associated with FRDA pathophysiology.
- Evident: as a narrative review, it lacks systematic search/inclusion criteria and quantitative synthesis; conclusions depend on cited literature and may reflect selection or interpretation bias.
- Evident: no primary data or new experimental validation are presented; disease associations are largely correlative.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
381 Not checked yet · 20 Own interpretation · 15 No basis given · 1 Own result
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Likewise, an excess of iron systemically and at the cellular level leads to deleterious effects including free radical-induced damage to cells, cellular components, tissues, and organs.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Deviations from normal iron levels have been indicated in the pathogenesis of aging, neurodegenerative disease, cancer, and infection (18, 23, 156, 180, 299, 334).”
What the sources say
- Not checked yetcites [18] Beard J. Iron deficiency alters brain development and functioning. J Nutr. 2003;133:1468S–1472S. doi: 10.1093/jn/133.5.1468S. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [23] Bishop GM. Robinson SR. Liu Q. Perry G. Atwood CS. Smith MA. Iron: a pathological mediator of Alzheimer disease? Dev Neurosci. 2002;24:184–187. doi: 10.1159/000065696. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [156] Kaur D. Andersen J. Does cellular iron dysregulation play a causative role in Parkinson's disease? Ageing Res Rev. 2004;3:327–343. doi: 10.1016/j.arr.2004.01.003. [DOI] [PubMed] [Google Scholar] source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“excess “labile iron” is potentially detrimental to the cell or organism or both because of its propensity to participate in oxidation–reduction reactions that generate harmful free radicals”
- Also stated in: § I. Introduction · plain
“This propensity to undergo oxidation-reduction reactions is also responsible for the toxicity of iron (229).”
What the sources say
- Not checked yetcites [229] Papanikolaou G. Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol. 2005;202:199–211. doi: 10.1016/j.taap.2004.06.021. [DOI] [PubMed] [Google Scholar] source
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § I. Introduction · plain
None of the sources cited for this claim have been checked yet.
In the paper
“Iron binding and release are coordinated by a conformational change in which the two subdomains of each lobe open, and the N1, N2, C1, and C2 domains twist (114, 115).”
What the sources say
- Not checked yetcites [114] Grossmann JG. Neu M. Evans RW. Lindley PF. Appel H. Hasnain SS. Metal-induced conformational changes in transferrins. J Mol Biol. 1993;229:585–590. doi: 10.1006/jmbi.1993.1063. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [115] Grossmann JG. Neu M. Pantos E. Schwab FJ. Evans RW. Townes-Andrews E. Lindley PF. Appel H. Thies WG. Hasnain SS. X-ray solution scattering reveals conformational changes upon iron uptake in lactoferrin, serum and ovo-transferrins. J Mol Biol. 1992;225:811–819. doi: 10.1016/0022-2836(92)90402-6. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In nonintestinal cells, circulating iron is bound to transferrin (Tf) and is imported via receptor-mediated endocytosis after binding to the transferrin receptor (TfR) (249).”
What the sources say
- Not checked yetcites [249] Ponka P. Beaumont C. Richardson DR. Function and regulation of transferrin and ferritin. Semin Hematol. 1998;35:35–54. [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Only 1 to 2 mg of iron comes from intestinal iron sources; thus, other mechanisms for iron regulation, including release of iron from cellular storage depots and recycling of iron from protein sources, are critically important to provide for organismal iron requirements.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Each day approximately 25 mg of iron is needed for erythropoiesis and other vital functions, while only 1 to 2 mg comes from intestinal iron sources.
In the paper
“Tf is also involved in the transport of iron from reticuloendocytic cells [red blood cell (RBC) recycling] and the liver to proliferative cells throughout the body, thereby controlling the levels of “labile iron” (293).”
What the sources say
- Not checked yetcites [293] Thorstensen K. Romslo I. The role of transferrin in the mechanism of cellular iron uptake. Biochem J. 1990;271:1–9. doi: 10.1042/bj2710001. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Because Tf and TfR are absent from enterocytes, Tf binds iron and plays an essential role in the transport of iron only once it is exported from duodenal enterocytes into the bloodstream.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Tf and TfR are absent from enterocytes.
In the paper
“The promoter of TfR1 contains a hypoxia-responsive element (HRE) within a 100-bp sequence located upstream of the transcription start site (190).”
What the sources say
- Not checked yetcites [190] Lok CN. Ponka P. Identification of a hypoxia response element in the transferrin receptor gene. J Biol Chem. 1999;274:24147–24152. doi: 10.1074/jbc.274.34.24147. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Both IRP1 and IRP2 are activated by iron-deficient conditions, leading them to bind the target IREs (130).”
What the sources say
- Not checked yetcites [130] Hentze MW. Kuhn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci U S A. 1996;93:8175–8182. doi: 10.1073/pnas.93.16.8175. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Tf bound with iron releases iron at acidic pH because of major conformational changes including a 54- to 63-degree rotation between the two domains on each lobe (103).”
What the sources say
- Not checked yetcites [103] Gerstein M. Anderson BF. Norris GE. Baker EN. Lesk AM. Chothia C. Domain closure in lactoferrin: two hinges produce a see-saw motion between alternative close-packed interfaces. J Mol Biol. 1993;234:357–372. doi: 10.1006/jmbi.1993.1592. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“TfR1 mRNA contains five iron-regulatory elements (IREs), which convey posttran-scriptional regulation of expression by cellular iron concentration (41).”
What the sources say
- Not checked yetcites [41] Casey JL. Hentze MW. Koeller DM. Caughman SW. Rouault TA. Klausner RD. Harford JB. Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science. 1988;240:924–928. doi: 10.1126/science.2452485. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“As shown in Fig. 1, once Fe-Tf is bound to TfR1, the complex is endocytosed into the cell in an acidic endosome.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“When iron levels exceed the binding capacity of the available Tf, free circulating iron may be available as non-Tf-bound iron (NTBI).”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“TfR2 has a lower affinity for Fe-Tf than does TfR1 (160, 320).”
What the sources say
- Not checked yetcites [160] Kawabata H. Yang R. Hirama T. Vuong PT. Kawano S. Gombart AF. Koeffler HP. Molecular cloning of transferrin receptor 2: a new member of the transferrin receptor-like family. J Biol Chem. 1999;274:20826–20832. doi: 10.1074/jbc.274.30.20826. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [320] West AP Jr. Bennett MJ. Sellers VM. Andrews NC. Enns CA. Bjorkman PJ. Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE. J Biol Chem. 2000;275:38135–38138. doi: 10.1074/jbc.C000664200. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“TfR2 is primarily expressed in hepatocytes and in the iron-absorbing cells of the intestine and duodenum (35).”
What the sources say
- Not checked yetcites [35] Camaschella C. Roetto A. De Gobbi M. Genetic haemochromatosis: genes and mutations associated with iron loading. Best Pract Res Clin Haematol. 2002;15:261–276. doi: 10.1016/s1521-6926(02)90207-0. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“IRP binding to an IRE in the 5′ UTR blocks the assembly of the 43S translation preinitiation complex (112).”
What the sources say
- Not checked yetcites [112] Gray NK. Hentze MW. Iron regulatory protein prevents binding of the 43S translation pre-initiation complex to ferritin and eALAS mRNAs. EMBO J. 1994;13:3882–3891. doi: 10.1002/j.1460-2075.1994.tb06699.x. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“HFE-deficient mice developed severe iron overload and iron overload-related pathophysiology similar to that of humans with HH (336).”
What the sources say
- Not checked yetcites [336] Zhou XY. Tomatsu S. Fleming RE. Parkkila S. Waheed A. Jiang J. Fei Y. Brunt EM. Ruddy DA. Prass CE. Schatzman RC. O'Neill R. Britton RS. Bacon BR. Sly WS. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A. 1998;95:2492–2497. doi: 10.1073/pnas.95.5.2492. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“In in vitro studies in hepatoma, K562, and HeLa cells, hypoxic conditions resulted in twofold to threefold increased TfR1 mRNA expression (190, 295).”
What the sources say
- Not checked yetcites [190] Lok CN. Ponka P. Identification of a hypoxia response element in the transferrin receptor gene. J Biol Chem. 1999;274:24147–24152. doi: 10.1074/jbc.274.34.24147. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [295] Toth I. Yuan L. Rogers JT. Boyce H. Bridges KR. Hypoxia alters iron-regulatory protein-1 binding capacity and modulates cellular iron homeostasis in human hepatoma and erythroleukemia cells. J Biol Chem. 1999;274:4467–4473. doi: 10.1074/jbc.274.7.4467. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Recently, low levels of H2O2 were shown to increase TfR1 expression (8).”
What the sources say
- Not checked yetcites [8] Andriopoulos B. Hegedusch S. Mangin J. Riedel HD. Hebling U. Wang J. Pantopoulos K. Mueller S. Sustained hydrogen peroxide induces iron uptake by transferrin receptor-1 independent of the iron regulatory protein/iron-responsive element network. J Biol Chem. 2007;282:20301–20308. doi: 10.1074/jbc.M702463200. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Studies of TfR2 expression in a mouse model for hemochromatosis revealed that TfR2 was not downregulated in conditions of iron overload (90), supporting the absence of an iron-mediated posttranscriptional regulatory mechanism.”
What the sources say
- Not checked yetcites [90] Fleming RE. Migas MC. Holden CC. Waheed A. Britton RS. Tomatsu S. Bacon BR. Sly WS. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci U S A. 2000;97:2214–2219. doi: 10.1073/pnas.040548097. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A recent study suggests that the SLC39A zinc transporter, Zip14, may be involved in uptake of NTBI (188).”
What the sources say
- Not checked yetcites [188] Liuzzi JP. Aydemir F. Nam H. Knutson MD. Cousins RJ. Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci U S A. 2006;103:13612–13617. doi: 10.1073/pnas.0606424103. [DOI] [PMC free article] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Two molecules of Fe-Tf bind to the TfR homodimer on a conserved argi-nine-glycine-aspartate sequence located in the helical domain of TfR (75).”
What the sources say
- Not checked yetcites [75] Dubljevic V. Sali A. Goding JW. A conserved RGD (Arg-Gly-Asp) motif in the transferrin receptor is required for binding to transferrin. Biochem J. 1999;341:11–14. [PMC free article] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Treatment of HepB3 human hepatoma cells with an iron chelator, desferrioxamine, increased transcription of TfR1 (21).”
What the sources say
- Not checked yetcites [21] Bianchi L. Tacchini L. Cairo G. HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation. Nucleic Acids Res. 1999;27:4223–4227. doi: 10.1093/nar/27.21.4223. [DOI] [PMC free article] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Individuals with iron-overload disorders such as HH or β-thalassemia may have plasma NTBI in the micromolar range (144).”
What the sources say
- Not checked yetcites [144] Jacobs EM. Hendriks JC. van Tits BL. Evans PJ. Breuer W. Liu DY. Jansen EH. Jauhiainen K. Sturm B. Porter JB. Scheiber-Mo-jdehkar B. von Bonsdorff L. Cabantchik ZI. Hider RC. Swinkels DW. Results of an international round robin for the quantification of serum non-transferrin-bound iron: need for defining standardization and a clinically relevant isoform. Anal Biochem. 2005;341:241–250. doi: 10.1016/j.ab.2005.03.008. [DOI] [PubMed] [Google Scholar] source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In this manner, HFE appears to block Tf binding to TfR through direct competition for the same binding site (179).”
What the sources say
- Not checked yetcites [179] Lebron JA. West AP Jr. Bjorkman PJ. The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor. J Mol Biol. 1999;294:239–245. doi: 10.1006/jmbi.1999.3252. [DOI] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“When iron concentrations are high, IRPs are degraded or inactivated, causing the downregulation of TfR1.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“In iron-replete cells, IRP1, which has ∼30% homology to mitochondrial aconitase based on amino acid alignments, loses its affinity for the IRE, and converts to a cytosolic aconitase (127, 263).”
What the sources say
- Not checked yetcites [127] Hentze MW. Argos P. Homology between IRE-BP, a regulatory RNA-binding protein, aconitase, and isopropylmalate isomerase. Nucleic Acids Res. 1991;19:1739–1740. doi: 10.1093/nar/19.8.1739. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [263] Rouault TA. Stout CD. Kaptain S. Harford JB. Klausner RD. Structural relationship between an iron-regulated RNA-binding protein (IRE-BP) and aconitase: functional implications. Cell. 1991;64:881–883. doi: 10.1016/0092-8674(91)90312-m. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Expression of exogenous Fpn stimulates iron efflux (198).”
What the sources say
- Not checked yetcites [198] McKie AT. Marciani P. Rolfs A. Brennan K. Wehr K. Barrow D. Miret S. Bomford A. Peters TJ. Farzaneh F. Hediger MA. Hentze MW. Simpson RJ. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000;5:299–309. doi: 10.1016/s1097-2765(00)80425-6. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“They also have high levels of iron in cells of the reticuloendothelial system as well as in hepatocytes, as a result of impaired iron efflux (123).”
What the sources say
- Not checked yetcites [123] Harris ZL. Durley AP. Man TK. Gitlin JD. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci U S A. 1999;96:10812–10817. doi: 10.1073/pnas.96.19.10812. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In the intestine, where Cp is not expressed, Fpn couples with another multicopper oxidase, hephaestin (Heph) (313).”
What the sources say
- Not checked yetcites [313] Vulpe CD. Kuo YM. Murphy TL. Cowley L. Askwith C. Libina N. Gitschier J. Anderson GJ. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet. 1999;21:195–199. doi: 10.1038/5979. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“DMT1 is critical to the export of iron released from Tf in the acidic endosome into the cytosol (see Fig. 1) (117).”
What the sources say
- Not checked yetcites [117] Gunshin H. Mackenzie B. Berger UV. Gunshin Y. Romero MF. Boron WF. Nussberger S. Gollan JL. Hediger MA. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 1997;388:482–488. doi: 10.1038/41343. [DOI] [PubMed] [Google Scholar] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“DCytb appears to be involved in the reduction of Fe3+ in the intestine, allowing it to be transported by DMT1 (197).”
What the sources say
- Not checked yetcites [197] McKie AT. Barrow D. Latunde-Dada GO. Rolfs A. Sager G. Mudaly E. Mudaly M. Richardson C. Barlow D. Bomford A. Peters TJ. Raja KB. Shirali S. Hediger MA. Farzaneh F. Simpson RJ. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science. 2001;291:1755–1759. doi: 10.1126/science.1057206. [DOI] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Nonheme iron is predominantly insoluble Fe3+ and must be reduced before transport by DMT1.
In the paper
“Disruption of the sequence Y555XLXX in the cytoplasmic tail of DMT1 inhibited the localization of both DMT1A and DMT1B isoforms on the plasma membrane, but not in the endosome (286).”
What the sources say
- Not checked yetcites [286] Tabuchi M. Tanaka N. Nishida-Kitayama J. Ohno H. Kishi F. Alternative splicing regulates the subcellular localization of divalent metal transporter 1 isoforms. Mol Biol Cell. 2002;13:4371–4387. doi: 10.1091/mbc.E02-03-0165. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Fpn and Heph colocalize on the basolateral membrane of absorptive enterocytes of the duodenum and intestines (121).”
What the sources say
- Not checked yetcites [121] Han O. Kim EY. Colocalization of ferroportin-1 with hephaestin on the basolateral membrane of human intestinal absorptive cells. J Cell Biochem. 2007;101:1000–1010. doi: 10.1002/jcb.21392. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Heph was identified through study of sex-linked anemia (Sla) mice, which are deficient in transfer of iron absorbed in the intestines into the plasma (313).”
What the sources say
- Not checked yetcites [313] Vulpe CD. Kuo YM. Murphy TL. Cowley L. Askwith C. Libina N. Gitschier J. Anderson GJ. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet. 1999;21:195–199. doi: 10.1038/5979. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“DMT1A was regulated by iron in human Caco-2 cells, a model system for intestinal iron absorption (see Fig. 2) (137).”
What the sources say
- Not checked yetcites [137] Hubert N. Hentze MW. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc Natl Acad Sci U S A. 2002;99:12345–12350. doi: 10.1073/pnas.192423399. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“DMT1 products include four different transcripts that occur as a result of alternative splicing at either the 3′ or 5′ end.”
What the sources say
- Not checked yetcites [137] Hubert N. Hentze MW. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc Natl Acad Sci U S A. 2002;99:12345–12350. doi: 10.1073/pnas.192423399. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Exogenous Fpn expressed in Xenopus oocytes served as a ferrous iron exporter (72).”
What the sources say
- Not checked yetcites [72] Donovan A. Brownlie A. Zhou Y. Shepard J. Pratt SJ. Moynihan J. Paw BH. Drejer A. Barut B. Zapata A. Law TC. Brugnara C. Lux SE. Pinkus GS. Pinkus JL. Kingsley PD. Palis J. Fleming MD. Andrews NC. Zon LI. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000;403:776–781. doi: 10.1038/35001596. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In a different pedigree of autosomal dominant hemochromatosis, another missense mutation of Fpn (N144H) was identified (218).”
What the sources say
- Not checked yetcites [218] Njajou OT. Vaessen N. Joosse M. Berghuis B. van Dongen JW. Breuning MH. Snijders PJ. Rutten WP. Sandkuijl LA. Oostra BA. van Duijn CM. Heutink P. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet. 2001;28:213–214. doi: 10.1038/90038. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Cp also functions as an antioxidant, because it converts Fe2+ to Fe3+, thereby decreasing the potential formation of reactive oxygen species (ROS) via Fenton chemistry (118).”
What the sources say
- Not checked yetcites [118] Gutteridge JM. Quinlan GJ. Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidising proteins. Biochim Biophys Acta. 1992;1159:248–254. doi: 10.1016/0167-4838(92)90052-f. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“DMT1 is a metal-ion transporter with a uniquely broad range of divalent substrates such as Cd2+, Pb2+, Zn2+, Mn2+, Cu2+, and Co2+.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Patients with the A77D mutation exhibit mainly early iron overload in the reticuloendocytic macrophages (205).”
What the sources say
- Not checked yetcites [205] Montosi G. Donovan A. Totaro A. Garuti C. Pignatti E. Cassanelli S. Trenor CC. Gasparini P. Andrews NC. Pietrangelo A. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest. 2001;108:619–623. doi: 10.1172/JCI13468. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The authors concluded that the iron overload was a result of a gain-of-function mutation that would augment the iron-transport function of Fpn in enterocytes, thereby causing increased efflux of iron by the intestines (218).”
What the sources say
- Not checked yetcites [218] Njajou OT. Vaessen N. Joosse M. Berghuis B. van Dongen JW. Breuning MH. Snijders PJ. Rutten WP. Sandkuijl LA. Oostra BA. van Duijn CM. Heutink P. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet. 2001;28:213–214. doi: 10.1038/90038. [DOI] [PubMed] [Google Scholar] source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Further study revealed that regulation of DMT1 by iron is largely dependent on the cell line.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“In glioma cells, astrocytes, and macrophages, Fpn associates with ceruloplasmin (Cp) (123, 148).”
What the sources say
- Not checked yetcites [123] Harris ZL. Durley AP. Man TK. Gitlin JD. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci U S A. 1999;96:10812–10817. doi: 10.1073/pnas.96.19.10812. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [148] Jeong SY. David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem. 2003;278:27144–27148. doi: 10.1074/jbc.M301988200. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In mice, hepcidin was required for the development of anemia during inflammation (214).”
What the sources say
- Not checked yetcites [214] Nemeth E. Rivera S. Gabayan V. Keller C. Taudorf S. Pedersen BK. Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271–1276. doi: 10.1172/JCI20945. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“the upregulation of hepcidin during inflammation (a precipitating event in the development of hypoferremia) occurs, at least in part, through the action of IL-6 (214).”
What the sources say
- Not checked yetcites [214] Nemeth E. Rivera S. Gabayan V. Keller C. Taudorf S. Pedersen BK. Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271–1276. doi: 10.1172/JCI20945. [DOI] [PMC free article] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Its expression is increased in response to iron and inflammation (247)”
What the sources say
- Not checked yetcites [247] Pigeon C. Ilyin G. Courselaud B. Leroyer P. Turlin B. Brissot P. Loreal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276:7811–7819. doi: 10.1074/jbc.M008923200. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“An alternative mechanism of hepcidin regulation through a signaling pathway involving hemojuvelin (HFE2, also known as HJV) and bone morphogenetic proteins (BMP) was recently identified (14).”
What the sources say
- Not checked yetcites [14] Babitt JL. Huang FW. Wrighting DM. Xia Y. Sidis Y. Samad TA. Campagna JA. Chung RT. Schneyer AL. Woolf CJ. Andrews NC. Lin HY. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006;38:531–539. doi: 10.1038/ng1777. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Activation of STAT3 transcription factor by IL-6 results in the transactivation of a STAT binding sequence in the hepcidin promoter (245, 310).”
What the sources say
- Not checked yetcites [245] Pietrangelo A. Dierssen U. Valli L. Garuti C. Rump A. Corradini E. Ernst M. Klein C. Trautwein C. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology. 2007;132:294–300. doi: 10.1053/j.gastro.2006.10.018. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [310] Verga Falzacappa MV. Vujic Spasic M. Kessler R. Stolte J. Hentze MW. Muckenthaler MU. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood. 2007;109:353–358. doi: 10.1182/blood-2006-07-033969. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“It negatively regulates iron efflux by binding Fpn and triggering its internalization and subsequent degradation (215).”
What the sources say
- Not checked yetcites [215] Nemeth E. Tuttle MS. Powelson J. Vaughn MB. Donovan A. Ward DM. Ganz T. Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090–2093. doi: 10.1126/science.1104742. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“suggesting that C/EBPα modulates hepcidin transcription (58).”
What the sources say
- Not checked yetcites [58] Courselaud B. Pigeon C. Inoue Y. Inoue J. Gonzalez FJ. Leroyer P. Gilot D. Boudjema K. Guguen-Guillouzo C. Brissot P. Loreal O. Ilyin G. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism: cross-talk between C/EBP pathway and iron metabolism. J Biol Chem. 2002;277:41163–41170. doi: 10.1074/jbc.M202653200. [DOI] [PubMed] [Google Scholar] source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“mice deficient in C/EBPα exhibited lower levels of hepcidin mRNA,”
What the sources say
- Not checked yetcites [58] Courselaud B. Pigeon C. Inoue Y. Inoue J. Gonzalez FJ. Leroyer P. Gilot D. Boudjema K. Guguen-Guillouzo C. Brissot P. Loreal O. Ilyin G. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism: cross-talk between C/EBP pathway and iron metabolism. J Biol Chem. 2002;277:41163–41170. doi: 10.1074/jbc.M202653200. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The 5′ UTR of Fpn mRNA contains an IRE (198).”
What the sources say
- Not checked yetcites [198] McKie AT. Marciani P. Rolfs A. Brennan K. Wehr K. Barrow D. Miret S. Bomford A. Peters TJ. Farzaneh F. Hediger MA. Hentze MW. Simpson RJ. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000;5:299–309. doi: 10.1016/s1097-2765(00)80425-6. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Mutation of two adjacent tyrosine residues at the phosphorylation site blocks internalization.”
What the sources say
- Not checked yetcites [66] De Domenico I. Ward DM. Langelier C. Vaughn MB. Nemeth E. Sundquist WI. Ganz T. Musci G. Kaplan J. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell. 2007;18:2569–2578. doi: 10.1091/mbc.E07-01-0060. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The mRNA of hepcidin does not contain this element (99),”
What the sources say
- Not checked yetcites [99] Ganz T. Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol. 2006;290:G199–G203. doi: 10.1152/ajpgi.00412.2005. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Studies in the liver demonstrated that C/EBPα plays a role in the iron-mediated regulation of hepcidin mRNA (58).”
What the sources say
- Not checked yetcites [58] Courselaud B. Pigeon C. Inoue Y. Inoue J. Gonzalez FJ. Leroyer P. Gilot D. Boudjema K. Guguen-Guillouzo C. Brissot P. Loreal O. Ilyin G. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism: cross-talk between C/EBP pathway and iron metabolism. J Biol Chem. 2002;277:41163–41170. doi: 10.1074/jbc.M202653200. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Tissue-specific overexpression of hepcidin in murine liver resulted in body iron deficiency and severe microcytic hypochromic anemia of mice at birth (216).”
What the sources say
- Not checked yetcites [216] Nicolas G. Chauvet C. Viatte L. Danan JL. Bigard X. Devaux I. Beaumont C. Kahn A. Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110:1037–1044. doi: 10.1172/JCI15686. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“suggesting that a sensor other than the IRE-IRP system may be necessary to regulate hepcidin translation in response to iron concentrations.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“hepcidin mRNA was increased in the murine liver and in hepatocytes in response to stimulation with LPS (247).”
What the sources say
- Not checked yetcites [247] Pigeon C. Ilyin G. Courselaud B. Leroyer P. Turlin B. Brissot P. Loreal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276:7811–7819. doi: 10.1074/jbc.M008923200. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“This ubiquitination results in the subsequent degradation of Fpn.”
What the sources say
- Not checked yetcites [65] De Domenico I. Ward DM. di Patti MC. Jeong SY. David S. Musci G. Kaplan J. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 2007;26:2823–2831. doi: 10.1038/sj.emboj.7601735. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Administration of synthetic hepcidin induced rapid decline in serum iron levels (hypoferremia) in mice (258).”
What the sources say
- Not checked yetcites [258] Rivera S. Nemeth E. Gabayan V. Lopez MA. Farshidi D. Ganz T. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood. 2005;106:2196–2199. doi: 10.1182/blood-2005-04-1766. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“After hepcidin binding, Fpn is tyrosine phosphorylated on the plasma membrane (66).”
What the sources say
- Not checked yetcites [66] De Domenico I. Ward DM. Langelier C. Vaughn MB. Nemeth E. Sundquist WI. Ganz T. Musci G. Kaplan J. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell. 2007;18:2569–2578. doi: 10.1091/mbc.E07-01-0060. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Iron overload induces hepcidin mRNA in hepatocytes (247);”
What the sources say
- Not checked yetcites [247] Pigeon C. Ilyin G. Courselaud B. Leroyer P. Turlin B. Brissot P. Loreal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276:7811–7819. doi: 10.1074/jbc.M008923200. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“and decreased by hypoxia and anemia (216).”
What the sources say
- Not checked yetcites [216] Nicolas G. Chauvet C. Viatte L. Danan JL. Bigard X. Devaux I. Beaumont C. Kahn A. Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110:1037–1044. doi: 10.1172/JCI15686. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Such an IRE in the 5′ UTR of mRNA is also located in other genes involved in the regulation of iron levels in the cell, including ferritin (heavy and light chains) and eALAS, which is involved in heme synthesis in erythroid cells (see Fig. 2) (131).”
What the sources say
- Not checked yetcites [131] Hentze MW. Muckenthaler MU. Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell. 2004;117:285–297. doi: 10.1016/s0092-8674(04)00343-5. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“levels of C/EBPα transcription factor in murine liver are doubled in response to iron loading,”
What the sources say
- Not checked yetcites [58] Courselaud B. Pigeon C. Inoue Y. Inoue J. Gonzalez FJ. Leroyer P. Gilot D. Boudjema K. Guguen-Guillouzo C. Brissot P. Loreal O. Ilyin G. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism: cross-talk between C/EBP pathway and iron metabolism. J Biol Chem. 2002;277:41163–41170. doi: 10.1074/jbc.M202653200. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Several lines of evidence indicate that hepcidin is a negative regulator of plasma iron.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Disruption of murine Heph and Cp genes resulted in increasing retinal iron concentrations with age that caused pathologic changes reminiscent of those seen in human aceruloplasminemia (119).”
What the sources say
- Not checked yetcites [119] Hahn P. Qian Y. Dentchev T. Chen L. Beard J. Harris ZL. Dunaief JL. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci U S A. 2004;101:13850–13855. doi: 10.1073/pnas.0405146101. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Fpn is posttranslationally regulated by a peptide hormone, hepcidin (215).”
What the sources say
- Not checked yetcites [215] Nemeth E. Tuttle MS. Powelson J. Vaughn MB. Donovan A. Ward DM. Ganz T. Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090–2093. doi: 10.1126/science.1104742. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“This study showed that BMP could upregulate hepcidin in hepatocytes.”
What the sources say
- Not checked yetcites [14] Babitt JL. Huang FW. Wrighting DM. Xia Y. Sidis Y. Samad TA. Campagna JA. Chung RT. Schneyer AL. Woolf CJ. Andrews NC. Lin HY. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006;38:531–539. doi: 10.1038/ng1777. [DOI] [PubMed] [Google Scholar] source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The mechanism by which IL-6 induces hepcidin mRNA involves the activation of STAT3 (324).”
What the sources say
- Not checked yetcites [324] Wrighting DM. Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006;108:3204–3209. doi: 10.1182/blood-2006-06-027631. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“in hepatocytes derived from HIF-1α-knockout mice, hepcidin expression in response to iron deficiency was increased (242).”
What the sources say
- Not checked yetcites [242] Peyssonnaux C. Zinkernagel AS. Schuepbach RA. Rankin E. Vaulont S. Haase VH. Nizet V. Johnson RS. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs) J Clin Invest. 2007;117:1926–1932. doi: 10.1172/JCI31370. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In the brain, the oligodendrocytes, microglia, and neurons express ferritin (53).”
What the sources say
- Not checked yetcites [53] Connor JR. Boeshore KL. Benkovic SA. Menzies SL. Isoforms of ferritin have a specific cellular distribution in the brain. J Neurosci Res. 1994;37:461–465. doi: 10.1002/jnr.490370405. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“downstream activation of Smad4 was required for BMP-mediated hepcidin upregulation,”
What the sources say
- Not checked yetcites [14] Babitt JL. Huang FW. Wrighting DM. Xia Y. Sidis Y. Samad TA. Campagna JA. Chung RT. Schneyer AL. Woolf CJ. Andrews NC. Lin HY. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006;38:531–539. doi: 10.1038/ng1777. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Induction by administration of exogenous BMPs was greater than that caused by treatment with LPS (300).”
What the sources say
- Not checked yetcites [300] Truksa J. Peng H. Lee P. Beutler E. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci U S A. 2006;103:10289–10293. doi: 10.1073/pnas.0603124103. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“HIF-1α was shown to bind to TfR1 HRE.”
What the sources say
- Not checked yetcites [242] Peyssonnaux C. Zinkernagel AS. Schuepbach RA. Rankin E. Vaulont S. Haase VH. Nizet V. Johnson RS. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs) J Clin Invest. 2007;117:1926–1932. doi: 10.1172/JCI31370. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“More recently, BMP9, BMP4, and BMP2 were identified as inducers of hepcidin (300).”
What the sources say
- Not checked yetcites [300] Truksa J. Peng H. Lee P. Beutler E. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci U S A. 2006;103:10289–10293. doi: 10.1073/pnas.0603124103. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Murine erythroleukemia cells that overexpress ferritin H displayed lower levels of the labile iron pool and ROS (78).”
What the sources say
- Not checked yetcites [78] Epsztejn S. Glickstein H. Picard V. Slotki IN. Breuer W. Beaumont C. Cabantchik ZI. H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood. 1999;94:3593–3603. [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The H subunit has ferroxidase activity, which converts Fe2+ to Fe3+ for storage inside the shell (178)”
What the sources say
- Not checked yetcites [178] Lawson DM. Treffry A. Artymiuk PJ. Harrison PM. Yewdall SJ. Luzzago A. Cesareni G. Levi S. Arosio P. Identification of the ferroxidase centre in ferritin. FEBS Lett. 1989;254:207–210. doi: 10.1016/0014-5793(89)81040-3. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“BMP-mediated induction of hepcidin was similar in wild-type congenic strains, and IL-6 knockout, HFE knockout, and TfR2 mutant mice,”
What the sources say
- Not checked yetcites [300] Truksa J. Peng H. Lee P. Beutler E. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci U S A. 2006;103:10289–10293. doi: 10.1073/pnas.0603124103. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“HIF-1 appears to function as a negative regulator of hepcidin expression:”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“When ferritin H was transgenically overexpressed into Parkinson disease (PD) model mice, reduced oxidative stress was found (159).”
What the sources say
- Not checked yetcites [159] Kaur D. Yantiri F. Rajagopalan S. Kumar J. Mo JQ. Boonplueang R. Viswanath V. Jacobs R. Yang L. Beal MF. DiMonte D. Volitaskis I. Ellerby L. Cherny RA. Bush AI. Andersen JK. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron. 2003;37:899–909. doi: 10.1016/s0896-6273(03)00126-0. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“None of the ferritin H-deficient mice survived past embryonic day 9.5 (85).”
What the sources say
- Not checked yetcites [85] Ferreira C. Bucchini D. Martin ME. Levi S. Arosio P. Grand-champ B. Beaumont C. Early embryonic lethality of H ferritin gene deletion in mice. J Biol Chem. 2000;275:3021–3024. doi: 10.1074/jbc.275.5.3021. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Ferritin is found in the cytoplasm, nucleus, and mitochondria of cells (summarized in Table 1).”
What the sources say
- Not checked yetcites Table 1
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The ratio of H and L subunits in the ferritin protein is not fixed and is tissue dependent (10).”
What the sources say
- Not checked yetcites [10] Arosio P. Yokota M. Drysdale JW. Structural and immunological relationships of isoferritins in normal and malignant cells. Cancer Res. 1976;36:1735–1739. [PubMed] [Google Scholar]
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“when HeLa cells stably transfected with tetracycline-inducible ferritin H and L were forced to overexpress ferritin, the accumulation of H2O2-induced ROS was reduced (59).”
What the sources say
- Not checked yetcites [59] Cozzi A. Corsi B. Levi S. Santambrogio P. Albertini A. Arosio P. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J Biol Chem. 2000;275:25122–25129. doi: 10.1074/jbc.M003797200. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“suggesting that BMP-mediated activation of hepcidin expression may not require these proteins (300).”
What the sources say
- Not checked yetcites [300] Truksa J. Peng H. Lee P. Beutler E. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci U S A. 2006;103:10289–10293. doi: 10.1073/pnas.0603124103. [DOI] [PMC free article] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“HIF-1 has been implicated in the transcriptional regulation of hepcidin in response to hypoxia (242).”
What the sources say
- Not checked yetcites [242] Peyssonnaux C. Zinkernagel AS. Schuepbach RA. Rankin E. Vaulont S. Haase VH. Nizet V. Johnson RS. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs) J Clin Invest. 2007;117:1926–1932. doi: 10.1172/JCI31370. [DOI] [PMC free article] [PubMed] [Google Scholar] source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Overexpression of HFE2 enhanced hepcidin production.”
What the sources say
- Not checked yetcites [14] Babitt JL. Huang FW. Wrighting DM. Xia Y. Sidis Y. Samad TA. Campagna JA. Chung RT. Schneyer AL. Woolf CJ. Andrews NC. Lin HY. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006;38:531–539. doi: 10.1038/ng1777. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Deletion of ferritin H in mice is embryonically lethal between 3.5 and 9.5 days of gestation (85).”
What the sources say
- Not checked yetcites [85] Ferreira C. Bucchini D. Martin ME. Levi S. Arosio P. Grand-champ B. Beaumont C. Early embryonic lethality of H ferritin gene deletion in mice. J Biol Chem. 2000;275:3021–3024. doi: 10.1074/jbc.275.5.3021. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Accumulating evidence shows that ferritin acts as an antioxidant protein (59, 60, 78, 159, 227, 243).”
What the sources say
- Not checked yetcites [59] Cozzi A. Corsi B. Levi S. Santambrogio P. Albertini A. Arosio P. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J Biol Chem. 2000;275:25122–25129. doi: 10.1074/jbc.M003797200. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [60] Cozzi A. Corsi B. Levi S. Santambrogio P. Biasiotto G. Arosio P. Analysis of the biologic functions of H- and L-ferritins in HeLa cells by transfection with siRNAs and cDNAs: evidence for a proliferative role of L-ferritin. Blood. 2004;103:2377–2383. doi: 10.1182/blood-2003-06-1842. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [78] Epsztejn S. Glickstein H. Picard V. Slotki IN. Breuer W. Beaumont C. Cabantchik ZI. H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood. 1999;94:3593–3603. [PubMed] [Google Scholar] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Ferritin is responsible for the sequestration of potentially harmful, reactive iron.
- Rests on an assumption: Ferritin stores iron in its unreactive Fe3+ form inside its shell as a result of a strong equilibrium between ferritin-bound iron (Fe3+) and the labile iron pool in the cells (Fe2+), preventing ROS formation via the Fenton reaction.
In the paper
“hepatocytes deficient in HFE2 had impaired hepcidin induction by BMP signaling (14).”
What the sources say
- Not checked yetcites [14] Babitt JL. Huang FW. Wrighting DM. Xia Y. Sidis Y. Samad TA. Campagna JA. Chung RT. Schneyer AL. Woolf CJ. Andrews NC. Lin HY. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006;38:531–539. doi: 10.1038/ng1777. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The gram-negative diplococcus, Neisseria meningitidis, rapidly induced ferritin degradation by the activation of the autophagy system, which allows meningococci replication in infected epithelial cells (173).”
What the sources say
- Not checked yetcites [173] Larson JA. Howie HL. So M. Neisseria meningitidis accelerates ferritin degradation in host epithelial cells to yield an essential iron source. Mol Microbiol. 2004;53:807–820. doi: 10.1111/j.1365-2958.2004.04169.x. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“the recombinant ferritin H protein was reported to activate T cells (111).”
What the sources say
- Not checked yetcites [111] Gray CP. Arosio P. Hersey P. Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells. Blood. 2002;99:3326–3334. doi: 10.1182/blood.v99.9.3326. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“mitochondrial ferritin genes do not have IRE in both the human and the mouse (74, 182).”
What the sources say
- Not checked yetcites [74] Drysdale J. Arosio P. Invernizzi R. Cazzola M. Volz A. Corsi B. Biasiotto G. Levi S. Mitochondrial ferritin: a new player in iron metabolism. Blood Cells Mol Dis. 2002;29:376–383. doi: 10.1006/bcmd.2002.0577. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [182] Levi S. Corsi B. Bosisio M. Invernizzi R. Volz A. Sanford D. Arosio P. Drysdale J. A human mitochondrial ferritin encoded by an intronless gene. J Biol Chem. 2001;276:24437–24440. doi: 10.1074/jbc.C100141200. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“and enhances ferritin degradation (64).”
What the sources say
- Not checked yetcites [64] De Domenico I. Vaughn MB. Li L. Bagley D. Musci G. Ward DM. Kaplan J. Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J. 2006;25:5396–5404. doi: 10.1038/sj.emboj.7601409. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“binding of ferritin L to the cell surface of liver, T-, and B-lymphoid cells was demonstrated (7, 208)”
What the sources say
- Not checked yetcites [7] Anderson GJ. Faulk WP. Arosio P. Moss D. Powell LW. Halliday JW. Identification of H- and L-ferritin subunit binding sites on human T and B lymphoid cells. Br J Haematol. 1989;73:260–264. doi: 10.1111/j.1365-2141.1989.tb00262.x. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [208] Moss D. Fargion S. Fracanzani AL. Levi S. Cappellini MD. Arosio P. Powell LW. Halliday JW. Functional roles of the ferritin receptors of human liver, hepatoma, lymphoid and erythroid cells. J Inorg Biochem. 1992;47:219–227. doi: 10.1016/0162-0134(92)84067-w. [DOI] [PubMed] [Google Scholar] source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“increased expression of mitochondrial ferritin in refractory anemia with ringed sideroblastic erythroblasts has been described at a very early stage of erythroid differentiation and is correlated with β-globin and GATA-1 induction involved in this process (288).”
What the sources say
- Not checked yetcites [288] Tehranchi R. Invernizzi R. Grandien A. Zhivotovsky B. Fadeel B. Forsblom AM. Travaglino E. Samuelsson J. Hast R. Nilsson L. Cazzola M. Wibom R. Hellstrom-Lindberg E. Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes. Blood. 2005;106:247–253. doi: 10.1182/blood-2004-12-4649. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Mouse T-cell immunoglobulin-domain and mucin-domain (TIM)-2 was identified as a ferritin H subunit receptor (48)”
What the sources say
- Not checked yetcites [48] Chen TT. Li L. Chung DH. Allen CD. Torti SV. Torti FM. Cyster JG. Chen CY. Brodsky FM. Niemi EC. Nakamura MC. Seaman WE. Daws MR. TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis. J Exp Med. 2005;202:955–965. doi: 10.1084/jem.20042433. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“ferritin H disruption by siRNA sensitized the cells to H2O2-induced oxidative stress (60)”
What the sources say
- Not checked yetcites [60] Cozzi A. Corsi B. Levi S. Santambrogio P. Biasiotto G. Arosio P. Analysis of the biologic functions of H- and L-ferritins in HeLa cells by transfection with siRNAs and cDNAs: evidence for a proliferative role of L-ferritin. Blood. 2004;103:2377–2383. doi: 10.1182/blood-2003-06-1842. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The functional elements of mitochondrial ferritin are similar to those of ferritin H, including ferroxidase activity and metal-binding sites (172)”
What the sources say
- Not checked yetcites [172] Langlois d'Estaintot B. Santambrogio P. Granier T. Gallois B. Chevalier JM. Precigoux G. Levi S. Arosio P. Crystal structure and biochemical properties of the human mitochondrial ferritin and its mutant Ser144Ala. J Mol Biol. 2004;340:277–293. doi: 10.1016/j.jmb.2004.04.036. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Mitochondrial ferritin is highly conserved among a wide variety of living creatures, including Drosophila (204, 332) and plants (204, 332)”
What the sources say
- Not checked yetcites [204] Missirlis F. Holmberg S. Georgieva T. Dunkov BC. Rouault TA. Law JH. Characterization of mitochondrial ferritin in Drosophila. Proc Natl Acad Sci U S A. 2006;103:5893–5898. doi: 10.1073/pnas.0601471103. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [332] Zancani M. Peresson C. Biroccio A. Federici G. Urbani A. Murgia I. Soave C. Micali F. Vianello A. Macri F. Evidence for the presence of ferritin in plant mitochondria. Eur J Biochem. 2004;271:3657–3664. doi: 10.1111/j.1432-1033.2004.04300.x. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Proteasome-mediated ferritin degradation has also been reported (199, 255).”
What the sources say
- Not checked yetcites [199] Mehlhase J. Sandig G. Pantopoulos K. Grune T. Oxidation-induced ferritin turnover in microglial cells: role of proteasome. Free Radic Biol Med. 2005;38:276–285. doi: 10.1016/j.freeradbiomed.2004.10.025. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [255] Reinheckel T. Sitte N. Ullrich O. Kuckelkorn U. Davies KJ. Grune T. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J. 1998;335:637–642. doi: 10.1042/bj3350637. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Ferritin H incorporation was not observed in the absence of TIM-2 (48).”
What the sources say
- Not checked yetcites [48] Chen TT. Li L. Chung DH. Allen CD. Torti SV. Torti FM. Cyster JG. Chen CY. Brodsky FM. Niemi EC. Nakamura MC. Seaman WE. Daws MR. TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis. J Exp Med. 2005;202:955–965. doi: 10.1084/jem.20042433. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“TIM-2-deficient mice showed increased levels of cytokines IL-4, IL-5, IL-6, and IL-10, which may result in increased inflammation (256).”
What the sources say
- Not checked yetcites [256] Rennert PD. Ichimura T. Sizing ID. Bailly V. Li Z. Rennard R. McCoon P. Pablo L. Miklasz S. Tarilonte L. Bonventre JV. T cell, Ig domain, mucin domain-2 gene-deficient mice reveal a novel mechanism for the regulation of Th2 immune responses and airway inflammation. J Immunol. 2006;177:4311–4321. doi: 10.4049/jimmunol.177.7.4311. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Only monoubiquitinated ferritin was reported in an Fpn-overexpression experiment (64).”
What the sources say
- Not checked yetcites [64] De Domenico I. Vaughn MB. Li L. Bagley D. Musci G. Ward DM. Kaplan J. Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J. 2006;25:5396–5404. doi: 10.1038/sj.emboj.7601409. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Elevated serum ferritin H levels were shown to be correlated with increased CD4+, CD25+, CD69− regulatory T cells (110).”
What the sources say
- Not checked yetcites [110] Gray CP. Arosio P. Hersey P. Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T-cell levels in patients with melanoma. Clin Cancer Res. 2003;9:2551–2559. [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Over-expression of Fpn accelerates export of cytosolic iron (215)”
What the sources say
- Not checked yetcites [215] Nemeth E. Tuttle MS. Powelson J. Vaughn MB. Donovan A. Ward DM. Ganz T. Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090–2093. doi: 10.1126/science.1104742. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“iron depletion by iron chelators was also shown to enhance lysosome-mediated ferritin degradation (165).”
What the sources say
- Not checked yetcites [165] Konijn AM. Glickstein H. Vaisman B. Meyron-Holtz EG. Slotki IN. Cabantchik ZI. The cellular labile iron pool and intracellular ferritin in K562 cells. Blood. 1999;94:2128–2134. [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Additional experiments also showed that ferritin L did not interact with TIM-2 (48).”
What the sources say
- Not checked yetcites [48] Chen TT. Li L. Chung DH. Allen CD. Torti SV. Torti FM. Cyster JG. Chen CY. Brodsky FM. Niemi EC. Nakamura MC. Seaman WE. Daws MR. TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis. J Exp Med. 2005;202:955–965. doi: 10.1084/jem.20042433. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“The regulation of ferritin synthesis by iron is mainly due to posttranscriptional regulation (107, 129, 262) through the binding of IRP1 and IRP2 to an IRE located in the 5′ UTR of ferritin mRNA (41)”
What the sources say
- Not checked yetcites [107] Goossen B. Caughman SW. Harford JB. Klausner RD. Hentze MW. Translational repression by a complex between the iron-responsive element of ferritin mRNA and its specific cytoplasmic binding protein is position-dependent in vivo. EMBO J. 1990;9:4127–4133. doi: 10.1002/j.1460-2075.1990.tb07635.x. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [129] Hentze MW. Caughman SW. Rouault TA. Barriocanal JG. Dancis A. Harford JB. Klausner RD. Identification of the iron-responsive element for the translational regulation of human ferritin mRNA. Science. 1987;238:1570–1573. doi: 10.1126/science.3685996. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [262] Rouault TA. Hentze MW. Caughman SW. Harford JB. Klausner RD. Binding of a cytosolic protein to the iron-responsive element of human ferritin messenger RNA. Science. 1988;241:1207–1210. doi: 10.1126/science.3413484. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Subsequent investigation revealed that Nrf2 and AP1 family transcription factors, in conjunction with transcriptional coactivator p300/CBP, are involved in the activation of the ARE (246, 302, 306, 307)”
What the sources say
- Not checked yetcites [246] Pietsch EC. Chan JY. Torti FM. Torti SV. Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones. J Biol Chem. 2003;278:2361–2369. doi: 10.1074/jbc.M210664200. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [302] Tsuji Y. Akebi N. Lam TK. Nakabeppu Y. Torti SV. Torti FM. FER-1, an enhancer of the ferritin H gene and a target of E1A-mediated transcriptional repression. Mol Cell Biol. 1995;15:5152–5164. doi: 10.1128/mcb.15.9.5152. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [306] Tsuji Y. Moran E. Torti SV. Torti FM. Transcriptional regulation of the mouse ferritin H gene: involvement of p300/CBP adaptor proteins in FER-1 enhancer activity. J Biol Chem. 1999;274:7501–7507. doi: 10.1074/jbc.274.11.7501. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Ferric ammonium citrate, cytokines, and H2O2 exposure resulted in a change in ferritin localization from the cytosol to the nucleus (292).”
What the sources say
- Not checked yetcites [292] Thompson KJ. Fried MG. Ye Z. Boyer P. Connor JR. Regulation, mechanisms and proposed function of ferritin translocation to cell nuclei. J Cell Sci. 2002;115:2165–2177. doi: 10.1242/jcs.115.10.2165. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“This region contained the unique bidirectional ARE motifs composed of an AP1-like, an SP1-like, and an AP1/NF-E2 sequence (302).”
What the sources say
- Not checked yetcites [302] Tsuji Y. Akebi N. Lam TK. Nakabeppu Y. Torti SV. Torti FM. FER-1, an enhancer of the ferritin H gene and a target of E1A-mediated transcriptional repression. Mol Cell Biol. 1995;15:5152–5164. doi: 10.1128/mcb.15.9.5152. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“IRP1-knockout mice survived with insignificant effects on iron homeostasis in kidney and brown fat that highly express IRP1 (55, 200).”
What the sources say
- Not checked yetcites [55] Cooperman SS. Meyron-Holtz EG. Olivierre-Wilson H. Ghosh MC. McConnell JP. Rouault TA. Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2. Blood. 2005;106:1084–1091. doi: 10.1182/blood-2004-12-4703. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [200] Meyron-Holtz EG. Ghosh MC. Iwai K. LaVaute T. Brazzolotto X. Berger UV. Land W. Ollivierre-Wilson H. Grinberg A. Love P. Rouault TA. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J. 2004;23:386–395. doi: 10.1038/sj.emboj.7600041. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“These facts suggest that although both IRPs control ferritin expression in vitro (161), IRP2 may have the primary role in ferritin regulation in response to iron.”
What the sources say
- Not checked yetcites [161] Kim HY. Klausner RD. Rouault TA. Translational repressor activity is equivalent and is quantitatively predicted by in vitro RNA binding for two iron-responsive element-binding proteins, IRP1 and IRP2. J Biol Chem. 1995;270:4983–4986. doi: 10.1074/jbc.270.10.4983. [DOI] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“overexpression or knockdown of ferritin expression in mammalian cells has proven the cytoprotective role of ferritin under prooxidative conditions (59, 60, 78, 159, 227, 243).”
What the sources say
- Not checked yetcites [59] Cozzi A. Corsi B. Levi S. Santambrogio P. Albertini A. Arosio P. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J Biol Chem. 2000;275:25122–25129. doi: 10.1074/jbc.M003797200. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [60] Cozzi A. Corsi B. Levi S. Santambrogio P. Biasiotto G. Arosio P. Analysis of the biologic functions of H- and L-ferritins in HeLa cells by transfection with siRNAs and cDNAs: evidence for a proliferative role of L-ferritin. Blood. 2004;103:2377–2383. doi: 10.1182/blood-2003-06-1842. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [78] Epsztejn S. Glickstein H. Picard V. Slotki IN. Breuer W. Beaumont C. Cabantchik ZI. H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood. 1999;94:3593–3603. [PubMed] [Google Scholar] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“induction of ferritin mRNA was observed in mouse liver (303) and erythroid cells (78) treated with oxidative stress–inducing compounds.”
What the sources say
- Not checked yetcites [303] Tsuji Y. Ayaki H. Whitman SP. Morrow CS. Torti SV. Torti FM. Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol Cell Biol. 2000;20:5818–5827. doi: 10.1128/mcb.20.16.5818-5827.2000. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [78] Epsztejn S. Glickstein H. Picard V. Slotki IN. Breuer W. Beaumont C. Cabantchik ZI. H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood. 1999;94:3593–3603. [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“ferritin translocated into the nucleus and bound to DNA without the requirement of a particular DNA-binding sequence (292).”
What the sources say
- Not checked yetcites [292] Thompson KJ. Fried MG. Ye Z. Boyer P. Connor JR. Regulation, mechanisms and proposed function of ferritin translocation to cell nuclei. J Cell Sci. 2002;115:2165–2177. doi: 10.1242/jcs.115.10.2165. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“This is regulated at the transcriptional level through an antioxidant-responsive element (ARE) (265) (also termed electrophile responsive element) (95) in the 5′-region of ferritin genes (133, 301, 302).”
What the sources say
- Not checked yetcites [265] Rushmore TH. Morton MR. Pickett CB. The antioxidant responsive element: activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem. 1991;266:11632–11639. [PubMed] [Google Scholar] source
- Not checked yetcites [133] Hintze KJ. Theil EC. DNA and mRNA elements with complementary responses to hemin, antioxidant inducers, and iron control ferritin-L expression. Proc Natl Acad Sci U S A. 2005;102:15048–15052. doi: 10.1073/pnas.0505148102. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [301] Tsuji Y. JunD activates transcription of the human ferritin H gene through an antioxidant response element during oxidative stress. Oncogene. 2005;24:7567–7578. doi: 10.1038/sj.onc.1208901. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The ferritin H ARE was originally identified in studies of the molecular mechanism by which mouse NIH-3T3 fibroblasts transformed with the adenovirus E1A oncogene displayed reduced ferritin H mRNA expression (304).”
What the sources say
- Not checked yetcites [304] Tsuji Y. Kwak E. Saika T. Torti SV. Torti FM. Preferential repression of the H subunit of ferritin by adenovirus E1A in NIH-3T3 mouse fibroblasts. J Biol Chem. 1993;268:7270–7275. [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“the inhibition of nuclear ferritin expression by the iron chelator deferoxamine (this may also decrease cytoplasmic ferritin expression) in corneal epithelial cells resulted in the sensitization of the cells to UV-induced DNA damage (32).”
What the sources say
- Not checked yetcites [32] Cai CX. Birk DE. Linsenmayer TF. Nuclear ferritin protects DNA from UV damage in corneal epithelial cells. Mol Biol Cell. 1998;9:1037–1051. doi: 10.1091/mbc.9.5.1037. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“nuclear ferritin acts like cytoplasmic ferritin, in that it prevents iron-mediated ROS production, thereby protecting DNA from strand damage (32).”
What the sources say
- Not checked yetcites [32] Cai CX. Birk DE. Linsenmayer TF. Nuclear ferritin protects DNA from UV damage in corneal epithelial cells. Mol Biol Cell. 1998;9:1037–1051. doi: 10.1091/mbc.9.5.1037. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“ferritin H translocation into the nucleus does not require ferroxidase activity (292).”
What the sources say
- Not checked yetcites [292] Thompson KJ. Fried MG. Ye Z. Boyer P. Connor JR. Regulation, mechanisms and proposed function of ferritin translocation to cell nuclei. J Cell Sci. 2002;115:2165–2177. doi: 10.1242/jcs.115.10.2165. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Overexpression of ferritoid resulted in a shift in ferritin H distribution from cytoplasm to nucleus (201).”
What the sources say
- Not checked yetcites [201] Millholland JM. Fitch JM. Cai CX. Gibney EP. Beazley KE. Linsenmayer TF. Ferritoid, a tissue-specific nuclear transport protein for ferritin in corneal epithelial cells. J Biol Chem. 2003;278:23963–23970. doi: 10.1074/jbc.M210050200. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Reporter analysis, using a series of deletions in the 5′ flanking region of the mouse ferritin H gene, revealed that the E1A-mediated transcriptional repression was mediated via a 75-bp region located 4.1 kb upstream from the transcription initiation site of the mouse ferritin H gene (Fig. 11).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“the glycosylation inhibitor, alloxan, prevented translocation of ferritin into the nucleus”
What the sources say
- Not checked yetcites [285] Surguladze N. Patton S. Cozzi A. Fried MG. Connor JR. Characterization of nuclear ferritin and mechanism of translocation. Biochem J. 2005;388:731–740. doi: 10.1042/BJ20041853. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“JunD deficiency induced ROS accumulation in the cells (101).”
What the sources say
- Not checked yetcites [101] Gerald D. Berra E. Frapart YM. Chan DA. Giaccia AJ. Mansuy D. Pouyssegur J. Yaniv M. Mechta-Grigoriou F. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell. 2004;118:781–794. doi: 10.1016/j.cell.2004.08.025. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Apoptosis induced by TNF-α was inhibited by NF-κB”
What the sources say
- Not checked yetcites [243] Pham CG. Bubici C. Zazzeroni F. Papa S. Jones J. Alvarez K. Jayawardena S. De Smaele E. Cong R. Beaumont C. Torti FM. Torti SV. Franzoso G. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell. 2004;119:529–542. doi: 10.1016/j.cell.2004.10.017. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“activating transcription factor 1 (ATF1) was shown to act as a repressor of the human ferritin H gene through the ARE (142)”
What the sources say
- Not checked yetcites [142] Iwasaki K. Hailemariam K. Tsuji Y. PIAS3 interacts with ATF1 and regulates the human ferritin H gene through an antioxidant-responsive element. J Biol Chem. 2007;282:22335–22343. doi: 10.1074/jbc.M701477200. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The NF-Y transcription factor was bound to a 100-bp region upstream from the transcription start site of the human ferritin H gene (194).”
What the sources say
- Not checked yetcites [194] Marziali G. Perrotti E. Ilari R. Testa U. Coccia EM. Battistini A. Transcriptional regulation of the ferritin heavy-chain gene: the activity of the CCAAT binding factor NF-Y is modulated in heme-treated Friend leukemia cells and during monocyte-to-macrophage differentiation. Mol Cell Biol. 1997;17:1387–1395. doi: 10.1128/mcb.17.3.1387. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Ferritin mRNA induction was observed during DMSO-or hemin-induced differentiation of mouse Friend leukemia cells (FLC) and hemin-mediated differentiation of K562 human chronic myelogenous leukemia cells (17, 143, 194).”
What the sources say
- Not checked yetcites [17] Battistini A. Coccia EM. Marziali G. Bulgarini D. Scalzo S. Fiorucci G. Romeo G. Affabris E. Testa U. Rossi GB. Peschle C. Intracellular heme coordinately modulates globin chain synthesis, transferrin receptor number, and ferritin content in differentiating Friend erythroleukemia cells. Blood. 1991;78:2098–2103. [PubMed] [Google Scholar] source
- Not checked yetcites [143] Iwasaki K. Mackenzie EL. Hailemariam K. Sakamoto K. Tsuji Y. Hemin-mediated regulation of an antioxidant-responsive element of the human ferritin H gene and role of Ref-1 during erythroid differentiation of K562 cells. Mol Cell Biol. 2006;26:2845–2856. doi: 10.1128/MCB.26.7.2845-2856.2006. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [194] Marziali G. Perrotti E. Ilari R. Testa U. Coccia EM. Battistini A. Transcriptional regulation of the ferritin heavy-chain gene: the activity of the CCAAT binding factor NF-Y is modulated in heme-treated Friend leukemia cells and during monocyte-to-macrophage differentiation. Mol Cell Biol. 1997;17:1387–1395. doi: 10.1128/mcb.17.3.1387. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Ferritin expression is induced during erythroid cell differentiation”
What the sources say
- Not checked yetcites [271] Schranzhofer M. Schifrer M. Cabrera JA. Kopp S. Chiba P. Beug H. Mullner EW. Remodeling the regulation of iron metabolism during erythroid differentiation to ensure efficient heme biosynthesis. Blood. 2006;107:4159–4167. doi: 10.1182/blood-2005-05-1809. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The human ferritin H ARE is a 55-bp bidirectional ARE composed of an AP-1-like and an AP-1/NF-E2 sequence located 4.5 kb upstream from the transcription start site (301).”
What the sources say
- Not checked yetcites [301] Tsuji Y. JunD activates transcription of the human ferritin H gene through an antioxidant response element during oxidative stress. Oncogene. 2005;24:7567–7578. doi: 10.1038/sj.onc.1208901. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Conversely, a far-upstream region was shown to be the important responsive element that activates ferritin transcription during erythroid differentiation (20, 143).”
What the sources say
- Not checked yetcites [20] Beaumont C. Seyhan A. Yachou AK. Grandchamp B. Jones R. Mouse ferritin H subunit gene: functional analysis of the promoter and identification of an upstream regulatory element active in erythroid cells. J Biol Chem. 1994;269:20281–20288. [PubMed] [Google Scholar] source
- Not checked yetcites [143] Iwasaki K. Mackenzie EL. Hailemariam K. Sakamoto K. Tsuji Y. Hemin-mediated regulation of an antioxidant-responsive element of the human ferritin H gene and role of Ref-1 during erythroid differentiation of K562 cells. Mol Cell Biol. 2006;26:2845–2856. doi: 10.1128/MCB.26.7.2845-2856.2006. [DOI] [PMC free article] [PubMed] [Google Scholar] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“This activation of mouse ferritin H occurred through two of the multiple NF-κB consensus sequences located 4.8 kb upstream from the transcription start site (171).”
What the sources say
- Not checked yetcites [171] Kwak EL. Larochelle DA. Beaumont C. Torti SV. Torti FM. Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. J Biol Chem. 1995;270:15285–15293. doi: 10.1074/jbc.270.25.15285. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“TfR induction was also observed in TNF-α– or IL-1–treated MRC5 human fibroblasts (305)”
What the sources say
- Not checked yetcites [305] Tsuji Y. Miller LL. Miller SC. Torti SV. Torti FM. Tumor necrosis factor-alpha and interleukin 1-alpha regulate transferrin receptor in human diploid fibroblasts: relationship to the induction of ferritin heavy chain. J Biol Chem. 1991;266:7257–7261. [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“decreased ferritin H expression was observed in Nrf2-knockout mice (290).”
What the sources say
- Not checked yetcites [290] Thimmulappa RK. Mai KH. Srisuma S. Kensler TW. Yamamoto M. Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 2002;62:5196–5203. [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“It should be noted that the 180-bp region (20) actually contains the mouse ferritin H ARE sequence identified as the responsive enhancer to electrophilic chemical stress (302, 303).”
What the sources say
- Not checked yetcites [20] Beaumont C. Seyhan A. Yachou AK. Grandchamp B. Jones R. Mouse ferritin H subunit gene: functional analysis of the promoter and identification of an upstream regulatory element active in erythroid cells. J Biol Chem. 1994;269:20281–20288. [PubMed] [Google Scholar] source
- Not checked yetcites [302] Tsuji Y. Akebi N. Lam TK. Nakabeppu Y. Torti SV. Torti FM. FER-1, an enhancer of the ferritin H gene and a target of E1A-mediated transcriptional repression. Mol Cell Biol. 1995;15:5152–5164. doi: 10.1128/mcb.15.9.5152. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [303] Tsuji Y. Ayaki H. Whitman SP. Morrow CS. Torti SV. Torti FM. Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol Cell Biol. 2000;20:5818–5827. doi: 10.1128/mcb.20.16.5818-5827.2000. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Nrf2 was shown to bind and activate the human ferritin H ARE (143, 301).”
What the sources say
- Not checked yetcites [143] Iwasaki K. Mackenzie EL. Hailemariam K. Sakamoto K. Tsuji Y. Hemin-mediated regulation of an antioxidant-responsive element of the human ferritin H gene and role of Ref-1 during erythroid differentiation of K562 cells. Mol Cell Biol. 2006;26:2845–2856. doi: 10.1128/MCB.26.7.2845-2856.2006. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [301] Tsuji Y. JunD activates transcription of the human ferritin H gene through an antioxidant response element during oxidative stress. Oncogene. 2005;24:7567–7578. doi: 10.1038/sj.onc.1208901. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“An upstream 180-bp region of the mouse ferritin H gene was characterized as serving as an inducible enhancer during N,N’-hexamethylene-bis-acetamide–induced differentiation of mouse erythroleukemia cells (20).”
What the sources say
- Not checked yetcites [20] Beaumont C. Seyhan A. Yachou AK. Grandchamp B. Jones R. Mouse ferritin H subunit gene: functional analysis of the promoter and identification of an upstream regulatory element active in erythroid cells. J Biol Chem. 1994;269:20281–20288. [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Inhibition of PIAS3 expression by siRNA resulted in diminished activation of the ferritin H transcription in response to ARE-activating agents (142).”
What the sources say
- Not checked yetcites [142] Iwasaki K. Hailemariam K. Tsuji Y. PIAS3 interacts with ATF1 and regulates the human ferritin H gene through an antioxidant-responsive element. J Biol Chem. 2007;282:22335–22343. doi: 10.1074/jbc.M701477200. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Ferritin H was found as a TNF-α– or IL-1–inducible gene (171, 243, 294).”
What the sources say
- Not checked yetcites [171] Kwak EL. Larochelle DA. Beaumont C. Torti SV. Torti FM. Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. J Biol Chem. 1995;270:15285–15293. doi: 10.1074/jbc.270.25.15285. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [243] Pham CG. Bubici C. Zazzeroni F. Papa S. Jones J. Alvarez K. Jayawardena S. De Smaele E. Cong R. Beaumont C. Torti FM. Torti SV. Franzoso G. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell. 2004;119:529–542. doi: 10.1016/j.cell.2004.10.017. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [294] Torti SV. Kwak EL. Miller SC. Miller LL. Ringold GM. Myambo KB. Young AP. Torti FM. The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene. J Biol Chem. 1988;263:12638–12644. [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The human ferritin L ARE was recently identified; it contains only one consensus ARE sequence located at 1.35 kb from the transcription start site (133).”
What the sources say
- Not checked yetcites [133] Hintze KJ. Theil EC. DNA and mRNA elements with complementary responses to hemin, antioxidant inducers, and iron control ferritin-L expression. Proc Natl Acad Sci U S A. 2005;102:15048–15052. doi: 10.1073/pnas.0505148102. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and the surplus of frataxin may not give additional advantage to the cells in cytoprotection from oxidative stress.”
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Similarly, the two-step processing of human frataxin was shown to give rise to an intermediate (aa 42 to 210) and mature (aa 56 to 210) frataxin (43)”
What the sources say
- Not checked yetcites [43] Cavadini P. Adamec J. Taroni F. Gakh O. Isaya G. Two-step processing of human frataxin by mitochondrial processing peptidase: precursor and intermediate forms are cleaved at different rates. J Biol Chem. 2000;275:41469–41475. doi: 10.1074/jbc.M006539200. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These results suggest that, in mouse in vivo models, 25% to 30% of wild-type frataxin levels might be sufficient to maintain the normal frataxin function”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Two molecular chaperones of the heat-shock protein 70 class, ssc1 and ssc2, were shown to facilitate mitochondrial frataxin import and maturation in yeast (162, 312).”
What the sources say
- Not checked yetcites [162] Knight SA. Sepuri NB. Pain D. Dancis A. Mt-Hsp70 homolog, Ssc2p, required for maturation of yeast frataxin and mitochondrial iron homeostasis. J Biol Chem. 1998;273:18389–18393. doi: 10.1074/jbc.273.29.18389. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [312] Voisine C. Schilke B. Ohlson M. Beinert H. Marszalek J. Craig EA. Role of the mitochondrial Hsp70s, Ssc1 and Ssq1, in the maturation of Yfh1. Mol Cell Biol. 2000;20:3677–3684. doi: 10.1128/mcb.20.10.3677-3684.2000. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Moreover, redox factor 1, which was shown to enhance DNA binding of b-zip transcription factors through reduction of conserved cysteine residues (325), was involved in the ferritin ARE activation by Nrf2 during K562 differentiation (143).”
What the sources say
- Not checked yetcites [325] Xanthoudakis S. Curran T. Redox regulation of AP-1: a link between transcription factor signaling and DNA repair. Adv Exp Med Biol. 1996;387:69–75. [PubMed] [Google Scholar] source
- Not checked yetcites [143] Iwasaki K. Mackenzie EL. Hailemariam K. Sakamoto K. Tsuji Y. Hemin-mediated regulation of an antioxidant-responsive element of the human ferritin H gene and role of Ref-1 during erythroid differentiation of K562 cells. Mol Cell Biol. 2006;26:2845–2856. doi: 10.1128/MCB.26.7.2845-2856.2006. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Importantly, the mature human frataxin 81 to 210 was shown to be active enough to rescue frataxin deficiency in cells of FRDA patients (52).”
What the sources say
- Not checked yetcites [52] Condo I. Ventura N. Malisan F. Rufini A. Tomassini B. Testi R. In vivo maturation of human frataxin. Hum Mol Genet. 2007;16:1534–1540. doi: 10.1093/hmg/ddm102. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A correlation between the length of the GAA repeat and deficiency of frataxin along with severity or onset of FRDA symptoms have been observed (76).”
What the sources say
- Not checked yetcites [76] Durr A. Cossee M. Agid Y. Campuzano V. Mignard C. Penet C. Mandel JL. Brice A. Koenig M. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med. 1996;335:1169–1175. doi: 10.1056/NEJM199610173351601. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In this study, increased actin glutathionylation was observed in fibroblasts of FRDA patients, which leads to impaired or decreased actin polymerization and microfilament organization (236).”
What the sources say
- Not checked yetcites [236] Pastore A. Tozzi G. Gaeta LM. Bertini E. Serafini V. Di Cesare S. Bonetto V. Casoni F. Carrozzo R. Federici G. Piemonte F. Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: a potential role in the pathogenesis of the disease. J Biol Chem. 2003;278:42588–42595. doi: 10.1074/jbc.M301872200. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In the case of human ferritin H transcription in K562 erythroid cells, hemin activates ferritin H ARE by recruiting several activators, such as JunD and Nrf2 (143).”
What the sources say
- Not checked yetcites [143] Iwasaki K. Mackenzie EL. Hailemariam K. Sakamoto K. Tsuji Y. Hemin-mediated regulation of an antioxidant-responsive element of the human ferritin H gene and role of Ref-1 during erythroid differentiation of K562 cells. Mol Cell Biol. 2006;26:2845–2856. doi: 10.1128/MCB.26.7.2845-2856.2006. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“It was shown that both yeast and human frataxin are processed to a mature form in two sequential cleavage steps with a mitochondrial processing peptidase (MPP) (28, 43, 167)”
What the sources say
- Not checked yetcites [28] Branda SS. Cavadini P. Adamec J. Kalousek F. Taroni F. Isaya G. Yeast and human frataxin are processed to mature form in two sequential steps by the mitochondrial processing peptidase. J Biol Chem. 1999;274:22763–22769. doi: 10.1074/jbc.274.32.22763. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [43] Cavadini P. Adamec J. Taroni F. Gakh O. Isaya G. Two-step processing of human frataxin by mitochondrial processing peptidase: precursor and intermediate forms are cleaved at different rates. J Biol Chem. 2000;275:41469–41475. doi: 10.1074/jbc.M006539200. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [167] Koutnikova H. Campuzano V. Koenig M. Maturation of wild-type and mutated frataxin by the mitochondrial processing peptidase. Hum Mol Genet. 1998;7:1485–1489. doi: 10.1093/hmg/7.9.1485. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Treatment of control fibroblasts with FeSO4 increased protein glutathionylation (236).”
What the sources say
- Not checked yetcites [236] Pastore A. Tozzi G. Gaeta LM. Bertini E. Serafini V. Di Cesare S. Bonetto V. Casoni F. Carrozzo R. Federici G. Piemonte F. Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: a potential role in the pathogenesis of the disease. J Biol Chem. 2003;278:42588–42595. doi: 10.1074/jbc.M301872200. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Solution and crystal structures of yeast and human frataxin revealed a compact αβ sandwich motif consisting of α1, β1, β2, β3, β4, β5, β6, β7, and α2 (71).”
What the sources say
- Not checked yetcites [71] Dhe-Paganon S. Shigeta R. Chi YI. Ristow M. Shoelson SE. Crystal structure of human frataxin. J Biol Chem. 2000;275:30753–30756. doi: 10.1074/jbc.C000407200. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“although FRDA patient cells showed higher sensitivity to H2O2 toxicity in a ubiquitously distributed iron-dependent manner (283).”
What the sources say
- Not checked yetcites [283] Sturm B. Bistrich U. Schranzhofer M. Sarsero JP. Rauen U. Scheiber-Mojdehkar B. de Groot H. Ioannou P. Petrat F. Friedreich's ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts: a decrease in antioxidative capacity? J Biol Chem. 2005;280:6701–6708. doi: 10.1074/jbc.M408717200. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“The hemin-responsive element in the ferritin promoter region was also shown to overlap with the ARE of each human ferritin H and L gene (133, 143).”
What the sources say
- Not checked yetcites [133] Hintze KJ. Theil EC. DNA and mRNA elements with complementary responses to hemin, antioxidant inducers, and iron control ferritin-L expression. Proc Natl Acad Sci U S A. 2005;102:15048–15052. doi: 10.1073/pnas.0505148102. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [143] Iwasaki K. Mackenzie EL. Hailemariam K. Sakamoto K. Tsuji Y. Hemin-mediated regulation of an antioxidant-responsive element of the human ferritin H gene and role of Ref-1 during erythroid differentiation of K562 cells. Mol Cell Biol. 2006;26:2845–2856. doi: 10.1128/MCB.26.7.2845-2856.2006. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Similarly, by using stable HeLa cell lines transfected with a GFP reporter containing a GAA:TTC repeat expansion (GAA-148 repeats), 5 to 50 μM of small molecules such as diminazene, distamycin, pentamidine, DAPI, and Hoescht 33258 have been shown to increase GFP expression by >20-fold (109).”
What the sources say
- Not checked yetcites [109] Grant L. Sun J. Xu H. Subramony SH. Chaires JB. Hebert MD. Rational selection of small molecules that increase transcription through the GAA repeats found in Friedreich's ataxia. FEBS Lett. 2006;580:5399–5405. doi: 10.1016/j.febslet.2006.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“It was demonstrated that Saccharomyces cerevisiae cells lacking the YFH1 gene, the yeast homologue of the human frataxin gene, showed low levels of cytochrome and ferrochelatase (181).”
What the sources say
- Not checked yetcites [181] Lesuisse E. Santos R. Matzanke BF. Knight SA. Camadro JM. Dancis A. Iron use for haeme synthesis is under control of the yeast frataxin homologue (Yfh1) Hum Mol Genet. 2003;12:879–889. doi: 10.1093/hmg/ddg096. [DOI] [PubMed] [Google Scholar] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“and microarray analysis of frataxin-deficient mouse heart cells revealed downregulation of the iron-sulfur scaffold protein Isu1, mitochondrial coproporphyrinogen oxidase, and ferrochelatase, which are all involved in the heme pathway (270).”
What the sources say
- Not checked yetcites [270] Schoenfeld RA. Napoli E. Wong A. Zhan S. Reutenauer L. Morin D. Buckpitt AR. Taroni F. Lonnerdal B. Ristow M. Puccio H. Cortopassi GA. Frataxin deficiency alters heme pathway transcripts and decreases mitochondrial heme metabolites in mammalian cells. Hum Mol Genet. 2005;14:3787–3799. doi: 10.1093/hmg/ddi393. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The trimer of yeast frataxin was shown to bind one atom of iron that constitutes the basic 24-subunit oligomer (151).”
What the sources say
- Not checked yetcites [151] Karlberg T. Schagerlof U. Gakh O. Park S. Ryde U. Lindahl M. Leath K. Garman E. Isaya G. Al-Karadaghi S. The structures of frataxin oligomers reveal the mechanism for the delivery and detoxification of iron. Structure. 2006;14:1535–1546. doi: 10.1016/j.str.2006.08.010. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“The GAA triplet-repeat expansion in the frataxin gene was shown to interfere with frataxin gene transcription (223) because of a self-associated triplex formation at long GAA:TTC repeats (sticky DNA) (22, 193, 267, 268).”
What the sources say
- Not checked yetcites [223] Ohshima K. Montermini L. Wells RD. Pandolfo M. Inhibitory effects of expanded GAA.TTC triplet repeats from intron I of the Friedreich ataxia gene on transcription and replication in vivo. J Biol Chem. 1998;273:14588–14595. doi: 10.1074/jbc.273.23.14588. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [22] Bidichandani SI. Ashizawa T. Patel PI. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am J Hum Genet. 1998;62:111–121. doi: 10.1086/301680. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [193] Mariappan SV. Catasti P. Silks LA., 3rd Bradbury EM. Gupta G. The high-resolution structure of the triplex formed by the GAA/TTC triplet repeat associated with Friedreich's ataxia. J Mol Biol. 1999;285:2035–2052. doi: 10.1006/jmbi.1998.2435. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Similar results were reported in mammalian cells in which human frataxin interacted with human ferrochelatase (331)”
What the sources say
- Not checked yetcites [331] Yoon T. Cowan JA. Frataxin-mediated iron delivery to ferrochelatase in the final step of heme biosynthesis. J Biol Chem. 2004;279:25943–25946. doi: 10.1074/jbc.C400107200. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The recent crystal-structure study of apo- or iron-loaded frataxin trimer and 24 subunit homo-oligomer formation demonstrated the architectural similarity between frataxin and ferritin (151).”
What the sources say
- Not checked yetcites [151] Karlberg T. Schagerlof U. Gakh O. Park S. Ryde U. Lindahl M. Leath K. Garman E. Isaya G. Al-Karadaghi S. The structures of frataxin oligomers reveal the mechanism for the delivery and detoxification of iron. Structure. 2006;14:1535–1546. doi: 10.1016/j.str.2006.08.010. [DOI] [PubMed] [Google Scholar] source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Yeast frataxin YFH1 interacts with the ISC-assembly complex composed of the scaffold protein Isu1 and the cysteine desulfurase Nfs1 in a ferrous iron–dependent manner (102), suggesting a role of YFH1 in ISC synthesis (Table 2).”
What the sources say
- Not checked yetcites [102] Gerber J. Muhlenhoff U. Lill R. An interaction between frataxin and Isu1/Nfs1 that is crucial for Fe/S cluster synthesis on Isu1. EMBO Rep. 2003;4:906–911. doi: 10.1038/sj.embor.embor918. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites Table 2
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The frataxin gene exhibits tissue-specific expression, with its mRNA most abundant in the heart, followed by the liver and skeletal muscle (166).”
What the sources say
- Not checked yetcites [166] Koutnikova H. Campuzano V. Foury F. Dolle P. Cazzalini O. Koenig M. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet. 1997;16:345–351. doi: 10.1038/ng0897-345. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“The same group demonstrated the ferroxidase activity of yeast frataxin (233) [similar to that of ferritin H, which oxidizes Fe2+ to Fe3+ (178)].”
What the sources say
- Not checked yetcites [233] Park S. Gakh O. Mooney SM. Isaya G. The ferroxidase activity of yeast frataxin. J Biol Chem. 2002;277:38589–38595. doi: 10.1074/jbc.M206711200. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [178] Lawson DM. Treffry A. Artymiuk PJ. Harrison PM. Yewdall SJ. Luzzago A. Cesareni G. Levi S. Arosio P. Identification of the ferroxidase centre in ferritin. FEBS Lett. 1989;254:207–210. doi: 10.1016/0014-5793(89)81040-3. [DOI] [PubMed] [Google Scholar] source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“To understand the molecular basis of the transcription of the frataxin gene, 5′-promoter/enhancer elements of the human frataxin gene were investigated, in which a 1,255-bp 5′-region of the frataxin gene was shown to contain the minimal promoter activity (113).”
What the sources say
- Not checked yetcites [113] Greene E. Entezam A. Kumari D. Usdin K. Ancient repeated DNA elements and the regulation of the human frataxin promoter. Genomics. 2005;85:221–230. doi: 10.1016/j.ygeno.2004.10.013. [DOI] [PubMed] [Google Scholar]
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Knocking down frataxin with siRNA in human culture cells (HeLa and 293 cells) caused a defect in ISC proteins, including aconitase (191, 281).”
What the sources say
- Not checked yetcites [191] Lu C. Cortopassi G. Frataxin knockdown causes loss of cytoplasmic iron-sulfur cluster functions, redox alterations and induction of heme transcripts. Arch Biochem Biophys. 2007;457:111–122. doi: 10.1016/j.abb.2006.09.010. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [281] Stehling O. Elsasser HP. Bruckel B. Muhlenhoff U. Lill R. Iron-sulfur protein maturation in human cells: evidence for a function of frataxin. Hum Mol Genet. 2004;13:3007–3015. doi: 10.1093/hmg/ddh324. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Of these, 83% were homozygous for a missense mutation to a gene resembling MHC class I genes, located on chromosome 6 (82).”
What the sources say
- Not checked yetcites [82] Feder JN. Gnirke A. Thomas W. Tsuchihashi Z. Ruddy DA. Basava A. Dormishian F. Domingo R Jr. Ellis MC. Fullan A. Hinton LM. Jones NL. Kimmel BE. Kronmal GS. Lauer P. Lee VK. Loeb DB. Mapa FA. McClelland E. Meyer NC. Mintier GA. Moeller N. Moore T. Morikang E. Prass CE. Quintana L. Starnes SM. Schatzman RC. Brunke KJ. Drayna DT. Risch NJ. Bacon BR. Wolff RK. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408. doi: 10.1038/ng0896-399. [DOI] [PubMed] [Google Scholar] source
plaincorrelationaln = 178- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Another trial for restoring frataxin expression is to use histone deacetylase inhibitors such as BML-210 (1 to 5 μM) that reverse frataxin-gene silencing through chromatin relaxation by inducing lysine acetylation of histone H3 and H4 (132).”
What the sources say
- Not checked yetcites [132] Herman D. Jenssen K. Burnett R. Soragni E. Perlman SL. Gottesfeld JM. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol. 2006;2:551–558. doi: 10.1038/nchembio815. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“It was recently reported that treatment of FRDA patients with 20 to 30 mg/kg of deferiprone (3-hydroxy-1,2-dimethylpyridine-4-one), an iron chelator that is orally active, membrane permeable, blood–brain barrier crossing, and that transfers chelated iron to transferrin, efficiently decreased brain iron accumulation without apparent hematologic or neurologic adverse effects (25).”
What the sources say
- Not checked yetcites [25] Boddaert N. Le Quan Sang KH. Rotig A. Leroy-Willig A. Gallet S. Brunelle F. Sidi D. Thalabard JC. Munnich A. Cabantchik ZI. Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood. 2007;110:401–408. doi: 10.1182/blood-2006-12-065433. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“HFE2 is expressed mainly in skeletal muscle, cardiac tissue, and liver.”
What the sources say
- Not checked yetcites [230] Papanikolaou G. Samuels ME. Ludwig EH. MacDonald ML. Franchini PL. Dube MP. Andres L. MacFarlane J. Sakellaropoulos N. Politou M. Nemeth E. Thompson J. Risler JK. Zaborowska C. Babakaiff R. Radomski CC. Pape TD. Davidas O. Christakis J. Brissot P. Lockitch G. Ganz T. Hayden MR. Goldberg YP. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet. 2004;36:77–82. doi: 10.1038/ng1274. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Later reports of HH pedigrees also observed this mutation in both alleles of the HFE gene that encodes a tyrosine instead of the normal cysteine at codon 282 (C282Y), as having a prevalence of between 60% and 100% (40, 147, 150).”
What the sources say
- Not checked yetcites [40] Carella M. D'Ambrosio L. Totaro A. Grifa A. Valentino MA. Piperno A. Girelli D. Roetto A. Franco B. Gasparini P. Camaschella C. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet. 1997;60:828–832. [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [147] Jazwinska EC. Cullen LM. Busfield F. Pyper WR. Webb SI. Powell LW. Morris CP. Walsh TP. Haemochromatosis and HLA-H. Nat Genet. 1996;14:249–251. doi: 10.1038/ng1196-249. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [150] Jouanolle AM. Gandon G. Jezequel P. Blayau M. Campion ML. Yaouanq J. Mosser J. Fergelot P. Chauvel B. Bouric P. Carn G. Andrieux N. Gicquel I. Le Gall JY. David V. Haemochromatosis and HLA-H. Nat Genet. 1996;14:251–252. doi: 10.1038/ng1196-251. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Indeed, HIF-2α, but not HIF-1α, specifically activated an HRE that is located ∼2 kb upstream from the transcription-initiation site of the mouse frataxin gene (224).”
What the sources say
- Not checked yetcites [224] Oktay Y. Dioum E. Matsuzaki S. Ding K. Yan LJ. Haller RG. Szweda LI. Garcia JA. Hypoxia-inducible factor 2alpha regulates expression of the mitochondrial aconitase chaperone protein frataxin. J Biol Chem. 2007;282:11750–11756. doi: 10.1074/jbc.M611133200. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Later, a mouse model for type 1 HH was identified; the HFE mutant mouse manifested the same set of alterations in systemic iron regulation and subsequent iron overload as observed in humans (336).”
What the sources say
- Not checked yetcites [336] Zhou XY. Tomatsu S. Fleming RE. Parkkila S. Waheed A. Jiang J. Fei Y. Brunt EM. Ruddy DA. Prass CE. Schatzman RC. O'Neill R. Britton RS. Bacon BR. Sly WS. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A. 1998;95:2492–2497. doi: 10.1073/pnas.95.5.2492. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Likewise, analogues of the electron-transport chain component coenzyme Q10 and small-molecule glutathione peroxidase mimetics such as ebselen [2-phenyl-1, 2-benzisoselenazol-3 (2H)-one] showed similar cytoprotective effects (146).”
What the sources say
- Not checked yetcites [146] Jauslin ML. Wirth T. Meier T. Schoumacher F. A cellular model for Friedreich ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy. Hum Mol Genet. 2002;11:3055–3063. doi: 10.1093/hmg/11.24.3055. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The iron chelator deferoxamine was shown to protect FRDA fibroblasts from H2O2-induced cytotoxicity (321).”
What the sources say
- Not checked yetcites [321] Wong A. Yang J. Cavadini P. Gellera C. Lonnerdal B. Taroni F. Cortopassi G. The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet. 1999;8:425–430. doi: 10.1093/hmg/8.3.425. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The membrane-permeable antioxidant, Idebenone [2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone], as well as its derivative decylubiquinone, was shown to protect FRDA fibroblasts from toxicity caused by glutathione-depletion conditions (146).”
What the sources say
- Not checked yetcites [146] Jauslin ML. Wirth T. Meier T. Schoumacher F. A cellular model for Friedreich ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy. Hum Mol Genet. 2002;11:3055–3063. doi: 10.1093/hmg/11.24.3055. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In addition, in contrast to wild-type HFE2, the mutant isoforms were not regulated by iron levels.”
What the sources say
- Not checked yetcites [278] Silvestri L. Pagani A. Fazi C. Gerardi G. Levi S. Arosio P. Camaschella C. Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis. Blood. 2007;109:4503–4510. doi: 10.1182/blood-2006-08-041004. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“This particular type of HH is associated with a mutation that was mapped via positional cloning to chromosome 1q (230). The mutation occurs in a gene encoding hemojuvelin (HFE2).”
What the sources say
- Not checked yetcites [230] Papanikolaou G. Samuels ME. Ludwig EH. MacDonald ML. Franchini PL. Dube MP. Andres L. MacFarlane J. Sakellaropoulos N. Politou M. Nemeth E. Thompson J. Risler JK. Zaborowska C. Babakaiff R. Radomski CC. Pape TD. Davidas O. Christakis J. Brissot P. Lockitch G. Ganz T. Hayden MR. Goldberg YP. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet. 2004;36:77–82. doi: 10.1038/ng1274. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Prototypical HH is characterized by progressive iron loading, particularly in the liver, heart, and pancreas (131).”
What the sources say
- Not checked yetcites [131] Hentze MW. Muckenthaler MU. Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell. 2004;117:285–297. doi: 10.1016/s0092-8674(04)00343-5. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“3-nitropropionic acid (2 to 8 mM) and erythropoietin (1.1 to 9.9 unit/ml) appear to stimulate frataxin expression in lymphocytes derived from normal and FRDA patients (284, 308)”
What the sources say
- Not checked yetcites [284] Sturm B. Stupphann D. Kaun C. Boesch S. Schranzhofer M. Wojta J. Goldenberg H. Scheiber-Mojdehkar B. Recombinant human erythropoietin: effects on frataxin expression in vitro. Eur J Clin Invest. 2005;35:711–717. doi: 10.1111/j.1365-2362.2005.01568.x. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [308] Turano M. Tammaro A. De Biase I. Lo Casale MS. Ruggiero G. Monticelli A. Cocozza S. Pianese L. 3-Nitropropionic acid increases frataxin expression in human lymphoblasts and in transgenic rat PC12 cells. Neurosci Lett. 2003;350:184–186. doi: 10.1016/s0304-3940(03)00906-6. [DOI] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Because decreased expression of frataxin (ranging from 5% to 30% of normal frataxin expression level) causes FRDA, strategies to enhance expression of frataxin will be a promising approach to treating the disease.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Those with HH have markedly increased risk for developing hepatocellular carcinoma (77).”
What the sources say
- Not checked yetcites [77] Elmberg M. Hultcrantz R. Ekbom A. Brandt L. Olsson S. Olsson R. Lindgren S. Loof L. Stal P. Wallerstedt S. Almer S. Sandberg-Gertzen H. Askling J. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology. 2003;125:1733–1741. doi: 10.1053/j.gastro.2003.09.035. [DOI] [PubMed] [Google Scholar] source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Furthermore, the mitochondria-targeted antioxidants MitoQ (coenzyme Q10 derivative) and MitoVitE (vitamin E derivative) exhibited a significant increase in the efficacy of cytoprotection of FRDA fibroblasts from oxidative stress–mediated toxicity when compared with Idebenone (145).”
What the sources say
- Not checked yetcites [145] Jauslin ML. Meier T. Smith RA. Murphy MP. Mitochondriatargeted antioxidants protect Friedreich ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J. 2003;17:1972–1974. doi: 10.1096/fj.03-0240fje. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Disruption of the disulfide bridge results in decreased binding affinity for both β2-microglobulin and TfR (84).”
What the sources say
- Not checked yetcites [84] Feder JN. Tsuchihashi Z. Irrinki A. Lee VK. Mapa FA. Morikang E. Prass CE. Starnes SM. Wolff RK. Parkkila S. Sly WS. Schatzman RC. The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem. 1997;272:14025–14028. doi: 10.1074/jbc.272.22.14025. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Increased incidence of arthritis also is observed in HH (54).”
What the sources say
- Not checked yetcites [54] Conrad ME. Umbreit JN. Moore EG. Parmley RT. Hereditary hemochromatosis: a prevalent disorder of iron metabolism with an elusive etiology. Am J Hematol. 1994;47:218–224. doi: 10.1002/ajh.2830470313. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Befitting a model of altered iron-mediated mechanisms of damage in neurodegeneration, markers of oxidative stress, including lipid and protein oxidation, have been observed in PD and AD (334).”
What the sources say
- Not checked yetcites [334] Zecca L. Youdim MB. Riederer P. Connor JR. Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci. 2004;5:863–873. doi: 10.1038/nrn1537. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Levels of accumulation of iron in the striatum of rhesus monkeys were positively correlated with aging-related motor deficits (42).”
What the sources say
- Not checked yetcites [42] Cass WA. Grondin R. Andersen AH. Zhang Z. Hardy PA. Hussey-Andersen LK. Rayens WS. Gerhardt GA. Gash DM. Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys. Neurobiol Aging. 2007;28:258–271. doi: 10.1016/j.neurobiolaging.2005.12.010. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In hyperferritinemia-cataract syndrome, mutation of the ferritin L IRE leads to constitutive expression of ferritin L.”
What the sources say
- Not checked yetcites [19] Beaumont C. Leneuve P. Devaux I. Scoazec JY. Berthier M. Loiseau MN. Grandchamp B. Bonneau D. Mutation in the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinaemia and cataract. Nat Genet. 1995;11:444–446. doi: 10.1038/ng1295-444. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Ferritin was identified as the downstream mediator of the antioxidant and protective activities of NF-κB in response to TNF-α signaling in inflammation and apoptosis (243, 294).”
What the sources say
- Not checked yetcites [243] Pham CG. Bubici C. Zazzeroni F. Papa S. Jones J. Alvarez K. Jayawardena S. De Smaele E. Cong R. Beaumont C. Torti FM. Torti SV. Franzoso G. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell. 2004;119:529–542. doi: 10.1016/j.cell.2004.10.017. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [294] Torti SV. Kwak EL. Miller SC. Miller LL. Ringold GM. Myambo KB. Young AP. Torti FM. The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene. J Biol Chem. 1988;263:12638–12644. [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Many studies set a precedent of ferritin in cytoprotection against free-iron–catalyzed production of ROS (227, 243, 301).”
What the sources say
- Not checked yetcites [227] Orino K. Lehman L. Tsuji Y. Ayaki H. Torti SV. Torti FM. Ferritin and the response to oxidative stress. Biochem J. 2001;357:241–247. doi: 10.1042/0264-6021:3570241. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [243] Pham CG. Bubici C. Zazzeroni F. Papa S. Jones J. Alvarez K. Jayawardena S. De Smaele E. Cong R. Beaumont C. Torti FM. Torti SV. Franzoso G. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell. 2004;119:529–542. doi: 10.1016/j.cell.2004.10.017. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [301] Tsuji Y. JunD activates transcription of the human ferritin H gene through an antioxidant response element during oxidative stress. Oncogene. 2005;24:7567–7578. doi: 10.1038/sj.onc.1208901. [DOI] [PMC free article] [PubMed] [Google Scholar] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Although not associated with iron overloading, this condition results in the accumulation and aggregation of ferritin L in the lens, leading to the formation of cataracts (19).”
What the sources say
- Not checked yetcites [19] Beaumont C. Leneuve P. Devaux I. Scoazec JY. Berthier M. Loiseau MN. Grandchamp B. Bonneau D. Mutation in the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinaemia and cataract. Nat Genet. 1995;11:444–446. doi: 10.1038/ng1295-444. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Another form of hereditary iron overload results from mutation of the IRE in ferritin H mRNA and results in an autosomal-dominant iron-overload disorder.”
What the sources say
- Not checked yetcites [154] Kato J. Fujikawa K. Kanda M. Fukuda N. Sasaki K. Takayama T. Kobune M. Takada K. Takimoto R. Hamada H. Ikeda T. Niitsu Y. A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet. 2001;69:191–197. doi: 10.1086/321261. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirectSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The role of TfR2 in the uptake of Fe-Tf is unclear, as it binds Fe-Tf with ∼30-fold less affinity than TfR1 (298).”
What the sources say
- Not checked yetcites [298] Trinder D. Baker E. Transferrin receptor 2: a new molecule in iron metabolism. Int J Biochem Cell Biol. 2003;35:292–296. doi: 10.1016/s1357-2725(02)00258-3. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Expression of the IRE mutant enhanced translational repression of ferritin H (154).”
What the sources say
- Not checked yetcites [154] Kato J. Fujikawa K. Kanda M. Fukuda N. Sasaki K. Takayama T. Kobune M. Takada K. Takimoto R. Hamada H. Ikeda T. Niitsu Y. A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet. 2001;69:191–197. doi: 10.1086/321261. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Several studies have observed colocalization of such oxidative-damage indicators with regions of iron accumulation (334).”
What the sources say
- Not checked yetcites [334] Zecca L. Youdim MB. Riederer P. Connor JR. Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci. 2004;5:863–873. doi: 10.1038/nrn1537. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“This A to U transition at position 49 was associated with an increased affinity for IRP compared with the wild type.”
What the sources say
- Not checked yetcites [154] Kato J. Fujikawa K. Kanda M. Fukuda N. Sasaki K. Takayama T. Kobune M. Takada K. Takimoto R. Hamada H. Ikeda T. Niitsu Y. A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet. 2001;69:191–197. doi: 10.1086/321261. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaincorrelationalSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“At the other end of the spectrum, excess iron concentrations are particularly harmful because the highly oxidative microenvironment of the brain lends itself to the production of ROS (180).”
What the sources say
- Not checked yetcites [180] Lee DW. Andersen JK. Kaur D. Iron dysregulation and neurodegeneration: the molecular connection. Mol Interv. 2006;6:89–97. doi: 10.1124/mi.6.2.6. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Recent evidence has implicated abnormal iron metabolism in the pathogenesis of neurodegeneration (120, 241).”
What the sources say
- Not checked yetcites [120] Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging. 2001;18:685–716. doi: 10.2165/00002512-200118090-00004. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [241] Perry G. Cash AD. Smith MA. Alzheimer disease and oxidative stress. J Biomed Biotechnol. 2002;2:120–123. doi: 10.1155/S1110724302203010. [DOI] [PMC free article] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Type 4 HH is caused by a mutation in the Fpn gene (205, 218).”
What the sources say
- Not checked yetcites [205] Montosi G. Donovan A. Totaro A. Garuti C. Pignatti E. Cassanelli S. Trenor CC. Gasparini P. Andrews NC. Pietrangelo A. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest. 2001;108:619–623. doi: 10.1172/JCI13468. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [218] Njajou OT. Vaessen N. Joosse M. Berghuis B. van Dongen JW. Breuning MH. Snijders PJ. Rutten WP. Sandkuijl LA. Oostra BA. van Duijn CM. Heutink P. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet. 2001;28:213–214. doi: 10.1038/90038. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Disruption of normal Fpn function may lead to a number of different iron-loading conditions because of its function as an iron exporter and its important role in recycling of iron during erythrophagocytosis (67, 68).”
What the sources say
- Not checked yetcites [67] De Domenico I. Ward DM. Musci G. Kaplan J. Iron overload due to mutations in ferroportin. Haematologica. 2006;91:92–95. [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [68] De Domenico I. Ward DM. Nemeth E. Vaughn MB. Musci G. Ganz T. Kaplan J. The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci U S A. 2005;102:8955–8960. doi: 10.1073/pnas.0503804102. [DOI] [PMC free article] [PubMed] [Google Scholar]
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Furthermore, aberrant levels of increased brain iron have been observed in Alzheimer disease (AD) and Parkinson disease (PD) (23, 156).”
What the sources say
- Not checked yetcites [23] Bishop GM. Robinson SR. Liu Q. Perry G. Atwood CS. Smith MA. Iron: a pathological mediator of Alzheimer disease? Dev Neurosci. 2002;24:184–187. doi: 10.1159/000065696. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [156] Kaur D. Andersen J. Does cellular iron dysregulation play a causative role in Parkinson's disease? Ageing Res Rev. 2004;3:327–343. doi: 10.1016/j.arr.2004.01.003. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Interestingly, disruption of Cp and Heph in mice, which are necessary for the ferroxidase activity associated with Fpn activity and iron efflux, resulted in iron accumulation in the retina and subsequent retinal degeneration (119).”
What the sources say
- Not checked yetcites [119] Hahn P. Qian Y. Dentchev T. Chen L. Beard J. Harris ZL. Dunaief JL. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci U S A. 2004;101:13850–13855. doi: 10.1073/pnas.0405146101. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Iron content was the best predictor of motor deficit (42).”
What the sources say
- Not checked yetcites [42] Cass WA. Grondin R. Andersen AH. Zhang Z. Hardy PA. Hussey-Andersen LK. Rayens WS. Gerhardt GA. Gash DM. Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys. Neurobiol Aging. 2007;28:258–271. doi: 10.1016/j.neurobiolaging.2005.12.010. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A study that examined postmortem unfixed frozen brain sections from elderly normal or PD-affected individuals showed that individual neurons from brains of individuals with PD had significantly elevated iron concentrations (220).”
What the sources say
- Not checked yetcites [220] Oakley AE. Collingwood JF. Dobson J. Love G. Perrott HR. Edwardson JA. Elstner M. Morris CM. Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology. 2007;68:1820–1825. doi: 10.1212/01.wnl.0000262033.01945.9a. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“It is apparent that many of the proteins involved in iron homeostasis throughout the body are also present in the brain (206).”
What the sources say
- Not checked yetcites [206] Moos T. Morgan EH. The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann N Y Acad Sci. 2004;1012:14–26. doi: 10.1196/annals.1306.002. [DOI] [PubMed] [Google Scholar] source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Mutations in hepcidin that introduced either a frameshift or premature stop codon have been identified in individuals with HH type 2 (259).”
What the sources say
- Not checked yetcites [259] Roetto A. Papanikolaou G. Politou M. Alberti F. Girelli D. Christakis J. Loukopoulos D. Camaschella C. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 2003;33:21–22. doi: 10.1038/ng1053. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“It was revealed that a point mutation in the IRE consensus sequence is in ferritin H mRNA in a family with dominant iron-loading disorder (154).”
What the sources say
- Not checked yetcites [154] Kato J. Fujikawa K. Kanda M. Fukuda N. Sasaki K. Takayama T. Kobune M. Takada K. Takimoto R. Hamada H. Ikeda T. Niitsu Y. A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet. 2001;69:191–197. doi: 10.1086/321261. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaincorrelationalSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Ferritin H was transcriptionally activated by JunD through an ARE in the ferritin H promoter in response to oxidative stressors, including H2O2 (301).”
What the sources say
- Not checked yetcites [301] Tsuji Y. JunD activates transcription of the human ferritin H gene through an antioxidant response element during oxidative stress. Oncogene. 2005;24:7567–7578. doi: 10.1038/sj.onc.1208901. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In addition, overexpression of ferritin H protected cells from the toxicity of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a drug used to create experimental models of PD) (159).”
What the sources say
- Not checked yetcites [159] Kaur D. Yantiri F. Rajagopalan S. Kumar J. Mo JQ. Boonplueang R. Viswanath V. Jacobs R. Yang L. Beal MF. DiMonte D. Volitaskis I. Ellerby L. Cherny RA. Bush AI. Andersen JK. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron. 2003;37:899–909. doi: 10.1016/s0896-6273(03)00126-0. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Global deletion of IRP2 in mice manifested in aberrant accumulation of iron within the brain that correlated with tremor, and movement disorders such as bradykinesia and ataxia (175) (Table 4).”
What the sources say
- Not checked yetcites [175] LaVaute T. Smith S. Cooperman S. Iwai K. Land W. Meyron-Holtz E. Drake SK. Miller G. Abu-Asab M. Tsokos M. Switzer R., 3rd Grinberg A. Love P. Tresser N. Rouault TA. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet. 2001;27:209–214. doi: 10.1038/84859. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Chelation of “labile iron” also protected cells from this toxicity, suggesting that iron may play a role in the pathogenesis of PD, at least in the MPTP model (159).”
What the sources say
- Not checked yetcites [159] Kaur D. Yantiri F. Rajagopalan S. Kumar J. Mo JQ. Boonplueang R. Viswanath V. Jacobs R. Yang L. Beal MF. DiMonte D. Volitaskis I. Ellerby L. Cherny RA. Bush AI. Andersen JK. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron. 2003;37:899–909. doi: 10.1016/s0896-6273(03)00126-0. [DOI] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Increased iron content in afflicted regions in PD and evidence of oxidative stress are present.
In the paper
“Mutation of Cp has also been linked to several incidents of PD.”
What the sources say
- Not checked yetcites [134] Hochstrasser H. Bauer P. Walter U. Behnke S. Spiegel J. Csoti I. Zeiler B. Bornemann A. Pahnke J. Becker G. Riess O. Berg D. Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology. 2004;63:1912–1917. doi: 10.1212/01.wnl.0000144276.29988.c3. [DOI] [PubMed] [Google Scholar] source
plaincorrelationaln = 176- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In HEK293 cells, the I63T GPI-linked isoform of Cp remained in the endoplasmic reticulum.”
What the sources say
- Not checked yetcites [135] Hochstrasser H. Tomiuk J. Walter U. Behnke S. Spiegel J. Kruger R. Becker G. Riess O. Berg D. Functional relevance of ceruloplasmin mutations in Parkinson's disease. FASEB J. 2005;19:1851–1853. doi: 10.1096/fj.04-3486fje. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“An IRE was recently identified at +51 to +94 from the 5′ cap in the 5′-UTR of Alzheimer amyloid precursor protein (260), a critical mediator of the formation of plaques involved in the pathogenesis of AD.”
What the sources say
- Not checked yetcites [260] Rogers JT. Randall JD. Cahill CM. Eder PS. Huang X. Gunshin H. Leiter L. McPhee J. Sarang SS. Utsuki T. Greig NH. Lahiri DK. Tanzi RE. Bush AI. Giordano T. Gullans SR. An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript. J Biol Chem. 2002;277:45518–45528. doi: 10.1074/jbc.M207435200. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“It may be noted that chemicals used to model PD, such as MPTP, 6-hydroxydopamine (6-OHDA), and rotenone, were shown to increase expression of key members of the signaling pathway associated with the UPR in ER stress (136, 327).”
What the sources say
- Not checked yetcites [136] Holtz WA. O'Malley KL. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J Biol Chem. 2003;278:19367–19377. doi: 10.1074/jbc.M211821200. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [327] Yamamuro A. Yoshioka Y. Ogita K. Maeda S. Involvement of endoplasmic reticulum stress on the cell death induced by 6-hydroxydopamine in human neuroblastoma SH-SY5Y cells. Neurochem Res. 2006;31:657–664. doi: 10.1007/s11064-006-9062-6. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“This study also showed that Cp localizes with the Lewy bodies associated with the pathology of PD (134).”
What the sources say
- Not checked yetcites [134] Hochstrasser H. Bauer P. Walter U. Behnke S. Spiegel J. Csoti I. Zeiler B. Bornemann A. Pahnke J. Becker G. Riess O. Berg D. Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology. 2004;63:1912–1917. doi: 10.1212/01.wnl.0000144276.29988.c3. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Such clustered α-synuclein has been shown, along with iron, to be a constituent of Lewy bodies in PD (157).”
What the sources say
- Not checked yetcites [157] Kaur D. Andersen JK. Ironing out Parkinson's disease: Is therapeutic treatment with iron chelators a real possibility? Aging Cell. 2002;1:17–21. doi: 10.1046/j.1474-9728.2002.00001.x. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Aggregation of α-synuclein is a hallmark of PD.
In the paper
“Prolonged elevation of ferritin levels in dopaminergic neurons of the midbrain resulted in a progressive age-related neurodegeneration of these cells, suggesting that increased ferritin may not necessarily be cytoprotective and may play a role in neurodegeneration (158).”
What the sources say
- Not checked yetcites [158] Kaur D. Rajagopalan S. Chinta S. Kumar J. Di Monte D. Cherny RA. Andersen JK. Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration. Brain Res. 2007;1140:188–194. doi: 10.1016/j.brainres.2006.03.006. [DOI] [PubMed] [Google Scholar] source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“These mice also demonstrated an increase in markers of oxidative stress, including SOD activity, oxidative protein modifications, and apoptotic indicators (291).”
What the sources say
- Not checked yetcites [291] Thompson K. Menzies S. Muckenthaler M. Torti FM. Wood T. Torti SV. Hentze MW. Beard J. Connor J. Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress. J Neurosci Res. 2003;71:46–63. doi: 10.1002/jnr.10463. [DOI] [PubMed] [Google Scholar] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Coexposure to iron and H2O2 were shown to enhance α-synuclein aggregation in vitro (126).”
What the sources say
- Not checked yetcites [126] Hashimoto M. Hsu LJ. Xia Y. Takeda A. Sisk A. Sundsmo M. Masliah E. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. Neuroreport. 1999;10:717–721. doi: 10.1097/00001756-199903170-00011. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“IRP has an important role in the sensing of iron levels and transmission of signals to regulate posttranscriptionally a number of important factors involved in iron management (131).”
What the sources say
- Not checked yetcites [131] Hentze MW. Muckenthaler MU. Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell. 2004;117:285–297. doi: 10.1016/s0092-8674(04)00343-5. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Chelation of “labile iron” also protected cells from this toxicity, suggesting that iron may play a role in the pathogenesis of PD, at least in the MPTP model (159).”
What the sources say
- Not checked yetcites [159] Kaur D. Yantiri F. Rajagopalan S. Kumar J. Mo JQ. Boonplueang R. Viswanath V. Jacobs R. Yang L. Beal MF. DiMonte D. Volitaskis I. Ellerby L. Cherny RA. Bush AI. Andersen JK. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron. 2003;37:899–909. doi: 10.1016/s0896-6273(03)00126-0. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Furthermore, generation of heterozygous ferritin H–null mutants shows brain iron levels similar to those of the wild type, despite a 50% expression of ferritin H that corresponded with increases in proteins involved in iron regulation, such as Tf, TfR, ferritin L, DMT1, and Cp (291).”
What the sources say
- Not checked yetcites [291] Thompson K. Menzies S. Muckenthaler M. Torti FM. Wood T. Torti SV. Hentze MW. Beard J. Connor J. Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress. J Neurosci Res. 2003;71:46–63. doi: 10.1002/jnr.10463. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Cultured neurons from mice deficient in PERK (PKR-like ER kinase), which have an impaired UPR, exhibited enhanced sensitivity to 6-OHDA treatment (266).”
What the sources say
- Not checked yetcites [266] Ryu EJ. Harding HP. Angelastro JM. Vitolo OV. Ron D. Greene LA. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J Neurosci. 2002;22:10690–10698. doi: 10.1523/JNEUROSCI.22-24-10690.2002. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Depletion of ferritin iron induces the monoubiquitination of ferritin subunits.”
What the sources say
- Not checked yetcites [64] De Domenico I. Vaughn MB. Li L. Bagley D. Musci G. Ward DM. Kaplan J. Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J. 2006;25:5396–5404. doi: 10.1038/sj.emboj.7601409. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Evidence for a dual role of cytoprotective agent and mediator of iron-catalyzed ROS–mediated damage exists and warrants further examination.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In this study, five unique missense variations were identified including, a single incidence of I63T, D554E, which correlated with PD and positive ultrasound for increased substantia nigra iron levels, and R793H, which was linked to increased levels of iron levels in individuals with PD and their age/ethnic-matched individuals.”
What the sources say
- Not checked yetcites [134] Hochstrasser H. Bauer P. Walter U. Behnke S. Spiegel J. Csoti I. Zeiler B. Bornemann A. Pahnke J. Becker G. Riess O. Berg D. Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology. 2004;63:1912–1917. doi: 10.1212/01.wnl.0000144276.29988.c3. [DOI] [PubMed] [Google Scholar] source
plaincorrelationalSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“IRP2 was also sensitive to iron levels, whereas IRP1 was not, suggesting that IRP2 is the predominant posttranscriptional regulator of key genes involved iron homeostasis (200).”
What the sources say
- Not checked yetcites [200] Meyron-Holtz EG. Ghosh MC. Iwai K. LaVaute T. Brazzolotto X. Berger UV. Land W. Ollivierre-Wilson H. Grinberg A. Love P. Rouault TA. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J. 2004;23:386–395. doi: 10.1038/sj.emboj.7600041. [DOI] [PMC free article] [PubMed] [Google Scholar] source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Conditions of iron chelation may lead to ferritin being degraded through a lysosomal pathway (64).”
What the sources say
- Not checked yetcites [64] De Domenico I. Vaughn MB. Li L. Bagley D. Musci G. Ward DM. Kaplan J. Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J. 2006;25:5396–5404. doi: 10.1038/sj.emboj.7601409. [DOI] [PMC free article] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In addition, retention of the I63T mutant Cp isoform in the endoplasmic reticulum (ER) may lead to cell death.”
What the sources say
- Not checked yetcites [135] Hochstrasser H. Tomiuk J. Walter U. Behnke S. Spiegel J. Kruger R. Becker G. Riess O. Berg D. Functional relevance of ceruloplasmin mutations in Parkinson's disease. FASEB J. 2005;19:1851–1853. doi: 10.1096/fj.04-3486fje. [DOI] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Furthermore, generation of heterozygous ferritin H–null mutants shows brain iron levels similar to those of the wild type, despite a 50% expression of ferritin H that corresponded with increases in proteins involved in iron regulation, such as Tf, TfR, ferritin L, DMT1, and Cp (291).”
What the sources say
- Not checked yetcites [291] Thompson K. Menzies S. Muckenthaler M. Torti FM. Wood T. Torti SV. Hentze MW. Beard J. Connor J. Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress. J Neurosci Res. 2003;71:46–63. doi: 10.1002/jnr.10463. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In this study, five unique missense variations were identified including, a single incidence of I63T, D554E, which correlated with PD and positive ultrasound for increased substantia nigra iron levels, and R793H, which was linked to increased levels of iron levels in individuals with PD and their age/ethnic-matched individuals.”
What the sources say
- Not checked yetcites [134] Hochstrasser H. Bauer P. Walter U. Behnke S. Spiegel J. Csoti I. Zeiler B. Bornemann A. Pahnke J. Becker G. Riess O. Berg D. Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology. 2004;63:1912–1917. doi: 10.1212/01.wnl.0000144276.29988.c3. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Heme-transport proteins have recently been identified in several different cell types [reviewed in (174)].”
What the sources say
- Not checked yetcites [174] Latunde-Dada GO. Simpson RJ. McKie AT. Recent advances in mammalian haem transport. Trends Biochem Sci. 2006;31:182–188. doi: 10.1016/j.tibs.2006.01.005. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Cells derived from the cerebellum of neonatal Cp-knockout mice were more sensitive to oxidative stress in vitro (239).”
What the sources say
- Not checked yetcites [239] Patel BN. Dunn RJ. Jeong SY. Zhu Q. Julien JP. David S. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci. 2002;22:6578–6586. doi: 10.1523/JNEUROSCI.22-15-06578.2002. , [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Two different mutations in the ferritin L gene have been linked to neurodegenerative conditions (50, 62).”
What the sources say
- Not checked yetcites [50] Chinnery PF. Crompton DE. Birchall D. Jackson MJ. Coulthard A. Lombes A. Quinn N. Wills A. Fletcher N. Mottershead JP. Cooper P. Kellett M. Bates D. Burn J. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain. 2007;130:110–119. doi: 10.1093/brain/awl319. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [62] Curtis AR. Fey C. Morris CM. Bindoff LA. Ince PG. Chinnery PF. Coulthard A. Jackson MJ. Jackson AP. McHale DP. Hay D. Barker WA. Markham AF. Bates D. Curtis A. Burn J. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet. 2001;28:350–354. doi: 10.1038/ng571. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Histochemical analysis revealed abnormal ferritin and iron aggregates (62).”
What the sources say
- Not checked yetcites [62] Curtis AR. Fey C. Morris CM. Bindoff LA. Ince PG. Chinnery PF. Coulthard A. Jackson MJ. Jackson AP. McHale DP. Hay D. Barker WA. Markham AF. Bates D. Curtis A. Burn J. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet. 2001;28:350–354. doi: 10.1038/ng571. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Inability to export iron may explain tissue iron accumulation.”
What the sources say
- Not checked yetcites [148] Jeong SY. David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem. 2003;278:27144–27148. doi: 10.1074/jbc.M301988200. [DOI] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Shells formed with mutant L chains, which are normally involved in stability of assembled ferritin, may confer instability or enhanced degradation.”
What the sources say
- Not checked yetcites [311] Vidal R. Ghetti B. Takao M. Brefel-Courbon C. Uro-Coste E. Glazier BS. Siani V. Benson MD. Calvas P. Miravalle L. Rascol O. Delisle MB. Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol. 2004;63:363–380. doi: 10.1093/jnen/63.4.363. [DOI] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In addition, HeLa cells that express mutant ferritin L chains exhibited a phenotype of iron loading (61).”
What the sources say
- Not checked yetcites [61] Cozzi A. Santambrogio P. Corsi B. Campanella A. Arosio P. Levi S. Characterization of the l-ferritin variant 460InsA responsible of a hereditary ferritinopathy disorder. Neurobiol Dis. 2006;23:644–652. doi: 10.1016/j.nbd.2006.05.004. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition to increases in brain iron with age and in various pathologic conditions, altered brain iron metabolism is implicated in the pathogenesis of neurodegeneration by animal models involving mutation or deficiency in various proteins that regulate iron metabolism, or both, as well as by the neurodegenerative conditions caused by mutations in such proteins.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Another and less frequent mutation on ferritin L is a two-nucleotide insertion (498–499InsTC), which changes the final nine amino acids of the C-terminus (311).”
What the sources say
- Not checked yetcites [311] Vidal R. Ghetti B. Takao M. Brefel-Courbon C. Uro-Coste E. Glazier BS. Siani V. Benson MD. Calvas P. Miravalle L. Rascol O. Delisle MB. Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol. 2004;63:363–380. doi: 10.1093/jnen/63.4.363. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Adult Cp-knockout mice exhibited accumulation of iron in the cerebellum and brainstem that correlated with the development of deficits in coordination of movement (148).”
What the sources say
- Not checked yetcites [148] Jeong SY. David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem. 2003;278:27144–27148. doi: 10.1074/jbc.M301988200. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Over time, dystonias and dementia may develop (326).”
What the sources say
- Not checked yetcites [326] Xu X. Pin S. Gathinji M. Fuchs R. Harris ZL. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Ann N Y Acad Sci. 2004;1012:299–305. doi: 10.1196/annals.1306.024. [DOI] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“GPI-anchored Cp was required for export of iron from astrocytes (148) (Table 4).”
What the sources say
- Not checked yetcites [148] Jeong SY. David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem. 2003;278:27144–27148. doi: 10.1074/jbc.M301988200. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 159
- Probably not a substantial claim. 14
- The quote only partly states this claim. 1
In the paper
“when ferrous iron interacts with H2O2, it undergoes the Fenton reaction (229). The Fenton reaction produces ferric iron, −OH, and the hydroxyl radical. It may also result in the peroxidation of adjacent lipids and lead to oxidative damage of DNA and other macromolecules.”
What the sources say
- Not checked yetcites [229] Papanikolaou G. Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol. 2005;202:199–211. doi: 10.1016/j.taap.2004.06.021. [DOI] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Most cytoplasmic iron is in its reduced (ferrous) form.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Each of the homologous amino domains binds one atom of Fe3+.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In conjunction with this dichromatic nature, both severe iron overload and iron deficiency may be deleterious.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“iron deficiency is a serious problem that causes cell damage, reduction of cell growth and proliferation, hypoxia, and death.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In this sense, Tf serves as a storage sink for sequestering iron extracellularly until iron is needed, and then allowing it to reach target tissues.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The change in pH in the endosome causes the iron to disassociate from Tf, and it is then exported from the endosome into the cytosol by a divalent metal transporter after reduction of iron by a ferric reductase”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Furthermore, TfR2 is not redundant for TfR1, for TfR1 knockout is embryonically lethal (184), despite the presence of TfR2.”
What the sources say
- Not checked yetcites [184] Levy JE. Jin O. Fujiwara Y. Kuo F. Andrews NC. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet. 1999;21:396–399. doi: 10.1038/7727. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This protein, named heme carrier protein 1 (HCP1), is abundantly expressed on the brush border of enterocytes in the duodenum, the primary location of intestinal iron absorption, and it appears to mediate cellular heme uptake (Fig. 3).”
What the sources say
- Not checked yetcites [277] Shayeghi M. Latunde-Dada GO. Oakhill JS. Laftah AH. Takeuchi K. Halliday N. Khan Y. Warley A. McCann FE. Hider RC. Frazer DM. Anderson GJ. Vulpe CD. Simpson RJ. McKie AT. Identification of an intestinal heme transporter. Cell. 2005;122:789–801. doi: 10.1016/j.cell.2005.06.025. [DOI] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Deficiencies in TfR1 and TfR2 have different phenotypic outcomes: TfR1 deficiency results in low tissue iron levels, whereas TfR2 inadequacy leads to the development of hemochromatosis (34, 89).”
What the sources say
- Not checked yetcites [34] Camaschella C. Roetto A. Cali A. De Gobbi M. Garozzo G. Carella M. Majorano N. Totaro A. Gasparini P. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 2000;25:14–15. doi: 10.1038/75534. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [89] Fleming RE. Ahmann JR. Migas MC. Waheed A. Koeffler HP. Kawabata H. Britton RS. Bacon BR. Sly WS. Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis. Proc Natl Acad Sci U S A. 2002;99:10653–10658. doi: 10.1073/pnas.162360699. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Two different TfRs, TfR1 and TfR2, are expressed and serve as gatekeepers for iron-bound Tf (Fe-Tf) (Fig. 1).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Unlike TfR1, TfR2 does not contain an IRE in its mRNA and does not appear to be regulated in an iron-dependent manner (90, 315).”
What the sources say
- Not checked yetcites [90] Fleming RE. Migas MC. Holden CC. Waheed A. Britton RS. Tomatsu S. Bacon BR. Sly WS. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci U S A. 2000;97:2214–2219. doi: 10.1073/pnas.040548097. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [315] Waheed A. Parkkila S. Saarnio J. Fleming RE. Zhou XY. Tomatsu S. Britton RS. Bacon BR. Sly WS. Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. Proc Natl Acad Sci U S A. 1999;96:1579–1584. doi: 10.1073/pnas.96.4.1579. [DOI] [PMC free article] [PubMed] [Google Scholar] source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“IRP2 is degraded in conditions of iron excess, via a 73–amino acid domain called the iron-dependent degradation domain, which seems to be required for IRP2 degradation after protein oxidation by iron (140, 141).”
What the sources say
- Not checked yetcites [140] Iwai K. Drake SK. Wehr NB. Weissman AM. LaVaute T. Minato N. Klausner RD. Levine RL. Rouault TA. Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins. Proc Natl Acad Sci U S A. 1998;95:4924–4928. doi: 10.1073/pnas.95.9.4924. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [141] Iwai K. Klausner RD. Rouault TA. Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2. EMBO J. 1995;14:5350–5357. doi: 10.1002/j.1460-2075.1995.tb00219.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Stable overexpression of HFE in Chinese hamster ovary cells resulted in lower levels of TfR-mediated cellular iron uptake and decreased intracellular iron concentration (314).”
What the sources say
- Not checked yetcites [314] Waheed A. Grubb JH. Zhou XY. Tomatsu S. Fleming RE. Costaldi ME. Britton RS. Bacon BR. Sly WS. Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci U S A. 2002;99:3117–3122. doi: 10.1073/pnas.042701499. [DOI] [PMC free article] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“For example, during heme-mediated gene regulation, heme induces IRP2 oxidation on Cys201, which is followed by enhanced IRP2 degradation (328).”
What the sources say
- Not checked yetcites [328] Yamanaka K. Ishikawa H. Megumi Y. Tokunaga F. Kanie M. Rouault TA. Morishima I. Minato N. Ishimori K. Iwai K. Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2. Nat Cell Biol. 2003;5:336–340. doi: 10.1038/ncb952. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Five IREs are located in the 3′ UTR of TfR1, allowing the binding of IRP during iron-deficient conditions to stabilize the mRNA, thereby causing upregulation of TfR1 (41, 211).”
What the sources say
- Not checked yetcites [41] Casey JL. Hentze MW. Koeller DM. Caughman SW. Rouault TA. Klausner RD. Harford JB. Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science. 1988;240:924–928. doi: 10.1126/science.2452485. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [211] Mullner EW. Kuhn LC. A stem-loop in the 3’ untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell. 1988;53:815–825. doi: 10.1016/0092-8674(88)90098-0. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This NTBI appears to be primarily absorbed by the liver and may contribute to cellular iron loading.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Overexpression of murine Zip14 resulted in increased uptake of Fe2+ by HEK293 cells, whereas decreased Zip14 expression by siRNA decreased iron accumulation in murine hepatocyte, AML12 cells (188).”
What the sources say
- Not checked yetcites [188] Liuzzi JP. Aydemir F. Nam H. Knutson MD. Cousins RJ. Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci U S A. 2006;103:13612–13617. doi: 10.1073/pnas.0606424103. [DOI] [PMC free article] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These results suggest that TfR1 and TfR2 are differentially regulated and thereby may serve diverse roles in terms of iron sensing and regulation.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Heme iron is obtained from meat sources and is more readily absorbed than nonheme iron obtained from consumption of grains and vegetables.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
In the paper
“Its expression was increased by an iron-deficient diet, and it was highly expressed in the rat duodenum.”
What the sources say
- Not checked yetcites [117] Gunshin H. Mackenzie B. Berger UV. Gunshin Y. Romero MF. Boron WF. Nussberger S. Gollan JL. Hediger MA. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 1997;388:482–488. doi: 10.1038/41343. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Simultaneous studies characterized Fpn, which is abundantly expressed on the basolateral membrane of polarized enterocytes in the duodenum, in the cytosol of reticuloendothelial cells, and on the basal surface of syncytiotrophoblasts of the placenta (1, 72, 198).”
What the sources say
- Not checked yetcites [1] Abboud S. Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem. 2000;275:19906–19912. doi: 10.1074/jbc.M000713200. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [72] Donovan A. Brownlie A. Zhou Y. Shepard J. Pratt SJ. Moynihan J. Paw BH. Drejer A. Barut B. Zapata A. Law TC. Brugnara C. Lux SE. Pinkus GS. Pinkus JL. Kingsley PD. Palis J. Fleming MD. Andrews NC. Zon LI. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000;403:776–781. doi: 10.1038/35001596. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [198] McKie AT. Marciani P. Rolfs A. Brennan K. Wehr K. Barrow D. Miret S. Bomford A. Peters TJ. Farzaneh F. Hediger MA. Hentze MW. Simpson RJ. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000;5:299–309. doi: 10.1016/s1097-2765(00)80425-6. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The DMT1B promoter contains a putative NF-κB element, and NF-κB bound to this response element during differentiation (231).”
What the sources say
- Not checked yetcites [231] Paradkar PN. Roth JA. Post-translational and transcriptional regulation of DMT1 during P19 embryonic carcinoma cell differentiation by retinoic acid. Biochem J. 2006;394:173–183. doi: 10.1042/BJ20051296. [DOI] [PMC free article] [PubMed] [Google Scholar] source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In humans, deficiency in Cp results in a disease called aceruloplasminemia, which leads to late-onset degeneration of the retina and basal ganglia because of the pathologic accumulation of iron in various tissues, including the aforementioned affected tissues as well as the liver, spleen, and pancreas (106).”
What the sources say
- Not checked yetcites [106] Gitlin JD. Aceruloplasminemia. Pediatr Res. 1998;44:271–276. doi: 10.1203/00006450-199809000-00001. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“DMT1A is expressed mainly in the duodenum and in epithelial cells, whereas DMT1B is expressed predominantly in erythroid cells (38, 39).”
What the sources say
- Not checked yetcites [38] Canonne-Hergaux F. Gruenheid S. Ponka P. Gros P. Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron. Blood. 1999;93:4406–4417. [PubMed] [Google Scholar] source
- Not checked yetcites [39] Canonne-Hergaux F. Zhang AS. Ponka P. Gros P. Characterization of the iron transporter DMT1 (NRAMP2/DCT1) in red blood cells of normal and anemic mk/mk mice. Blood. 2001;98:3823–3830. doi: 10.1182/blood.v98.13.3823. [DOI] [PubMed] [Google Scholar]
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Mutations in this gene may cause autosomal dominant hemochromatosis; a missense mutation (A77D), which was proposed to lead to Fpn haploinsufficiency, was shown to be related to an iron-overloaded phenotype (205).”
What the sources say
- Not checked yetcites [205] Montosi G. Donovan A. Totaro A. Garuti C. Pignatti E. Cassanelli S. Trenor CC. Gasparini P. Andrews NC. Pietrangelo A. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest. 2001;108:619–623. doi: 10.1172/JCI13468. [DOI] [PMC free article] [PubMed] [Google Scholar]
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Increased nitric oxide levels during retinoic acid-induced differentiation of P19 cells resulted in the downregulation of both DMT+IRE and DMT-IRE isoforms as well as DMT1B, but not DMT1A (231).”
What the sources say
- Not checked yetcites [231] Paradkar PN. Roth JA. Post-translational and transcriptional regulation of DMT1 during P19 embryonic carcinoma cell differentiation by retinoic acid. Biochem J. 2006;394:173–183. doi: 10.1042/BJ20051296. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Years later, it was revealed that Cp has ferroxidase activity and catalyzes the oxidation of Fe2+ to Fe3+ (228) (see Fig. 4).”
What the sources say
- Not checked yetcites [228] Osaki S. Kinetic studies of ferrous ion oxidation with crystalline human ferroxidase (ceruloplasmin) J Biol Chem. 1966;241:5053–5059. [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Cp-knockout mice are normal at birth, but progressively accumulate iron, leading to a prominent elevation of iron content in the liver and spleen (123).”
What the sources say
- Not checked yetcites [123] Harris ZL. Durley AP. Man TK. Gitlin JD. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci U S A. 1999;96:10812–10817. doi: 10.1073/pnas.96.19.10812. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Fpn (also termed Ireg1, MTP1) was originally identified by positional cloning to identify the causative gene for hypochromic anemia of “weissherbst” mutant zebrafish (72).”
What the sources say
- Not checked yetcites [72] Donovan A. Brownlie A. Zhou Y. Shepard J. Pratt SJ. Moynihan J. Paw BH. Drejer A. Barut B. Zapata A. Law TC. Brugnara C. Lux SE. Pinkus GS. Pinkus JL. Kingsley PD. Palis J. Fleming MD. Andrews NC. Zon LI. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000;403:776–781. doi: 10.1038/35001596. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Recently, an endosomal ferric reductase, Steap3, was identified (222). It was shown to colocalize with TfR1 and DMT1, and furthermore, its deletion was associated with the nm1054 mouse, which has hypochromic microcytic anemia caused by a defect in Fe-Tf cycle (221, 222).”
What the sources say
- Not checked yetcites [221] Ohgami RS. Campagna DR. Antiochos B. Wood EB. Sharp JJ. Barker JE. Fleming MD. nm1054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse. Blood. 2005;106:3625–3631. doi: 10.1182/blood-2005-01-0379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Not checked yetcites [222] Ohgami RS. Campagna DR. Greer EL. Antiochos B. McDonald A. Chen J. Sharp JJ. Fujiwara Y. Barker JE. Fleming MD. Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet. 2005;37:1264–1269. doi: 10.1038/ng1658. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“at normal physiologic concentrations, nonheme iron does not readily cross a plasma membrane via passive diffusion; instead, it must be actively transported.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“DMT1A appears to be mostly localized to the apical membrane of polarized intestinal epithelial cells, and thus may play an important role in systemic iron absorption through the intestine, whereas DMT1B is more broadly expressed and also localized to erythroid cells (38, 39), suggesting that it may play a more widespread role in iron transport”
What the sources say
- Not checked yetcites [38] Canonne-Hergaux F. Gruenheid S. Ponka P. Gros P. Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron. Blood. 1999;93:4406–4417. [PubMed] [Google Scholar] source
- Not checked yetcites [39] Canonne-Hergaux F. Zhang AS. Ponka P. Gros P. Characterization of the iron transporter DMT1 (NRAMP2/DCT1) in red blood cells of normal and anemic mk/mk mice. Blood. 2001;98:3823–3830. doi: 10.1182/blood.v98.13.3823. [DOI] [PubMed] [Google Scholar]
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Hepcidin is synthesized by the liver as an 84–amino acid precursor, which is processed and then secreted as a final 25–amino acid peptide (232).”
What the sources say
- Not checked yetcites [232] Park CH. Valore EV. Waring AJ. Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276:7806–7810. doi: 10.1074/jbc.M008922200. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“The N-terminus of hepcidin is critical to the negative regulation of Fpn; deletion of all five of the amino acids of the N-terminus completely abrogated the hypoferremia (213).”
What the sources say
- Not checked yetcites [213] Nemeth E. Preza GC. Jung CL. Kaplan J. Waring AJ. Ganz T. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood. 2006;107:328–333. doi: 10.1182/blood-2005-05-2049. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“HFE2 is a BMP coreceptor, and its mutation suppresses BMP signaling (14).”
What the sources say
- Not checked yetcites [14] Babitt JL. Huang FW. Wrighting DM. Xia Y. Sidis Y. Samad TA. Campagna JA. Chung RT. Schneyer AL. Woolf CJ. Andrews NC. Lin HY. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006;38:531–539. doi: 10.1038/ng1777. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, in conditions of iron depletion, the translation of Fpn is decreased, resulting in a decrease in iron export.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The hepcidin promoter contains several CCAAT/enhancer-binding protein (C/EBP) consensus sequences. In addition, hepatocyte nuclear factor 4 and signal transducer and activator of transcription (STAT) motifs have also been identified in DNA encoding hepcidin (58).”
What the sources say
- Not checked yetcites [58] Courselaud B. Pigeon C. Inoue Y. Inoue J. Gonzalez FJ. Leroyer P. Gilot D. Boudjema K. Guguen-Guillouzo C. Brissot P. Loreal O. Ilyin G. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism: cross-talk between C/EBP pathway and iron metabolism. J Biol Chem. 2002;277:41163–41170. doi: 10.1074/jbc.M202653200. [DOI] [PubMed] [Google Scholar]
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The researchers treated primary human hepatocytes with LPS, observed an increase in hepcidin mRNA, and were able to abrogate the induction of hepcidin mRNA by treatment with anti-IL-6 antibodies.”
What the sources say
- Not checked yetcites [214] Nemeth E. Rivera S. Gabayan V. Keller C. Taudorf S. Pedersen BK. Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271–1276. doi: 10.1172/JCI20945. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“when Cp was absent, Fe2+ remained bound to Fpn, leading to ubiquitination on Fpn Lys253 (65).”
What the sources say
- Not checked yetcites [65] De Domenico I. Ward DM. di Patti MC. Jeong SY. David S. Musci G. Kaplan J. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 2007;26:2823–2831. doi: 10.1038/sj.emboj.7601735. [DOI] [PMC free article] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“IL-6-knockout mice did not increase hepcidin mRNA in response to turpentine, another stimulus causing inflammation, and correspondingly, they did not show a decrease in serum iron (214).”
What the sources say
- Not checked yetcites [214] Nemeth E. Rivera S. Gabayan V. Keller C. Taudorf S. Pedersen BK. Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271–1276. doi: 10.1172/JCI20945. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Fpn degradation is abrogated by oxidation, depletion of extracellular Fe2+, or mutation of Lys253 to Ala (65).”
What the sources say
- Not checked yetcites [65] De Domenico I. Ward DM. di Patti MC. Jeong SY. David S. Musci G. Kaplan J. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 2007;26:2823–2831. doi: 10.1038/sj.emboj.7601735. [DOI] [PMC free article] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Once inside the cell, Fpn is ubiquitinated after dephosphorylation, and ultimately, Fpn undergoes degradation in the lysosome (Fig. 6) (66).”
What the sources say
- Not checked yetcites [66] De Domenico I. Ward DM. Langelier C. Vaughn MB. Nemeth E. Sundquist WI. Ganz T. Musci G. Kaplan J. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell. 2007;18:2569–2578. doi: 10.1091/mbc.E07-01-0060. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“H expression is abundant in the heart, whereas the L subunit is predominant in the liver and spleen (125).”
What the sources say
- Not checked yetcites [125] Harrison PM. Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta. 1996;1275:161–203. doi: 10.1016/0005-2728(96)00022-9. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“the synthesized ferritins consist of only L-subunit homopolymers (85), which lack ferroxidase activity and has lower iron-incorporation capability (183).”
What the sources say
- Not checked yetcites [85] Ferreira C. Bucchini D. Martin ME. Levi S. Arosio P. Grand-champ B. Beaumont C. Early embryonic lethality of H ferritin gene deletion in mice. J Biol Chem. 2000;275:3021–3024. doi: 10.1074/jbc.275.5.3021. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [183] Levi S. Girelli D. Perrone F. Pasti M. Beaumont C. Corrocher R. Albertini A. Arosio P. Analysis of ferritins in lymphoblastoid cell lines and in the lens of subjects with hereditary hyperferritinemia-cataract syndrome. Blood. 1998;91:4180–4187. [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“hepatocytes and liver samples from mice with deleted von Hip-pel-Lindau (VHL), which is the negative regulator of HIF-1, were iron deficient and showed increased expression of Fpn (Fig. 7) (242).”
What the sources say
- Not checked yetcites [242] Peyssonnaux C. Zinkernagel AS. Schuepbach RA. Rankin E. Vaulont S. Haase VH. Nizet V. Johnson RS. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs) J Clin Invest. 2007;117:1926–1932. doi: 10.1172/JCI31370. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Oligodendrocytes have equal amounts of both H and L subunits, whereas microglia express L-rich ferritin, and neurons have H-subunit abundant ferritin (206, 333).”
What the sources say
- Not checked yetcites [206] Moos T. Morgan EH. The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann N Y Acad Sci. 2004;1012:14–26. doi: 10.1196/annals.1306.002. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [333] Zecca L. Stroppolo A. Gatti A. Tampellini D. Toscani M. Gallorini M. Giaveri G. Arosio P. Santambrogio P. Fariello RG. Karatekin E. Kleinman MH. Turro N. Hornykiewicz O. Zucca FA. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc Natl Acad Sci U S A. 2004;101:9843–9848. doi: 10.1073/pnas.0403495101. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Ferritin H is induced by NF-κB in response to TNF-α treatment, resulting in suppression of ROS and inhibition of apoptosis (243).”
What the sources say
- Not checked yetcites [243] Pham CG. Bubici C. Zazzeroni F. Papa S. Jones J. Alvarez K. Jayawardena S. De Smaele E. Cong R. Beaumont C. Torti FM. Torti SV. Franzoso G. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell. 2004;119:529–542. doi: 10.1016/j.cell.2004.10.017. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Ferritin H and L subunits are encoded by two different genes (322).”
What the sources say
- Not checked yetcites [322] Worwood M. Brook JD. Cragg SJ. Hellkuhl B. Jones BM. Perera P. Roberts SH. Shaw DJ. Assignment of human ferritin genes to chromosomes 11 and 19q13.3–––19qter. Hum Genet. 1985;69:371–374. doi: 10.1007/BF00291657. [DOI] [PubMed] [Google Scholar]
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Smad4-knockout mice had lower levels of hepcidin and did not induce hepcidin in response to iron loading or IL-6 stimulation (14).”
What the sources say
- Not checked yetcites [14] Babitt JL. Huang FW. Wrighting DM. Xia Y. Sidis Y. Samad TA. Campagna JA. Chung RT. Schneyer AL. Woolf CJ. Andrews NC. Lin HY. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006;38:531–539. doi: 10.1038/ng1777. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“the ferritin L subunit stabilizes ferritin structure and facilitates the uptake of iron into the shell (9).”
What the sources say
- Not checked yetcites [9] Arosio P. Levi S. Ferritin, iron homeostasis, and oxidative damage. Free Radic Biol Med. 2002;33:457–463. doi: 10.1016/s0891-5849(02)00842-0. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This ubiquitous protein consists of 24 subunits of heavy (H) and light (L) chains in various ratios and can sequester 4,500 iron atoms (125).”
What the sources say
- Not checked yetcites [125] Harrison PM. Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta. 1996;1275:161–203. doi: 10.1016/0005-2728(96)00022-9. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“administration of soluble HJV inhibited BMP-mediated induction of hepcidin and resulted in increased levels of Fpn in vivo (15).”
What the sources say
- Not checked yetcites [15] Babitt JL. Huang FW. Xia Y. Sidis Y. Andrews NC. Lin HY. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest. 2007;117:1933–1939. doi: 10.1172/JCI31342. [DOI] [PMC free article] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Serum ferritin has been thought to reflect the iron stores in the body and to increase as a secreted byproduct of intracellular ferritin synthesis (250, 297).”
What the sources say
- Not checked yetcites [250] Prieto J. Barry M. Sherlock S. Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology. 1975;68:525–533. [PubMed] [Google Scholar] source
- Not checked yetcites [297] Tran TN. Eubanks SK. Schaffer KJ. Zhou CY. Linder MC. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood. 1997;90:4979–4986. [PubMed] [Google Scholar] source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Several studies showed that ferritin also binds to erythroid precursors (100), brain tissue (138), and placental microvilli membranes (186).”
What the sources say
- Not checked yetcites [100] Gelvan D. Fibach E. Meyron-Holtz EG. Konijn AM. Ferritin uptake by human erythroid precursors is a regulated iron uptake pathway. Blood. 1996;88:3200–3207. [PubMed] [Google Scholar] source
- Not checked yetcites [138] Hulet SW. Powers S. Connor JR. Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains. J Neurol Sci. 1999;165:48–55. doi: 10.1016/s0022-510x(99)00077-5. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [186] Liao QK. Kong PA. Gao J. Li FY. Qian ZM. Expression of ferritin receptor in placental microvilli membrane in pregnant women with different iron status at mid-term gestation. Eur J Clin Nutr. 2001;55:651–656. doi: 10.1038/sj.ejcn.1601195. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The structure of mitochondrial ferritin was determined at 1.38 angstrom resolution and was very similar to that of ferritin H, with ∼80% homology in the amino acid sequences (172).”
What the sources say
- Not checked yetcites [172] Langlois d'Estaintot B. Santambrogio P. Granier T. Gallois B. Chevalier JM. Precigoux G. Levi S. Arosio P. Crystal structure and biochemical properties of the human mitochondrial ferritin and its mutant Ser144Ala. J Mol Biol. 2004;340:277–293. doi: 10.1016/j.jmb.2004.04.036. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Serum ferritin is identical to cytoplasmic ferritin, but the primary component of serum ferritin is the ferritin L subunit, which contains little iron (323).”
What the sources say
- Not checked yetcites [323] Worwood M. Dawkins S. Wagstaff M. Jacobs A. The purification and properties of ferritin from human serum. Biochem J. 1976;157:97–103. doi: 10.1042/bj1570097. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The highest expression level was observed in testis; other tissue has very little expression (74, 182).”
What the sources say
- Not checked yetcites [74] Drysdale J. Arosio P. Invernizzi R. Cazzola M. Volz A. Corsi B. Biasiotto G. Levi S. Mitochondrial ferritin: a new player in iron metabolism. Blood Cells Mol Dis. 2002;29:376–383. doi: 10.1006/bcmd.2002.0577. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [182] Levi S. Corsi B. Bosisio M. Invernizzi R. Volz A. Sanford D. Arosio P. Drysdale J. A human mitochondrial ferritin encoded by an intronless gene. J Biol Chem. 2001;276:24437–24440. doi: 10.1074/jbc.C100141200. [DOI] [PubMed] [Google Scholar]
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Mitochondrial ferritin was originally reported as an unusual intronless gene on chromosome 5q23.1 that encodes a 242–amino acid precursor of a ferritin H-like protein, which has a long N-terminal leader sequence with 60 amino acids for mitochondrial import (182).”
What the sources say
- Not checked yetcites [182] Levi S. Corsi B. Bosisio M. Invernizzi R. Volz A. Sanford D. Arosio P. Drysdale J. A human mitochondrial ferritin encoded by an intronless gene. J Biol Chem. 2001;276:24437–24440. doi: 10.1074/jbc.C100141200. [DOI] [PubMed] [Google Scholar]
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Lysosome-mediated ferritin degradation uses the autophagy system under particular conditions (173, 226) and iron chelator treatment (165)”
What the sources say
- Not checked yetcites [173] Larson JA. Howie HL. So M. Neisseria meningitidis accelerates ferritin degradation in host epithelial cells to yield an essential iron source. Mol Microbiol. 2004;53:807–820. doi: 10.1111/j.1365-2958.2004.04169.x. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [226] Ollinger K. Roberg K. Nutrient deprivation of cultured rat hepatocytes increases the desferrioxamine-available iron pool and augments the sensitivity to hydrogen peroxide. J Biol Chem. 1997;272:23707–23711. doi: 10.1074/jbc.272.38.23707. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [165] Konijn AM. Glickstein H. Vaisman B. Meyron-Holtz EG. Slotki IN. Cabantchik ZI. The cellular labile iron pool and intracellular ferritin in K562 cells. Blood. 1999;94:2128–2134. [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Amino acid and serum depletion activate autophagy, resulting in ferritin degradation, which sensitized cells to H2O2-induced oxidative stress because of an increased “labile iron” pool, which caused ROS production via the Fenton reaction (226).”
What the sources say
- Not checked yetcites [226] Ollinger K. Roberg K. Nutrient deprivation of cultured rat hepatocytes increases the desferrioxamine-available iron pool and augments the sensitivity to hydrogen peroxide. J Biol Chem. 1997;272:23707–23711. doi: 10.1074/jbc.272.38.23707. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“It appears that Fpn expression enhances ferritin degradation via a proteasomal degradation-dependent pathway, because proteasome inhibitors treatment prevented ferritin degradation (64).”
What the sources say
- Not checked yetcites [64] De Domenico I. Vaughn MB. Li L. Bagley D. Musci G. Ward DM. Kaplan J. Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J. 2006;25:5396–5404. doi: 10.1038/sj.emboj.7601409. [DOI] [PMC free article] [PubMed] [Google Scholar]
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Ferritoid is a 30-kDa protein consisting of 270 amino acids specifically expressed in corneal epithelial cells (201).”
What the sources say
- Not checked yetcites [201] Millholland JM. Fitch JM. Cai CX. Gibney EP. Beazley KE. Linsenmayer TF. Ferritoid, a tissue-specific nuclear transport protein for ferritin in corneal epithelial cells. J Biol Chem. 2003;278:23963–23970. doi: 10.1074/jbc.M210050200. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“IRP2-knockout mice showed abnormal induction of ferritin expression, resulting in iron misregulation in intestinal mucosa and the CNS (55, 200).”
What the sources say
- Not checked yetcites [55] Cooperman SS. Meyron-Holtz EG. Olivierre-Wilson H. Ghosh MC. McConnell JP. Rouault TA. Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2. Blood. 2005;106:1084–1091. doi: 10.1182/blood-2004-12-4703. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Not checked yetcites [200] Meyron-Holtz EG. Ghosh MC. Iwai K. LaVaute T. Brazzolotto X. Berger UV. Land W. Ollivierre-Wilson H. Grinberg A. Love P. Rouault TA. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J. 2004;23:386–395. doi: 10.1038/sj.emboj.7600041. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Nuclear ferritin was found to be glycosylated, and three potential glycosylation sites were identified in the N-terminal region (Thr1, Thr2, and Ser4) of ferritin H, whereas the ferritin L subunit appeared to contain only one (Ser2) (285).”
What the sources say
- Not checked yetcites [285] Surguladze N. Patton S. Cozzi A. Fried MG. Connor JR. Characterization of nuclear ferritin and mechanism of translocation. Biochem J. 2005;388:731–740. doi: 10.1042/BJ20041853. [DOI] [PMC free article] [PubMed] [Google Scholar] source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“iron binding to IRP1 competes with IRP1–IRE interaction, so that increased iron levels in cells enhances translation of ferritin proteins (317).”
What the sources say
- Not checked yetcites [317] Walden WE. Selezneva AI. Dupuy J. Volbeda A. Fontecilla-Camps JC. Theil EC. Volz K. Structure of dual function iron regulatory protein 1 complexed with ferritin IRE-RNA. Science. 2006;314:1903–1908. doi: 10.1126/science.1133116. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“the binding of this mutant ferritin H to DNA was lower and less effective for the protection of DNA from UV damage”
What the sources say
- Not checked yetcites [292] Thompson KJ. Fried MG. Ye Z. Boyer P. Connor JR. Regulation, mechanisms and proposed function of ferritin translocation to cell nuclei. J Cell Sci. 2002;115:2165–2177. doi: 10.1242/jcs.115.10.2165. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Nuclear ferritin is produced from the same mRNA as cytosolic ferritin and is composed predominantly of ferritin H”
What the sources say
- Not checked yetcites [31] Cai CX. Birk DE. Linsenmayer TF. Ferritin is a developmentally regulated nuclear protein of avian corneal epithelial cells. J Biol Chem. 1997;272:12831–12839. doi: 10.1074/jbc.272.19.12831. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [32] Cai CX. Birk DE. Linsenmayer TF. Nuclear ferritin protects DNA from UV damage in corneal epithelial cells. Mol Biol Cell. 1998;9:1037–1051. doi: 10.1091/mbc.9.5.1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“PMA induces IRP1 and IRP2 phosphorylation and enhances this binding to ferritin IRE, resulting in decreased ferritin expression during PMA induced HL-60 differentiation (269).”
What the sources say
- Not checked yetcites [269] Schalinske KL. Eisenstein RS. Phosphorylation and activation of both iron regulatory proteins 1 and 2 in HL-60 cells. J Biol Chem. 1996;271:7168–7176. doi: 10.1074/jbc.271.12.7168. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“H2O2-induced oxidative stress and phorbol 12-myristate 13-acetate (PMA) have been shown to modulate the activity of IRP1 and IRP2 (269).”
What the sources say
- Not checked yetcites [269] Schalinske KL. Eisenstein RS. Phosphorylation and activation of both iron regulatory proteins 1 and 2 in HL-60 cells. J Biol Chem. 1996;271:7168–7176. doi: 10.1074/jbc.271.12.7168. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Ferritin H translation was also shown to be transiently repressed by H2O2 treatment, in which IRP1 binding to the ferritin H IRE is increased (33, 303).”
What the sources say
- Not checked yetcites [33] Caltagirone A. Weiss G. Pantopoulos K. Modulation of cellular iron metabolism by hydrogen peroxide: effects of H2O2 on the expression and function of iron-responsive element-containing mRNAs in B6 fibroblasts. J Biol Chem. 2001;276:19738–19745. doi: 10.1074/jbc.M100245200. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [303] Tsuji Y. Ayaki H. Whitman SP. Morrow CS. Torti SV. Torti FM. Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol Cell Biol. 2000;20:5818–5827. doi: 10.1128/mcb.20.16.5818-5827.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“protein inhibitor of activated STAT3 (PIAS3) was identified as an ATF1-binding partner and was shown to reverse ATF1-mediated ferritin H ARE repression by blocking ATF1 binding to the ARE (142).”
What the sources say
- Not checked yetcites [142] Iwasaki K. Hailemariam K. Tsuji Y. PIAS3 interacts with ATF1 and regulates the human ferritin H gene through an antioxidant-responsive element. J Biol Chem. 2007;282:22335–22343. doi: 10.1074/jbc.M701477200. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“All NF-Y subunits, A, B, and C, were required for binding to DNA; then at least the NF-YA subunit was required to activate the ferritin H gene in response to hemin treatment during differentiation of monocytes to macrophages (194).”
What the sources say
- Not checked yetcites [194] Marziali G. Perrotti E. Ilari R. Testa U. Coccia EM. Battistini A. Transcriptional regulation of the ferritin heavy-chain gene: the activity of the CCAAT binding factor NF-Y is modulated in heme-treated Friend leukemia cells and during monocyte-to-macrophage differentiation. Mol Cell Biol. 1997;17:1387–1395. doi: 10.1128/mcb.17.3.1387. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“tBHQ, sulforaphane, hemin, and high levels of iron activated this element (133)”
What the sources say
- Not checked yetcites [133] Hintze KJ. Theil EC. DNA and mRNA elements with complementary responses to hemin, antioxidant inducers, and iron control ferritin-L expression. Proc Natl Acad Sci U S A. 2005;102:15048–15052. doi: 10.1073/pnas.0505148102. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“JunD was also involved in the transcriptional activation of the human ferritin H gene via the ARE during treatment of HepG2 hepatocarcinoma cells with H2O2 or tert-butylhydroquinone (tBHQ), in which JunD phosphorylation at Ser-100 was induced (301).”
What the sources say
- Not checked yetcites [301] Tsuji Y. JunD activates transcription of the human ferritin H gene through an antioxidant response element during oxidative stress. Oncogene. 2005;24:7567–7578. doi: 10.1038/sj.onc.1208901. [DOI] [PMC free article] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“NF-κB is activated by TNF-α and has been shown to induce mouse and human ferritin H (171, 243).”
What the sources say
- Not checked yetcites [171] Kwak EL. Larochelle DA. Beaumont C. Torti SV. Torti FM. Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. J Biol Chem. 1995;270:15285–15293. doi: 10.1074/jbc.270.25.15285. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [243] Pham CG. Bubici C. Zazzeroni F. Papa S. Jones J. Alvarez K. Jayawardena S. De Smaele E. Cong R. Beaumont C. Torti FM. Torti SV. Franzoso G. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell. 2004;119:529–542. doi: 10.1016/j.cell.2004.10.017. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The proximal region of the human ferritin H gene was activated by NF-Y and p300 during hemin-induced FLC differentiation, and this proximal region was also responsible for cAMP (80, 194, 248).”
What the sources say
- Not checked yetcites [80] Faniello MC. Bevilacqua MA. Condorelli G. de Crombrugghe B. Maity SN. Avvedimento VE. Cimino F. Costanzo F. The B subunit of the CAAT-binding factor NFY binds the central segment of the Co-activator p300. J Biol Chem. 1999;274:7623–7626. doi: 10.1074/jbc.274.12.7623. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [194] Marziali G. Perrotti E. Ilari R. Testa U. Coccia EM. Battistini A. Transcriptional regulation of the ferritin heavy-chain gene: the activity of the CCAAT binding factor NF-Y is modulated in heme-treated Friend leukemia cells and during monocyte-to-macrophage differentiation. Mol Cell Biol. 1997;17:1387–1395. doi: 10.1128/mcb.17.3.1387. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [248] Pilz RB. Impaired erythroid-specific gene expression in cAMP-dependent protein kinase-deficient murine erythroleukemia cells. J Biol Chem. 1993;268:20252–20258. [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This activation mechanism was achieved by interaction of the NF-Y B subunit with p300/CBP; formation of this protein complex was enhanced by cAMP treatment (80)”
What the sources say
- Not checked yetcites [80] Faniello MC. Bevilacqua MA. Condorelli G. de Crombrugghe B. Maity SN. Avvedimento VE. Cimino F. Costanzo F. The B subunit of the CAAT-binding factor NFY binds the central segment of the Co-activator p300. J Biol Chem. 1999;274:7623–7626. doi: 10.1074/jbc.274.12.7623. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Nrf2 disruption in mice enhanced susceptibility to severe airway inflammation, asthma, and cigarette smoke–induced emphysema (253, 254)”
What the sources say
- Not checked yetcites [253] Rangasamy T. Cho CY. Thimmulappa RK. Zhen L. Srisuma SS. Kensler TW. Yamamoto M. Petrache I. Tuder RM. Biswal S. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest. 2004;114:1248–1259. doi: 10.1172/JCI21146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Not checked yetcites [254] Rangasamy T. Guo J. Mitzner WA. Roman J. Singh A. Fryer AD. Yamamoto M. Kensler TW. Tuder RM. Georas SN. Biswal S. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med. 2005;202:47–59. doi: 10.1084/jem.20050538. [DOI] [PMC free article] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Nrf2-knockout mice developed normally and survived to adult stage”
What the sources say
- Not checked yetcites [45] Chan K. Lu R. Chang JC. Kan YW. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci U S A. 1996;93:13943–13948. doi: 10.1073/pnas.93.24.13943. [DOI] [PMC free article] [PubMed] [Google Scholar]
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although the primary function of frataxin is still elusive, it has been unveiled by various biochemical and genetic approaches that frataxin is involved in iron–sulfur cluster (ISC) biosynthesis and mitochondrial iron homeostasis.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Frataxin is a nuclear-encoded mitochondrial protein conserved from yeast to human (166), but with no homology with proteins of known functional domains.”
What the sources say
- Not checked yetcites [166] Koutnikova H. Campuzano V. Foury F. Dolle P. Cazzalini O. Koenig M. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet. 1997;16:345–351. doi: 10.1038/ng0897-345. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“It was demonstrated that yeast mature frataxin directly binds iron (2), in which iron triggers assembly of frataxin oligomerization.”
What the sources say
- Not checked yetcites [2] Adamec J. Rusnak F. Owen WG. Naylor S. Benson LM. Gacy AM. Isaya G. Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich ataxia. Am J Hum Genet. 2000;67:549–562. doi: 10.1086/303056. [DOI] [PMC free article] [PubMed] [Google Scholar] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“For instance, the disruption of the yeast frataxin homologue (YFH1) in yeast strain (Δyfh1) induced an accumulation of iron in mitochondria and enhanced their sensitivity to oxidative stress (by H2O2 and iron overload) (13, 93).”
What the sources say
- Not checked yetcites [13] Babcock M. de Silva D. Oaks R. Davis-Kaplan S. Jiralerspong S. Montermini L. Pandolfo M. Kaplan J. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science. 1997;276:1709–1712. doi: 10.1126/science.276.5319.1709. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [93] Foury F. Cazzalini O. Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria. FEBS Lett. 1997;411:373–377. doi: 10.1016/s0014-5793(97)00734-5. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The same research group generated frataxin-overexpressing mice, which also showed normal iron metabolism with no signs of abnormalities (203).”
What the sources say
- Not checked yetcites [203] Miranda CJ. Santos MM. Ohshima K. Tessaro M. Sequeiros J. Pandolfo M. Frataxin overexpressing mice. FEBS Lett. 2004;572:281–288. doi: 10.1016/j.febslet.2004.07.022. [DOI] [PubMed] [Google Scholar]
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The first evidence of frataxin's role in mitochondrial iron regulation was obtained by deletion of yeast frataxin homologue, YFH1, and characterization of the yeast phenotype, which revealed that the deletion of YFH1 caused mitochondrial iron accumulation and increased sensitivity to H2O2 toxicity (13).”
What the sources say
- Not checked yetcites [13] Babcock M. de Silva D. Oaks R. Davis-Kaplan S. Jiralerspong S. Montermini L. Pandolfo M. Kaplan J. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science. 1997;276:1709–1712. doi: 10.1126/science.276.5319.1709. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Furthermore, in a mouse FRDA model, antioxidants (MnSOD mimetic or CuZnSOD overexpression) had no beneficial effect on the FRDA cardiomyopathy, along with the evidence for the absence of increased oxidative stress or decreased SOD expression in FRDA mouse tissues (273).”
What the sources say
- Not checked yetcites [273] Seznec H. Simon D. Bouton C. Reutenauer L. Hertzog A. Golik P. Procaccio V. Patel M. Drapier JC. Koenig M. Puccio H. Friedreich ataxia: the oxidative stress paradox. Hum Mol Genet. 2005;14:463–474. doi: 10.1093/hmg/ddi042. [DOI] [PubMed] [Google Scholar]
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“FRDA is most commonly (96% to 98%) caused by the homozygous hyperexpansion of a GAA trinucleotide repeat in the first intron of the frataxin gene, which results in a marked repression of frataxin transcription (37).”
What the sources say
- Not checked yetcites [37] Campuzano V. Montermini L. Molto MD. Pianese L. Cossee M. Cavalcanti F. Monros E. Rodius F. Duclos F. Monticelli A. Zara F. Canizares J. Koutnikova H. Bidichandani SI. Gellera C. Brice A. Trouillas P. De Michele G. Filla A. De Frutos R. Palau F. Patel PI. Di Donato S. Mandel JL. Cocozza S. Koenig M. Pandolfo M. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996;271:1423–1427. doi: 10.1126/science.271.5254.1423. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“It was demonstrated that the skeletal muscle of FRDA patients had impaired mitochondrial respiration and a profound deficit of ATP production (189)”
What the sources say
- Not checked yetcites [189] Lodi R. Cooper JM. Bradley JL. Manners D. Styles P. Taylor DJ. Schapira AH. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc Natl Acad Sci U S A. 1999;96:11492–11495. doi: 10.1073/pnas.96.20.11492. [DOI] [PMC free article] [PubMed] [Google Scholar]
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In yeast frataxin, the MPP cleaves the N-terminal 20 amino acids in the first step, followed by the second cleavage that gives rise to the mature yeast frataxin, consisting of 123 amino acids (aa 52 to 174) (28)”
What the sources say
- Not checked yetcites [28] Branda SS. Cavadini P. Adamec J. Kalousek F. Taroni F. Isaya G. Yeast and human frataxin are processed to mature form in two sequential steps by the mitochondrial processing peptidase. J Biol Chem. 1999;274:22763–22769. doi: 10.1074/jbc.274.32.22763. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Oligomycin-mediated oxidative stress induced both superoxide dismutases (SODs) and iron import in normal fibroblasts, whereas these responses were attenuated in FRDA patients' fibroblasts, suggesting that frataxin deficiency impairs an antioxidant defense mechanism (46).”
What the sources say
- Not checked yetcites [46] Chantrel-Groussard K. Geromel V. Puccio H. Koenig M. Munnich A. Rotig A. Rustin P. Disabled early recruitment of antioxidant defenses in Friedreich's ataxia. Hum Mol Genet. 2001;10:2061–2067. doi: 10.1093/hmg/10.19.2061. [DOI] [PubMed] [Google Scholar]
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“These mice exhibited a reduced life span and development of multiple hepatic tumor growths (289).”
What the sources say
- Not checked yetcites [289] Thierbach R. Schulz TJ. Isken F. Voigt A. Mietzner B. Drewes G. von Kleist-Retzow JC. Wiesner RJ. Magnuson MA. Puccio H. Pfeiffer AF. Steinberg P. Ristow M. Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice. Hum Mol Genet. 2005;14:3857–3864. doi: 10.1093/hmg/ddi410. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Homozygous deletions in the frataxin gene in mice caused embryonic lethality, indicating an important role of frataxin in mouse development (57).”
What the sources say
- Not checked yetcites [57] Cossee M. Puccio H. Gansmuller A. Koutnikova H. Dierich A. LeMeur M. Fischbeck K. Dolle P. Koenig M. Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum Mol Genet. 2000;9:1219–1226. doi: 10.1093/hmg/9.8.1219. [DOI] [PubMed] [Google Scholar]
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In both wild-type and frataxin transgenic mice, 5 mg/kg of doxorubicin challenge increased similar levels of serum creatine kinase and lactate dehydrogenase, markers for heart and skeletal muscle damage, suggesting that overexpression of frataxin did not protect from doxorubicin-induced cardiotoxicity (203).”
What the sources say
- Not checked yetcites [203] Miranda CJ. Santos MM. Ohshima K. Tessaro M. Sequeiros J. Pandolfo M. Frataxin overexpressing mice. FEBS Lett. 2004;572:281–288. doi: 10.1016/j.febslet.2004.07.022. [DOI] [PubMed] [Google Scholar]
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In contrast to these observations, homozygous insertion of a (GAA)230 repeat into the mouse frataxin gene (averaging 75% of wild-type frataxin expression levels) or heterozygous frataxin(-)/(GAA)230 repeat (reduction to 25% to 36% of wild-type mice frataxin levels that are compatible with frataxin expression level in mild but clinically evident FRDA patients) showed no obvious pathologic phenotype”
What the sources say
- Not checked yetcites [202] Miranda CJ. Santos MM. Ohshima K. Smith J. Li L. Bunting M. Cossee M. Koenig M. Sequeiros J. Kaplan J. Pandolfo M. Frataxin knockin mouse. FEBS Lett. 2002;512:291–297. doi: 10.1016/s0014-5793(02)02251-2. [DOI] [PubMed] [Google Scholar]
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Furthermore, yeast frataxin mutations that impair its ferroxidation or mineralization activity increased sensitivity to oxidative stress, suggesting the role of frataxin in iron detoxification and antioxidant defense (97).”
What the sources say
- Not checked yetcites [97] Gakh O. Park S. Liu G. Macomber L. Imlay JA. Ferreira GC. Isaya G. Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity. Hum Mol Genet. 2006;15:467–479. doi: 10.1093/hmg/ddi461. [DOI] [PubMed] [Google Scholar]
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“However, in FRDA patient lymphoblast and fibroblast cell lines, no difference was found between control and FRDA patient cells in the concentration of mitochondrial chelatable iron or TfR-mediated iron transport (283)”
What the sources say
- Not checked yetcites [283] Sturm B. Bistrich U. Schranzhofer M. Sarsero JP. Rauen U. Scheiber-Mojdehkar B. de Groot H. Ioannou P. Petrat F. Friedreich's ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts: a decrease in antioxidative capacity? J Biol Chem. 2005;280:6701–6708. doi: 10.1074/jbc.M408717200. [DOI] [PubMed] [Google Scholar]
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“As a potential pathogenesis of FRDA, increase in glutathionylation of total proteins was demonstrated in fibroblasts of FRDA patients, probably because of accumulation of iron and ROS.”
What the sources say
- Not checked yetcites [236] Pastore A. Tozzi G. Gaeta LM. Bertini E. Serafini V. Di Cesare S. Bonetto V. Casoni F. Carrozzo R. Federici G. Piemonte F. Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: a potential role in the pathogenesis of the disease. J Biol Chem. 2003;278:42588–42595. doi: 10.1074/jbc.M301872200. [DOI] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The GAA repeat in FRDA patients ranges from 100 to >1,000 repeats, whereas normal individuals have fewer than 35 repeats (37).”
What the sources say
- Not checked yetcites [37] Campuzano V. Montermini L. Molto MD. Pianese L. Cossee M. Cavalcanti F. Monros E. Rodius F. Duclos F. Monticelli A. Zara F. Canizares J. Koutnikova H. Bidichandani SI. Gellera C. Brice A. Trouillas P. De Michele G. Filla A. De Frutos R. Palau F. Patel PI. Di Donato S. Mandel JL. Cocozza S. Koenig M. Pandolfo M. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996;271:1423–1427. doi: 10.1126/science.271.5254.1423. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Furthermore, targeted disruption of hepatic frataxin expression caused increased oxidative stress, impaired mitochondrial function of respiration and ATP synthesis, along with decreased activity of ISC-containing proteins in liver (289).”
What the sources say
- Not checked yetcites [289] Thierbach R. Schulz TJ. Isken F. Voigt A. Mietzner B. Drewes G. von Kleist-Retzow JC. Wiesner RJ. Magnuson MA. Puccio H. Pfeiffer AF. Steinberg P. Ristow M. Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice. Hum Mol Genet. 2005;14:3857–3864. doi: 10.1093/hmg/ddi410. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The disease phenotype is prominent in the heart tissue and nervous system, suggesting that the required amount of frataxin in each tissue may be variable.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Similarly, cells derived from FRDA patients contained 40% increase in mitochondrial iron content and were more susceptible to iron-mediated cytotoxicity and hydrogen peroxide (287, 321)”
What the sources say
- Not checked yetcites [287] Tan G. Chen LS. Lonnerdal B. Gellera C. Taroni FA. Cortopassi GA. Frataxin expression rescues mitochondrial dysfunctions in FRDA cells. Hum Mol Genet. 2001;10:2099–2107. doi: 10.1093/hmg/10.19.2099. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [321] Wong A. Yang J. Cavadini P. Gellera C. Lonnerdal B. Taroni F. Cortopassi G. The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet. 1999;8:425–430. doi: 10.1093/hmg/8.3.425. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In yeast, it was demonstrated that frataxin is involved in mitochondrial iron efflux (252) or iron storage (96, 234).”
What the sources say
- Not checked yetcites [252] Radisky DC. Babcock MC. Kaplan J. The yeast frataxin homologue mediates mitochondrial iron efflux: evidence for a mitochondrial iron cycle. J Biol Chem. 1999;274:4497–4499. doi: 10.1074/jbc.274.8.4497. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [96] Gakh O. Adamec J. Gacy AM. Twesten RD. Owen WG. Isaya G. Physical evidence that yeast frataxin is an iron storage protein. Biochemistry. 2002;41:6798–6804. doi: 10.1021/bi025566+. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [234] Park S. Gakh O. O'Neill HA. Mangravita A. Nichol H. Ferreira GC. Isaya G. Yeast frataxin sequentially chaperones and stores iron by coupling protein assembly with iron oxidation. J Biol Chem. 2003;278:31340–31351. doi: 10.1074/jbc.M303158200. [DOI] [PubMed] [Google Scholar] source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The most abundant frataxin mRNA is a transcript from exon 1 to exon 5a, with a size of 1.3 kb (37).”
What the sources say
- Not checked yetcites [37] Campuzano V. Montermini L. Molto MD. Pianese L. Cossee M. Cavalcanti F. Monros E. Rodius F. Duclos F. Monticelli A. Zara F. Canizares J. Koutnikova H. Bidichandani SI. Gellera C. Brice A. Trouillas P. De Michele G. Filla A. De Frutos R. Palau F. Patel PI. Di Donato S. Mandel JL. Cocozza S. Koenig M. Pandolfo M. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996;271:1423–1427. doi: 10.1126/science.271.5254.1423. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Frataxin was also found to interact with aconitase in a citrate-dependent manner and protects or restores the aconitase activity by converting the inactive [3Fe-4S]1+ form to the active [4Fe-4S]2+ form of aconitase (29).”
What the sources say
- Not checked yetcites [29] Bulteau AL. O'Neill HA. Kennedy MC. Ikeda-Saito M. Isaya G. Szweda LI. Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity. Science. 2004;305:242–245. doi: 10.1126/science.1098991. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Growing evidence indicates that frataxin is involved in heme (ferrous-protoporphyrin IX) synthesis and ISC formation through interactions with proteins involved in these biosynthesis pathways (Table 2).”
What the sources say
- Not checked yetcites Table 2
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Interestingly, expression of human mitochondrial ferritin (ferritin H-like protein) or human ferritin L-chain rescued frataxin-deficient yeast (36, 70), suggesting functional homology between iron-storage protein ferritin and frataxin.”
What the sources say
- Not checked yetcites [36] Campanella A. Isaya G. O'Neill HA. Santambrogio P. Cozzi A. Arosio P. Levi S. The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast. Hum Mol Genet. 2004;13:2279–2288. doi: 10.1093/hmg/ddh232. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [70] Desmyter L. Dewaele S. Reekmans R. Nystrom T. Contreras R. Chen C. Expression of the human ferritin light chain in a frataxin mutant yeast affects ageing and cell death. Exp Gerontol. 2004;39:707–715. doi: 10.1016/j.exger.2004.01.008. [DOI] [PubMed] [Google Scholar]
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“It was reported that aconitase (an ISC-containing citric cycle enzyme that converts citrate to isocitrate) and mitochondrial ISC respiratory complexes I, II, and III are deficient in YFH1-deleted yeast, as well as FRDA patient cells (261), resulting in defects in ISC protein maturation, respiratory deficiency, and mitochondrial iron accumulation (47, 209).”
What the sources say
- Not checked yetcites [261] Rotig A. de Lonlay P. Chretien D. Foury F. Koenig M. Sidi D. Munnich A. Rustin P. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet. 1997;17:215–217. doi: 10.1038/ng1097-215. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [47] Chen OS. Hemenway S. Kaplan J. Inhibition of Fe-S cluster biosynthesis decreases mitochondrial iron export: evidence that Yfh1p affects Fe-S cluster synthesis. Proc Natl Acad Sci U S A. 2002;99:12321–12326. doi: 10.1073/pnas.192449599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Not checked yetcites [209] Muhlenhoff U. Richhardt N. Ristow M. Kispal G. Lill R. The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins. Hum Mol Genet. 2002;11:2025–2036. doi: 10.1093/hmg/11.17.2025. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The frataxin-deficient yeast also showed more production of hydrogen peroxide, higher sensitivity to DNA-damaging agents, and increased chromosomal instability (152), suggesting that detoxification of mitochondrial iron is a primary function of frataxin (97).”
What the sources say
- Not checked yetcites [152] Karthikeyan G. Lewis LK. Resnick MA. The mitochondrial protein frataxin prevents nuclear damage. Hum Mol Genet. 2002;11:1351–1362. doi: 10.1093/hmg/11.11.1351. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [97] Gakh O. Park S. Liu G. Macomber L. Imlay JA. Ferreira GC. Isaya G. Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity. Hum Mol Genet. 2006;15:467–479. doi: 10.1093/hmg/ddi461. [DOI] [PubMed] [Google Scholar]
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The attempt to restore frataxin expression by specifically targeting expanded GAA:TTC repeat demonstrated that β-alanine–linked polyamides bind the GAA:TTC repeat, resulting in disruption of the sticky-DNA conformation and alleviation of transcriptional repression of the frataxin gene in the FRDA lymphoid cell line (30).”
What the sources say
- Not checked yetcites [30] Burnett R. Melander C. Puckett JW. Son LS. Wells RD. Dervan PB. Gottesfeld JM. DNA sequence-specific polyamides alleviate transcription inhibition associated with long GAA.TTC repeats in Friedreich's ataxia. Proc Natl Acad Sci USA. 2006;103:11497–11502. doi: 10.1073/pnas.0604939103. [DOI] [PMC free article] [PubMed] [Google Scholar]
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Yeast Mrs3 and Mrs4 were shown to serve as mitochondrial iron-transport proteins (94) and to cooperate with YFH1 in providing iron for heme synthesis (335).”
What the sources say
- Not checked yetcites [94] Foury F. Roganti T. Deletion of the mitochondrial carrier genes MRS3 and MRS4 suppresses mitochondrial iron accumulation in a yeast frataxin-deficient strain. J Biol Chem. 2002;277:24475–24483. doi: 10.1074/jbc.M111789200. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [335] Zhang Y. Lyver ER. Knight SA. Lesuisse E. Dancis A. Frataxin and mitochondrial carrier proteins, Mrs3p and Mrs4p, cooperate in providing iron for heme synthesis. J Biol Chem. 2005;280:19794–19807. doi: 10.1074/jbc.M500397200. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The human frataxin gene is located on chromosome 9 (q13-q21.1) consisting of seven exons spanning >95 kb of the genomic DNA (37).”
What the sources say
- Not checked yetcites [37] Campuzano V. Montermini L. Molto MD. Pianese L. Cossee M. Cavalcanti F. Monros E. Rodius F. Duclos F. Monticelli A. Zara F. Canizares J. Koutnikova H. Bidichandani SI. Gellera C. Brice A. Trouillas P. De Michele G. Filla A. De Frutos R. Palau F. Patel PI. Di Donato S. Mandel JL. Cocozza S. Koenig M. Pandolfo M. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996;271:1423–1427. doi: 10.1126/science.271.5254.1423. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“which was rescued by treatment with the iron chelator deferoxamine (321) or by near-physiologic levels of frataxin expression (287).”
What the sources say
- Not checked yetcites [321] Wong A. Yang J. Cavadini P. Gellera C. Lonnerdal B. Taroni F. Cortopassi G. The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet. 1999;8:425–430. doi: 10.1093/hmg/8.3.425. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [287] Tan G. Chen LS. Lonnerdal B. Gellera C. Taroni FA. Cortopassi GA. Frataxin expression rescues mitochondrial dysfunctions in FRDA cells. Hum Mol Genet. 2001;10:2099–2107. doi: 10.1093/hmg/10.19.2099. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In the same study, YFH1 was shown to interact with the yeast ferrochelatase (Hem15p) in vitro, and that the YFH1 deficiency resulted in the defect of iron use in ferrochelatase activity (181).”
What the sources say
- Not checked yetcites [181] Lesuisse E. Santos R. Matzanke BF. Knight SA. Camadro JM. Dancis A. Iron use for haeme synthesis is under control of the yeast frataxin homologue (Yfh1) Hum Mol Genet. 2003;12:879–889. doi: 10.1093/hmg/ddg096. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In human mature frataxin, the structure is compact, with no signature of iron binding or oligomerization in the presence of iron (212)”
What the sources say
- Not checked yetcites [212] Musco G. Stier G. Kolmerer B. Adinolfi S. Martin S. Frenkiel T. Gibson T. Pastore A. Towards a structural understanding of Friedreich's ataxia: the solution structure of frataxin. Structure. 2000;8:695–707. doi: 10.1016/s0969-2126(00)00158-1. [DOI] [PubMed] [Google Scholar]
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Turning off the yeast frataxin promoter in an inducible system caused accumulation of iron in mitochondria and resulted in mitochondrial and nuclear oxidative DNA damage (153).”
What the sources say
- Not checked yetcites [153] Karthikeyan G. Santos JH. Graziewicz MA. Copeland WC. Isaya G. Van Houten B. Resnick MA. Reduction in frataxin causes progressive accumulation of mitochondrial damage. Hum Mol Genet. 2003;12:3331–3342. doi: 10.1093/hmg/ddg349. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“whereas the mature human frataxin was reported to assemble in >600-kDa homopolymers and bind ∼10 atoms of iron per frataxin oligomer (44).”
What the sources say
- Not checked yetcites [44] Cavadini P. O'Neill HA. Benada O. Isaya G. Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia. Hum Mol Genet. 2002;11:217–227. doi: 10.1093/hmg/11.3.217. [DOI] [PubMed] [Google Scholar]
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Type 1 HH is associated with several mutations of the HFE gene, which was originally identified during an analysis of 178 individuals with HH (82).”
What the sources say
- Not checked yetcites [82] Feder JN. Gnirke A. Thomas W. Tsuchihashi Z. Ruddy DA. Basava A. Dormishian F. Domingo R Jr. Ellis MC. Fullan A. Hinton LM. Jones NL. Kimmel BE. Kronmal GS. Lauer P. Lee VK. Loeb DB. Mapa FA. McClelland E. Meyer NC. Mintier GA. Moeller N. Moore T. Morikang E. Prass CE. Quintana L. Starnes SM. Schatzman RC. Brunke KJ. Drayna DT. Risch NJ. Bacon BR. Wolff RK. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408. doi: 10.1038/ng0896-399. [DOI] [PubMed] [Google Scholar] source
plaincorrelationaln = 178- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Hereditary hemochromatosis (HH) is the most common form of iron-overload disorder in individuals of northern European descent (299).”
What the sources say
- Not checked yetcites [299] Trinder D. Fox C. Vautier G. Olynyk JK. Molecular pathogenesis of iron overload. Gut. 2002;51:290–295. doi: 10.1136/gut.51.2.290. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Individuals with juvenile hemochromatosis incur cardiomyopathies, liver cirrhosis, and diabetes, and have increased morbidity associated with a decreased life expectancy because of systemic organ failure (244).”
What the sources say
- Not checked yetcites [244] Pietrangelo A. Hereditary hemochromatosis: a new look at an old disease. N Engl J Med. 2004;350:2383–2397. doi: 10.1056/NEJMra031573. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“HFE2 is a GPI-anchored protein that appears to be a sensor of dietary iron levels (230).”
What the sources say
- Not checked yetcites [230] Papanikolaou G. Samuels ME. Ludwig EH. MacDonald ML. Franchini PL. Dube MP. Andres L. MacFarlane J. Sakellaropoulos N. Politou M. Nemeth E. Thompson J. Risler JK. Zaborowska C. Babakaiff R. Radomski CC. Pape TD. Davidas O. Christakis J. Brissot P. Lockitch G. Ganz T. Hayden MR. Goldberg YP. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet. 2004;36:77–82. doi: 10.1038/ng1274. [DOI] [PubMed] [Google Scholar] source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In a mouse model for FRDA, the antioxidant Idebenone delayed the onset of cardiac dysfunction without improvement of deficiency in ISC proteins (274).”
What the sources say
- Not checked yetcites [274] Seznec H. Simon D. Monassier L. Criqui-Filipe P. Gansmuller A. Rustin P. Koenig M. Puccio H. Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia. Hum Mol Genet. 2004;13:1017–1024. doi: 10.1093/hmg/ddh114. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In addition, frataxin-encoding adeno-associated virus and lentivirus vectors increased frataxin expression and decreased sensitivity to oxidant stress in primary FRDA patient fibroblasts (86).”
What the sources say
- Not checked yetcites [86] Fleming J. Spinoulas A. Zheng M. Cunningham SC. Ginn SL. McQuilty RC. Rowe PB. Alexander IE. Partial correction of sensitivity to oxidant stress in Friedreich ataxia patient fibroblasts by frataxin-encoding adeno-associated virus and lentivirus vectors. Hum Gene Ther. 2005;16:947–956. doi: 10.1089/hum.2005.16.947. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Normal HFE protein associates with TfR, usually in conjunction with β2-microglobulin, and competes with Tf for TfR binding, thereby inhibiting Fe-Tf uptake via the TfR in cells (83, 179).”
What the sources say
- Not checked yetcites [83] Feder JN. Penny DM. Irrinki A. Lee VK. Lebron JA. Watson N. Tsuchihashi Z. Sigal E. Bjorkman PJ. Schatzman RC. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A. 1998;95:1472–1477. doi: 10.1073/pnas.95.4.1472. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Not checked yetcites [179] Lebron JA. West AP Jr. Bjorkman PJ. The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor. J Mol Biol. 1999;294:239–245. doi: 10.1006/jmbi.1999.3252. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In mice, HFE2 is localized to the surface of periportal hepatocytes, and HFE2-mutant mice display iron loading and a striking decrease in hepcidin upregulation in response to increased iron from exogenous sources, compared with controls (217).”
What the sources say
- Not checked yetcites [217] Niederkofler V. Salie R. Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest. 2005;115:2180–2186. doi: 10.1172/JCI25683. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, mutation of HFE2 appears to impede normal iron sensing, thus possibly allowing increased iron uptake through decreased expression of hepcidin, the negative regulator of Fpn.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Further studies demonstrated that the C282Y HFE mutant is retained in the ER and Golgi and is rapidly degraded (316).”
What the sources say
- Not checked yetcites [316] Waheed A. Parkkila S. Zhou XY. Tomatsu S. Tsuchihashi Z. Feder JN. Schatzman RC. Britton RS. Bacon BR. Sly WS. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci U S A. 1997;94:12384–12389. doi: 10.1073/pnas.94.23.12384. [DOI] [PMC free article] [PubMed] [Google Scholar]
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Resulting iron overload leads to a number of different pathologies, including structural damage from physical iron accumulation and oxidative damage to tissue, protein, lipids, and DNA resulting from iron-induced oxidative stress (229).”
What the sources say
- Not checked yetcites [229] Papanikolaou G. Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol. 2005;202:199–211. doi: 10.1016/j.taap.2004.06.021. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Recently, HIF-2α knockout mice were shown to have impaired mitochondrial respiration, sensitized mitochondrial permeability transition pore opening, and reduced activity of aconitase, because of marked reduction of frataxin mRNA expression in HIF-2α−/−livers (224).”
What the sources say
- Not checked yetcites [224] Oktay Y. Dioum E. Matsuzaki S. Ding K. Yan LJ. Haller RG. Szweda LI. Garcia JA. Hypoxia-inducible factor 2alpha regulates expression of the mitochondrial aconitase chaperone protein frataxin. J Biol Chem. 2007;282:11750–11756. doi: 10.1074/jbc.M611133200. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Another mutation (H63D) in HFE is commonly observed, but does not lead to the same HH phenotype, probably because it is processed and expressed in the same manner as wild-type HFE (316).”
What the sources say
- Not checked yetcites [316] Waheed A. Parkkila S. Zhou XY. Tomatsu S. Tsuchihashi Z. Feder JN. Schatzman RC. Britton RS. Bacon BR. Sly WS. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci U S A. 1997;94:12384–12389. doi: 10.1073/pnas.94.23.12384. [DOI] [PMC free article] [PubMed] [Google Scholar]
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“This mutation disrupts the formation of the disulfide bridge, which appears to be necessary for proper protein formation, causing the aberrant protein remains in the Golgi (24, 83).”
What the sources say
- Not checked yetcites [24] Bjorkman PJ. Parham P. Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem. 1990;59:253–288. doi: 10.1146/annurev.bi.59.070190.001345. [DOI] [PubMed] [Google Scholar]
- Not checked yetcites [83] Feder JN. Penny DM. Irrinki A. Lee VK. Lebron JA. Watson N. Tsuchihashi Z. Sigal E. Bjorkman PJ. Schatzman RC. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A. 1998;95:1472–1477. doi: 10.1073/pnas.95.4.1472. [DOI] [PMC free article] [PubMed] [Google Scholar] source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Studies of several mutant isoforms of HFE2 in HeLa and HepG2 cells revealed that several of the mutations resulted in the loss of the GPI anchor and were primarily retained in the ER or secreted as soluble protein (278).”
What the sources say
- Not checked yetcites [278] Silvestri L. Pagani A. Fazi C. Gerardi G. Levi S. Arosio P. Camaschella C. Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis. Blood. 2007;109:4503–4510. doi: 10.1182/blood-2006-08-041004. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“HH is classified on a genetic, biochemical, and clinical basis as types 1 through 4. The phenotype/clinical outcomes are used to determine the type (1 to 4) of hemochromatosis (210).”
What the sources say
- Not checked yetcites [210] Muir WA. McLaren GD. Braun W. Askari A. Evidence for heterogeneity in hereditary hemochromatosis: evaluation of 174 persons in nine families. Am J Med. 1984;76:806–814. doi: 10.1016/0002-9343(84)90991-4. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Initially, the deleterious effects of iron loading are not clinically significant, and manifest as discomfort in hand joints, increased skin pigmentation, and fatigue (16).”
What the sources say
- Not checked yetcites [16] Barton JC. Bertoli LF. Hemochromatosis: the genetic disorder of the twenty-first century. Nat Med. 1996;2:394–395. doi: 10.1038/nm0496-394. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These outcomes resulting from aberrant iron regulation indicate that either iron accumulation or oxidative damage may be involved in damage to sensitive systems such as the eye.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Iron deficiency may have deleterious effects on neurotransmission, myelination, and dopamine receptor and transporter functions (18).”
What the sources say
- Not checked yetcites [18] Beard J. Iron deficiency alters brain development and functioning. J Nutr. 2003;133:1468S–1472S. doi: 10.1093/jn/133.5.1468S. [DOI] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Type 3 HH is pathophysiologically similar to type 1; however, it occurs as a result of a mutation in TfR2 (34).”
What the sources say
- Not checked yetcites [34] Camaschella C. Roetto A. Cali A. De Gobbi M. Garozzo G. Carella M. Majorano N. Totaro A. Gasparini P. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 2000;25:14–15. doi: 10.1038/75534. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Individuals with PD typically have bradykinesias, dyskinesias, resting tremors, loss of reflexes, and inability to initiate movement, which are ameliorated by the administration of the dopamine precursor, levodopa (79).”
What the sources say
- Not checked yetcites [79] Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann N Y Acad Sci. 2003;991:1–14. doi: 10.1111/j.1749-6632.2003.tb07458.x. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Monkeys exhibited age-related declines in motor function and dopamine release in the striatum, whereas iron concentration in the striatum increased.”
What the sources say
- Not checked yetcites [42] Cass WA. Grondin R. Andersen AH. Zhang Z. Hardy PA. Hussey-Andersen LK. Rayens WS. Gerhardt GA. Gash DM. Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys. Neurobiol Aging. 2007;28:258–271. doi: 10.1016/j.neurobiolaging.2005.12.010. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In a study of a mouse model of type 3 HH, a premature stop codon (Y245X) was introduced in TfR2 to create an orthologous mutation to the Y250X observed in some individuals with type 3 HH (89). The resulting mutant mice showed aberrant iron homeostasis, including early hepatocellular iron overload coupled with decreased splenic iron and elevated transferrin saturation (89).”
What the sources say
- Not checked yetcites [89] Fleming RE. Ahmann JR. Migas MC. Waheed A. Koeffler HP. Kawabata H. Britton RS. Bacon BR. Sly WS. Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis. Proc Natl Acad Sci U S A. 2002;99:10653–10658. doi: 10.1073/pnas.162360699. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, TfR2 is important in iron homeostasis, and its absence leads to clinically significant disruption of iron homeostasis.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Studies have shown that TfR2 does not associate with HFE, suggesting an alternative role for TfR2 mutation in HH (320).”
What the sources say
- Not checked yetcites [320] West AP Jr. Bennett MJ. Sellers VM. Andrews NC. Enns CA. Bjorkman PJ. Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE. J Biol Chem. 2000;275:38135–38138. doi: 10.1074/jbc.C000664200. [DOI] [PubMed] [Google Scholar]
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Interestingly, iron accumulation in the liver in type 1 HH results in the downregulation of TfR1, but in the case of TfR2, it is continually expressed even during HH-mediated iron loading (90).”
What the sources say
- Not checked yetcites [90] Fleming RE. Migas MC. Holden CC. Waheed A. Britton RS. Tomatsu S. Bacon BR. Sly WS. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci U S A. 2000;97:2214–2219. doi: 10.1073/pnas.040548097. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In addition, TfR2 does not appear to be regulated by iron concentrations, for it lacks IRE in its mRNA and is not inducible by iron deficiency (90).”
What the sources say
- Not checked yetcites [90] Fleming RE. Migas MC. Holden CC. Waheed A. Britton RS. Tomatsu S. Bacon BR. Sly WS. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci U S A. 2000;97:2214–2219. doi: 10.1073/pnas.040548097. [DOI] [PMC free article] [PubMed] [Google Scholar] source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“This form of HH is autosomal dominant in nature, and various missense mutations lead to altered Fpn (92, 205, 218).”
What the sources say
- Not checked yetcites [92] Fleming RE. Sly WS. Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding. J Clin Invest. 2001;108:521–522. doi: 10.1172/JCI13739. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Not checked yetcites [205] Montosi G. Donovan A. Totaro A. Garuti C. Pignatti E. Cassanelli S. Trenor CC. Gasparini P. Andrews NC. Pietrangelo A. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest. 2001;108:619–623. doi: 10.1172/JCI13468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Not checked yetcites [218] Njajou OT. Vaessen N. Joosse M. Berghuis B. van Dongen JW. Breuning MH. Snijders PJ. Rutten WP. Sandkuijl LA. Oostra BA. van Duijn CM. Heutink P. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet. 2001;28:213–214. doi: 10.1038/90038. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The D544E Cp was expressed at lower levels and exhibited decreased ferroxidase activity (135).”
What the sources say
- Not checked yetcites [135] Hochstrasser H. Tomiuk J. Walter U. Behnke S. Spiegel J. Kruger R. Becker G. Riess O. Berg D. Functional relevance of ceruloplasmin mutations in Parkinson's disease. FASEB J. 2005;19:1851–1853. doi: 10.1096/fj.04-3486fje. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Prolonged elevation of ferritin levels in dopaminergic neurons of the midbrain resulted in a progressive age-related neurodegeneration of these cells, suggesting that increased ferritin may not necessarily be cytoprotective and may play a role in neurodegeneration (158).”
What the sources say
- Not checked yetcites [158] Kaur D. Rajagopalan S. Chinta S. Kumar J. Di Monte D. Cherny RA. Andersen JK. Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration. Brain Res. 2007;1140:188–194. doi: 10.1016/j.brainres.2006.03.006. [DOI] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Aberrant release of ferritin iron may lead to the production of ROS and may thereby serve as a mechanism by which altered iron management may lead to cellular damage.”
What the sources say
- Not checked yetcites [64] De Domenico I. Vaughn MB. Li L. Bagley D. Musci G. Ward DM. Kaplan J. Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J. 2006;25:5396–5404. doi: 10.1038/sj.emboj.7601409. [DOI] [PMC free article] [PubMed] [Google Scholar]
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“IRP1-knockout mice misregulate iron in specific tissues, namely in brown fat and kidney, whereas IRP2-knockout mice exhibit aberrant management of iron in multiple tissues.”
What the sources say
- Not checked yetcites [200] Meyron-Holtz EG. Ghosh MC. Iwai K. LaVaute T. Brazzolotto X. Berger UV. Land W. Ollivierre-Wilson H. Grinberg A. Love P. Rouault TA. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J. 2004;23:386–395. doi: 10.1038/sj.emboj.7600041. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In further investigation, the I63T mutant Cp isoform was expressed at half the normal level and displayed a distinct decrease in ferroxidase activity in vivo.”
What the sources say
- Not checked yetcites [135] Hochstrasser H. Tomiuk J. Walter U. Behnke S. Spiegel J. Kruger R. Becker G. Riess O. Berg D. Functional relevance of ceruloplasmin mutations in Parkinson's disease. FASEB J. 2005;19:1851–1853. doi: 10.1096/fj.04-3486fje. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In AD, IRP2 was localized in regions with redox active iron and was associated with such pathologic features as neurofibrillary tangles and senile plaques (280).”
What the sources say
- Not checked yetcites [280] Smith MA. Wehr K. Harris PL. Siedlak SL. Connor JR. Perry G. Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Res. 1998;788:232–236. doi: 10.1016/s0006-8993(98)00002-x. [DOI] [PubMed] [Google Scholar]
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“A study of brain tissue from control and AD-afflicted subjects demonstrated that IRP1 expression was similar in both groups, whereas IRP2 expression was altered in AD.”
What the sources say
- Not checked yetcites [280] Smith MA. Wehr K. Harris PL. Siedlak SL. Connor JR. Perry G. Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Res. 1998;788:232–236. doi: 10.1016/s0006-8993(98)00002-x. [DOI] [PubMed] [Google Scholar]
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Decreased expression of Cp and deficient ferroxidase activity may result in “free iron” accumulation and decreased antioxidant potential.”
What the sources say
- Not checked yetcites [135] Hochstrasser H. Tomiuk J. Walter U. Behnke S. Spiegel J. Kruger R. Becker G. Riess O. Berg D. Functional relevance of ceruloplasmin mutations in Parkinson's disease. FASEB J. 2005;19:1851–1853. doi: 10.1096/fj.04-3486fje. [DOI] [PubMed] [Google Scholar] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Interestingly, Fpn expression was recently shown to result in cytoplasmic iron exportation, iron release from ferritin, and subsequent ubiquitination of ferritin, targeting it for degradation by the proteasome (64).”
What the sources say
- Not checked yetcites [64] De Domenico I. Vaughn MB. Li L. Bagley D. Musci G. Ward DM. Kaplan J. Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J. 2006;25:5396–5404. doi: 10.1038/sj.emboj.7601409. [DOI] [PMC free article] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“IRP2 was also sensitive to iron levels, whereas IRP1 was not, suggesting that IRP2 is the predominant posttranscriptional regulator of key genes involved iron homeostasis (200).”
What the sources say
- Not checked yetcites [200] Meyron-Holtz EG. Ghosh MC. Iwai K. LaVaute T. Brazzolotto X. Berger UV. Land W. Ollivierre-Wilson H. Grinberg A. Love P. Rouault TA. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J. 2004;23:386–395. doi: 10.1038/sj.emboj.7600041. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In this study, five unique missense variations were identified including, a single incidence of I63T, D554E, which correlated with PD and positive ultrasound for increased substantia nigra iron levels, and R793H, which was linked to increased levels of iron levels in individuals with PD and their age/ethnic-matched individuals.”
What the sources say
- Not checked yetcites [134] Hochstrasser H. Bauer P. Walter U. Behnke S. Spiegel J. Csoti I. Zeiler B. Bornemann A. Pahnke J. Becker G. Riess O. Berg D. Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology. 2004;63:1912–1917. doi: 10.1212/01.wnl.0000144276.29988.c3. [DOI] [PubMed] [Google Scholar] source
plaincorrelationaln = 176- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
In the paper
“Through an IRP1-dependent mechanism, MPTP administration caused upregulation of TfR, which preceded increased iron and oxidative stress (276).”
What the sources say
- Not checked yetcites [276] Shang T. Kotamraju S. Kalivendi SV. Hillard CJ. Kalyanaraman B. 1-Methyl-4-phenylpyridinium-induced apoptosis in cerebellar granule neurons is mediated by transferrin receptor iron-dependent depletion of tetrahydrobiopterin and neuronal nitric-oxide synthase-derived superoxide. J Biol Chem. 2004;279:19099–19112. doi: 10.1074/jbc.M400101200. [DOI] [PubMed] [Google Scholar]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Dysregulation of iron metabolism causes numerous health problems including inflammatory, metabolic, hematologic, and neurodegenerative diseases.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
In the paper
“This IRE was functional, as demonstrated by specific binding to IRP that was destroyed by functional mutation, and decreased translation in response to intracellular iron chelation (260).”
What the sources say
- Not checked yetcites [260] Rogers JT. Randall JD. Cahill CM. Eder PS. Huang X. Gunshin H. Leiter L. McPhee J. Sarang SS. Utsuki T. Greig NH. Lahiri DK. Tanzi RE. Bush AI. Giordano T. Gullans SR. An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript. J Biol Chem. 2002;277:45518–45528. doi: 10.1074/jbc.M207435200. [DOI] [PubMed] [Google Scholar] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The absence of serum Cp results in low serum iron concentrations, anemia, and increased serum ferritin levels, whereas tissues, especially the retina and the basal ganglia, exhibit iron overload.”
What the sources say
- Not checked yetcites [326] Xu X. Pin S. Gathinji M. Fuchs R. Harris ZL. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Ann N Y Acad Sci. 2004;1012:299–305. doi: 10.1196/annals.1306.024. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The total absence of Cp results in an autosomal-recessive disorder, aceruloplasminemia, in which afflicted individuals have adult-onset neurodegeneration (124).”
What the sources say
- Not checked yetcites [124] Harris ZL. Takahashi Y. Miyajima H. Serizawa M. MacGillivray RT. Gitlin JD. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A. 1995;92:2539–2543. doi: 10.1073/pnas.92.7.2539. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Studies with recombinant mutant ferritin L showed that, although it was able to assemble into 24-subunit ferritin shells, the efficiency of assembly and capacity to incorporate iron were both decreased in vitro (61).”
What the sources say
- Not checked yetcites [61] Cozzi A. Santambrogio P. Corsi B. Campanella A. Arosio P. Levi S. Characterization of the l-ferritin variant 460InsA responsible of a hereditary ferritinopathy disorder. Neurobiol Dis. 2006;23:644–652. doi: 10.1016/j.nbd.2006.05.004. [DOI] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In the CNS, Cp is found in its GPI-anchored form on cellular membranes where it is associated with Fpn (65).”
What the sources say
- Not checked yetcites [65] De Domenico I. Ward DM. di Patti MC. Jeong SY. David S. Musci G. Kaplan J. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 2007;26:2823–2831. doi: 10.1038/sj.emboj.7601735. [DOI] [PMC free article] [PubMed] [Google Scholar]
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Linkage studies identified a one-nucleotide insertion of adenine at position 460–461, which alters the last 20 amino acids of the C-terminal of ferritin L associated with the development of a dominant adult-onset basal ganglia disease with symptoms similar to those of Huntington disease (HD) or parkinsonism (50).”
What the sources say
- Not checked yetcites [50] Chinnery PF. Crompton DE. Birchall D. Jackson MJ. Coulthard A. Lombes A. Quinn N. Wills A. Fletcher N. Mottershead JP. Cooper P. Kellett M. Bates D. Burn J. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain. 2007;130:110–119. doi: 10.1093/brain/awl319. [DOI] [PubMed] [Google Scholar] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Cp-knockout mice exhibit severe defects in iron egress from astrocytes, probably resulting from the lack of ferroxidase activity, which is necessary for the exporter function and stability of Fpn.”
What the sources say
- Not checked yetcites [148] Jeong SY. David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem. 2003;278:27144–27148. doi: 10.1074/jbc.M301988200. [DOI] [PubMed] [Google Scholar]
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Taken together, these results suggest a role for Cp in the regulation of cellular iron efflux and resistance to oxidative stress, and implicate Cp in the pathogenesis of neurodegeneration involving increased iron and oxidative damage, such as PD and AD.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Cp is similar to ferritin H in having ferroxidase activity and may serve an antioxidant role in addition to its role in iron regulation.
In the paper
“Mutations identified in aceruloplasminemia are nonsense mutations that result in the early termination of translation, causing serum Cp deficiency.”
What the sources say
- Not checked yetcites [124] Harris ZL. Takahashi Y. Miyajima H. Serizawa M. MacGillivray RT. Gitlin JD. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A. 1995;92:2539–2543. doi: 10.1073/pnas.92.7.2539. [DOI] [PMC free article] [PubMed] [Google Scholar] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, the absence of ferroxidase may lead to higher levels of Fe2+, which has an increased propensity to react and form ROS.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
Each day approximately 25 mg of iron is needed for erythropoiesis and other vital functions, while only 1 to 2 mg comes from intestinal iron sources.
“Each day ∼ 25 mg of iron is needed for erythropoiesis and other vital functions. Only 1 to 2 mg of iron comes from intestinal iron sources”
The paper relies on this without support.
Most cytoplasmic iron is in its reduced (ferrous) form.
“Most cytoplasmic iron is in its reduced form, meaning that it is an excellent substrate for oxidation.”
The paper relies on this without support.
Tf and TfR are absent from enterocytes.
“Because Tf and TfR are absent from enterocytes, Tf binds iron and plays an essential role in the transport of iron only once it is exported from duodenal enterocytes into the bloodstream.”
The paper relies on this without support.
Nonheme iron is predominantly insoluble Fe3+ and must be reduced before transport by DMT1.
“It is important to note that nonheme iron is predominantly insoluble Fe3+. It must be reduced before transport by DMT1.”
The paper relies on this without support.
Fpn is the only known iron exporter to date.
“The transmembrane protein ferroportin (Fpn) is the only known iron exporter to date”
The paper relies on this without support.
Iron must be oxidized to be incorporated into transferrin.
“Because Fpn transports Fe2+ into the plasma, and iron must be oxidized to be incorporated into transferrin (Tf), it is believed that Fpn cooperates with proteins that act as ferroxidases.”
The paper relies on this without support.
Ferritin is the major iron-storage protein at the cellular and organismal level.
“Ferritin is the major iron-storage protein at the cellular and organismal level.”
The paper relies on this without support.
Ferritin is responsible for the sequestration of potentially harmful, reactive iron.
“It is responsible for the sequestration of potentially harmful, reactive iron.”
The paper relies on this without support.
Ferritin stores iron in its unreactive Fe3+ form inside its shell as a result of a strong equilibrium between ferritin-bound iron (Fe3+) and the labile iron pool in the cells (Fe2+), preventing ROS formation via the Fenton reaction.
“Ferritin stores iron in its unreactive Fe3+ form inside its shell as a result of a strong equilibrium between ferritin-bound iron (Fe3+) and the labile iron pool in the cells (Fe2+), by which ferritin prevents the formation of ROS mediated by Fenton reaction.”
The paper relies on this without support.
Ferritin is ubiquitous in tissues, serum, and other multiple locations within the cell.
“Because of its important function in the storage of iron, ferritin is ubiquitous in tissues, serum, and in other multiple locations within the cell.”
The paper relies on this without support.
Ferritin is regulated at the transcriptional and posttranscriptional level by various pathways in response to diverse stimuli.
“It is regulated at the transcriptional and posttranscriptional level by various pathways in response to diverse stimuli.”
The paper relies on this without support.
In vertebrates, cytoplasmic ferritin is expressed in almost all tissues.
“In vertebrates, cytoplasmic ferritin is expressed in almost all tissues.”
The paper relies on this without support.
Proteasomal degradation commonly requires the attachment of polyubiquitin to a target protein that is misfolded.
“Proteasomal degradation commonly requires the attachment of polyubiquitin to a target protein that is misfolded, in most cases.”
The paper relies on this without support.
Polyubiquitination of ferritin protein has not been reported.
“However, polyubiquitination of ferritin protein has not been reported.”
The paper relies on this without support.
Both IRP1 and IRP2 are expressed ubiquitously in most tissues.
“Both IRP1 and IRP2 are expressed ubiquitously in most tissues.”
The paper relies on this without support.
Corneal epithelial cells are constantly exposed to UV that may cause DNA damage.
“Corneal epithelial cells are constantly exposed to UV that may cause DNA damage.”
The paper relies on this without support.
Ferritin does not possess a nuclear localization signal.
“ferritin does not possess a nuclear localization signal”
The paper relies on this without support.
Increased iron content in afflicted regions in PD and evidence of oxidative stress are present.
“The iron-storage protein, ferritin, has been studied in PD because of the increased iron content in the afflicted regions in PD and the increase in evidence of oxidative stress.”
The paper relies on this without support.
Aggregation of α-synuclein is a hallmark of PD.
“Another hallmark of PD is the aggregation of the protein α-synuclein.”
The paper relies on this without support.
An antibody for TfR that blocks iron uptake abrogates up-regulation of α-synuclein after MPP+ treatment.
“An antibody for the TfR, which blocked iron uptake, abrogated up-regulation of α-synuclein after MPP+ treatment.”
The paper relies on this without support.
Cp is similar to ferritin H in having ferroxidase activity and may serve an antioxidant role in addition to its role in iron regulation.
“Cp is similar to ferritin H in that it also has ferroxidase activity and thereby may serve an antioxidant role in addition to its role in iron regulation.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Under such circumstances, iron levels may exceed the binding capacity of Tf, giving rise to non-transferrin bound iron (NTB1).NTB1 is taken up by liver and has been shown to contribute to iron loading and hemochromatosis (Mackenzie et al., 2008).”
From Iron, Oxidative Stress and Health (2012) · cites this paper as Mackenzie et al., 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Conversely, when iron concentration is high, IRPs are inactivated resulting in degradation of TfR1 mRNA while translation of ferritin mRNA occurs.Thus when iron levels exceed the cellular needs, the IRE/IRP switch minimizes iron uptake and promotes iron storage”
From Iron, Oxidative Stress and Health (2012) · cites this paper as Mackenzie, Iwasaki and Tsuji, 2008
The cited source says what the claim attributes to it.
In the citing paper
“When iron is depleted, IRE-IRP interaction at the 3 ' UTR of TfR1 stabilizes mRNA, while imposing a steric blockade to ferritin mRNA translation.As a result, TfR1 is upregulated and stimulates acquisition of iron from plasma Tf to counteract low iron levels.Simultaneously ferritin synthesis is inhibited as storage of iron is not needed.”
From Iron, Oxidative Stress and Health (2012) · cites this paper as Mackenzie, Iwasaki and Tsuji, 2008
The cited source says what the claim attributes to it.
In the citing paper
“LIP is biologically active in intracellular metabolism but toxic if present in excess.Maintenance of appropriate LIP levels is critical for homeostasis (Mackenzie, Iwasaki and Tsuji, 2008).”
From Iron, Oxidative Stress and Health (2012) · cites this paper as Mackenzie, Iwasaki and Tsuji, 2008
The cited source says what the claim attributes to it.
In the citing paper
“Aberrant release of ferritin iron may lead to production of ROS (Mackenzie et al., 2008).”
From Iron, Oxidative Stress and Health (2012) · cites this paper as Mackenzie et al., 2008
In the citing paper
“In mammalian cells, ferritins assemble to form large (480 kDa) complexes with cavities capable of accommodating up to 4500 atoms of iron and function to modulate iron bioavailability and detoxification within cells [47].”
From Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis (2018) · cites this paper as [47]
In the citing paper
“Most cells subsequently down-regulate iron uptake mechanisms, particularly TfR1 and up-regulate iron efflux via ferroportin in order to regain homeostatic levels (Fig. 4E(i)) [47].”
From Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis (2018) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ VI. Functional Iron Overload and Human Health
“Cp −/− Hepatocyte iron overloading Acerulo-plasminemia 123 Macrophage iron overloading Accelerated iron export”
§ I. Regulation of divalent metal transporter 1
“They also have high levels of iron in cells of the reticuloendothelial system as well as in hepatocytes, as a result of impaired iron efflux (123).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ C. Iron regulation and neurodegeneration
“a single incidence of I63T, D554E, which correlated with PD and positive ultrasound for increased substantia nigra iron levels”
§ C. Iron regulation and neurodegeneration
“The D544E Cp was expressed at lower levels and exhibited decreased ferroxidase activity (135).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ II. Iron Transport
“Because Tf and TfR are absent from enterocytes, Tf binds iron and plays an essential role in the transport of iron only once it is exported from duodenal enterocytes into the bloodstream.”
§ II. Iron Transport
“TfR2 is primarily expressed in hepatocytes and in the iron-absorbing cells of the intestine and duodenum (35).”
Citations
Cites
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
Bootman, M. D., Missiaen, L., Parys, J. B., SMEDT, H. D., & Casteels, R. (1995) · Biochemical Journal · doi:10.1042/bj3060445 · Cited by 5,131
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Cloning and characterization of a mammalian proton-coupled metal-ion transporter
Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., Nussberger, S., Gollan, J. L., & Hediger, M. A. (1997) · Nature · doi:10.1038/41343 · Cited by 3,166
Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossée, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996) · Science · doi:10.1126/science.271.5254.1423 · Cited by 2,786
The ferritins: molecular properties, iron storage function and cellular regulation
Harrison, P. M., & Arosio, P. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(96)00022-9 · Cited by 2,667
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 9×
“On binding of wild-type hepcidin, Fpn is phosphorylated and subsequently endocytosed, ubiquitinated, and degraded by the 28S proteasome ( right ). served an increase in hepcidin mRNA, and were able to abro-gate the induction of hepcidin mRNA by treatment with anti–IL-6 antibodies.”
InfluentialTranscriptional regulation by the phosphorylation-dependent factor CREB
Mayr, B., & Montminy, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085068 · Cited by 2,587
Integrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
Research works printed but not linked: 8
- Arosio P, 1976, Cancer Res, 36, 1735
- 1987, J Lab Clin Med, 110, 690
- Carella M, 1997, Am J Hum Genet, 60, 828
- De Domenico I, 2006, Haematologica, 91, 92
- Gray CP, 2003, Clin Cancer Res, 9, 2551
- Ponka P, 1998, Semin Hematol, 35, 35
- 10.1172/jci200421146 · DOI
- Thimmulappa RK, 2002, Cancer Res, 62, 5196
Cited by
Sorted by citations
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
Ray, P. D., Huang, B.-W., & Tsuji, Y. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.01.008 · Cited by 4,373
Self-citationRegulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease
Bogdan, A. R., Miyazawa, M., Hashimoto, K., & Tsuji, Y. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.11.012 · Cited by 907
Self-citationYin, R., Mao, S.-Q., Zhao, B., Chong, Z., Yang, Y., Zhao, C., Zhang, D., Huang, H., Gao, J., Li, Z., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4028346 · Cited by 609
Binding and uptake of H-ferritin are mediated by human transferrin receptor-1
Li, L., Fang, C. J., Ryan, J. C., Niemi, E. C., Lebrón, J. A., Björkman, P. J., Arase, H., Torti, F. M., Torti, S. V., Nakamura, M. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913192107 · Cited by 558
Anticancer Activity of Metal Complexes: Involvement of Redox Processes
Jungwirth, U., Kowol, C. R., Keppler, B. K., Hartinger, C. G., Berger, W., & Heffeter, P. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3663 · Cited by 568
Metadata
- Authors
- Mackenzie, E. L., Iwasaki, K., & Tsuji, Y.
- Affiliations
- North Carolina State University (US)
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2008-06
- Volume
- 10
- Issue
- 6
- Pages
- 997-1030
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- PMC
- PMC2932529
- OpenAlex
- W2063804160
- Semantic Scholar
- 30be5cc97caac713f62ffa4010e5df065bdd4cfb
- Cited by
- 526
- References
- 351
- Citations by year
- 2026: 16 · 2025: 47 · 2024: 43 · 2023: 44 · 2022: 41 · 2021: 38 · 2020: 36 · 2019: 28 · 2018: 23 · 2017: 23 · 2016: 21 · 2015: 17 · 2014: 29 · 2013: 16 · 2012: 27
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antioxidants and Redox Signaling (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK60007, R01DK060007)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- iron homeostasis, labile iron, iron transport, iron storage, ferroportin, hepcidin, ferritin, frataxin, oxidative stress, iron overload, hemochromatosis, neurodegeneration, inflammation, free radicals
- MeSH terms
- Frataxin, Animals, Biological Transport, Humans, Iron, Transferrin, Oxidative Stress, Iron Overload, Iron-Binding Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review